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Summary 
 
 Studying the mechanism of action (MoA) of biocides against pathogenic 
microorganisms is crucial to understand their efficacy and limitations, and to develop 
more efficient microbicidal formulations. Combining alcohol and zinc has been reported 
to enhance microbicidal activity, but the reasons for such activity are unknown. This 
study focuses on the impact of combining ethanol and zinc salt at pH 10.5 against non-
enveloped viruses.  
 The study is focused on three different aspects: i) virucidal activity screening of 
ethanol:zinc combinations against bacteriophages and human viruses; ii) impact of 
ethanol:zinc combinations on virus structure, particularly  the viral capsid and nucleic 
acid,  using Transmission Electron Microscopy (TEM); Atomic Force Microscopy 
(AFM) and agarose gel DNA electrophoresis and iii) chemical speciation and stability 
of ethanol:zinc combinations over time. 
 The combination of ethanol with zinc salt was found to be more effective against 
viruses than control formulations containing sole active ingredients and/or excipients 
only. Activity test of 40%(w/v) ethanol with 0.1% (w/v) zinc salt with excipients (RB-
002 formulation) against F116 and adenovirus type 2 (AdV2) at 60 min contact time 
yielded 0.68 ± 0.02 and 5.26 ± 0.10 log10 reduction, respectively. In comparison, 0.1% 
(w/v) zinc salt only with excipient (RB-002G formulation) showed no virucidal activity 
against bacteriophage F116 (0.14 ± 0.02 log10 reduction) and AdV2 (0.80 ± 0.12 log10 
reduction) in suspension. Differences between activities against bacteriophage MS2 and 
poliovirus type 1 were similar as the ones found between F116 and AdV2. Formulation 
containing 40%(w/v) ethanol with 0.1% (w/v) zinc salt produced a range of structural 
damage to F116 and attP AdV5 indicating possible capsid alteration. Effect of the 
combined formulation on viral capsid was confirmed with AFM with a possible 
decreased in virus capsid stiffness and significant virus capsid height reduction over 10 
min contact time. F116 DNA damage was detected upon exposure to 40%(w/v) ethanol 
with 0.1% (w/v) zinc salt with excipients, but no damage was detected on AdV2 DNA 
through electrophoresis analysis. 
 The alcohol/zinc formulation system at pH 10.5 was shown to have promising 
virucidal activity against non-enveloped viruses at room temperature following an 
alteration of the viral capsid, and possible damage to the viral nucleic acid. This study 
also showed the limitations of using bacteriophage as surrogate for mammalian viruses.  
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1.Introduction 
1.1 Biocide overview 
 1.1.1 Historical background and current state of biocidal products 
 
The application of biocides as disinfectants, sterilants and preservatives go back 
to ancient times. Back then, the use of biocides was mainly based on empiric practices 
and a developed understanding on how it worked was non-existent. For instance, sulfur 
burned to sulfur oxide was used as a disinfectant for house fumigation approximately 
800 BC (Price, 2001). Other illustrative examples include use of metal-based vessels 
(mainly copper and silver) as well as salts and spices to preserve fish and meat (Block, 
2001; Patel, 2015). Louis Pasteur’s achievements towards the creation of microbiology 
scientific field and Robert Koch’s associations of diseases to microorganisms triggered 
a rapid development in the understanding of microbial diseases, preservation of food 
and disinfection practices (Block, 2001; Blevins and Bronze, 2010). At the end of 
nineteenth century, the use of iodine for wound disinfection, chlorine water in obstetrics 
and phenol (carbolic acid) for wound dressing and antiseptic surgery was reported 
(Russell, 2002). In the beginning of the twentieth century great advances in chemistry 
led to the introduction of novel biocides such as novel chlorine-releasing agents and 
quaternary ammonium compounds (QACs). Several agents introduced since 1945 
including biguanides, cationic/anionic/non-ionic surfactants, bisphenols, aldehydes, 
iodine-releasing agents and peracetic acid are still in use nowadays (Ortega Morente et 
al., 2013). In recent years, a deeper understanding of disinfection practices and hygiene 
concepts as well as emergence of resistance among target organisms have been leading 
to a stronger need for biocide research and development (Cerf et al., 2010; Fraise, 2013; 
Jutkina et al., 2018). More focus has been given to agent chemical properties, 
mechanisms of action and synergy through combination of agents rather than discovery 
of novel active agents. Additionally, high costs associated to the registration of a novel 
active substance under REACH process in the European Union market and toxicology 
and environmental impact research costs are one of the main causes the number of 
available biocides is decreasing nowadays even though the need for biocides in the 
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market is increasing (Bruns et al., 2005; Ferrario and Rabbit, 2012; Gustavsson et al., 
2017).  
 
1.1.2 Biocide definition and market data 
 
Biocidal products are chemical products based on inorganic or synthetic organic 
molecules (biocides) used for hampering spread and growth of harmful organisms and 
for preservation of materials from microbiological degradation (Chapman, 2003). In 
contrast to antibiotics, biocides employed to destroy bacteria (e.g. antiseptics and 
disinfectants) usually present a broad spectrum of action and possess several targets 
within the microbial cell (Maillard, 2002). Antibiotics tend to affect a specific microbial 
cell physiologic process, whereas biocides as disinfectants can interact with a wide 
range of cell components (e.g. cell wall, cytoplasmic membrane, DNA, RNA) trough 
physicochemical interactions or chemical reactions (McDonnell and Russel, 1999). 
Generally, biocide activity is highly influenced by many factors like chemical reactions 
of formulation components, presence of organic load, temperature, concentration, 
number of microorganisms, contact time, relative humidity, pH, type of surfaces and 
structure as well as genome content of the target organism (Russell, 2003). 
Due to their broad spectrum of action, biocides are applied in various sectors 
ranging from disinfection of healthcare settings to industrial processes as wells as 
preservation of product quality (e.g. foods, beverage and pharmaceutical formulations). 
Despite the major source of exposure in homes due to use of wipes and cleaning 
products, it is known that biocides are employed as preservatives in many consumer 
products we have contact with on a daily basis (Wieck et al., 2017). Table 1.1 shows a 
list of common areas of application with respective active substances grouped in 
chemical groups: 
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Table 5.1 Main areas of application of biocides with respective most commonly 
applied active substances (adapted from von Barbro et al. 2003; 
SCENIHR, 2009 and Wieck et al., 2017). 
Areas of application Active substances (biocides) 
Healthcare 
Quaternary ammonium compounds (QACs); 
Biguanides; Phenols; Alcohols; Aldehydes 
Household 
QACs; Biguanides; Anionic agents; Isothiazolinones; 
Halogens 
Food industry QACs; Organic acids;  
Pharmaceutical industry 
QACs; Alcohols; Anionic agents; Organic acids; 
Metallic salts 
Cosmetic industry QACs; Aldehydes 
Surface preservation QACs; Phenols;  
Veterinary hygiene Anionic surfactant; Glutaraldehyde 
 
Biocide addition to food and medicines is done mainly to avoid product 
degradation (e.g. malodours, changes of colour and organoleptics) (Paulus, 2004; 
Raczek, 2004; Condell et al., 2012) and spoilage, which could cause health risks to 
consumers, or affecting their perception of the product. Other examples of products in 
which biocides act as preservatives include paints, wood, textiles, coating films, leather 
and fuel (Kaehkoenen and Nordstroem, 2008; SCENHIR, 2009). In terms of 
disinfection, biocides are used for controlling of potential sources of contamination on 
inanimate and living surfaces. For example, in healthcare facilities biocides are used to 
decontaminate skin of patients and professionals and any instrument in contact with 
patients. It is assumed that proper use of biocide is essential for the success of programs 
associated to prevention and control of healthcare-associated infections (HAIs) 
(Maillard, 2005).  
Sterilization and disinfection processes in industrial settings are also relevant as 
they are important to establish and maintain quality control of product batches (Holah, 
2013). An example of application in industrial settings is that virus contamination of 
bioreactors associated to therapeutic drugs production line must be controlled; 
otherwise product availability and safety for consumer can be compromised (Hollark et 
al., 2010). 
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In terms of market value and potential, an industrial biocide market study carried 
out by Allied Market Research (2017) estimates that biocide total market was around 
US$ 6.5 billion in 2015 and it is forecasted to reach a market value of US$ 9.9 billion in 
2022. The global market increase will be driven mainly by industrial and public water 
treatment, paints, coating and personal care products industries (Allied Market 
Research, 2017).  
 
1.2 Viruses 
 
 1.2.1 Impact of viruses on humans  
 
 Viruses are one of the most common pathogens of humans, whose infections 
tend to cause substantial morbidity and mortality (Nwachuku and Gerba, 2006; Guidry 
et al. 2014). Despite major advances towards development of diagnostics and 
therapeutic methods, aspects associated to globalization like ease of world travel and 
interdependency of countries represent major challenges for infection contention. 
Emerging infectious diseases impose a major threat to human health and global 
instability (Dunn and Miller, 2014). There are three main factors associated to the 
emergence and re-emergence of infectious diseases: i) viral; ii) human and iii) 
ecological factors (Ka-Wai Hui, 2006). The first one is associated to natural genome 
recombination of viruses (Tumpey and Belser, 2009), while the latter ones are related to 
human population increase, social behaviour and climatic changes (Morens and Fauci, 
2013). Furthermore, unhygienic conditions and unawareness of people regarding 
prevention methods and lack of proper healthcare infrastructure in some regions of the 
globe can contribute to pandemics emergence (Maillard et al., 2013; Zambon, 2014). 
Examples of such emerging diseases are the HIV/AIDS, pandemic (H1N1) Influenza A 
and most recently the Ebola virus disease in West Africa (Fauci and Morens, 2012; 
WHO, 2014), as well as Zika and Yellow Fever virus outbreaks in South America 
(Makhluf and Shresta, 2018). It is accounted that approximately 75% of emerging 
diseases are caused by RNA viruses, most of which are transmitted through mucosal 
and respiratory route (Zambon, 2014). Viral pandemics could have strong negative 
impacts on economy at global level and interfere strongly with normal life activities 
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leading to public fear and other negative outcomes like social unrest and high mortality 
(Morens and Fauci, 2013; Dunn and Miller, 2014). 
 
 1.2.2 Nosocomial infection and disinfection practices 
 
 Viruses can also be associated to nosocomial infections, which are acquired 48 
hours after admission to hospital settings (Breathnach, 2013). Nosocomial infections 
can be endogenous, resulting from infectious agent within patient’s body, or exogenous, 
transmitted from source within hospital (Aitken and Jeffries, 2001). This type of 
infection is still responsible for considerable illness, mortality and financial burden to 
hospitals, patients and society (Breathnach, 2013). To illustrate this, it is estimated that 
5 to 10% of in-patients in British and Irish hospitals have a nosocomial infection, where 
higher prevalence is found in intensive care units and surgical wards. Infections 
acquired through invasive surgery present a mortality index as high as 20% (Huttunen et 
al., 2013). Financial costs in the UK in terms of increased hospital stay was estimated at 
£1000 million per year (Plowman et al., 2001). For instance, it was estimated that in the 
United States nosocomial infections increase the hospital care cost of a patient by 
US$10,375 and tends to increase length of stay by 3.30 days (Hassan et al., 2010).  A 
summary of most common viruses related to nosocomial infections including its 
transmission route and control of spread guidelines is found in Table 1.2.  
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Table 1.6 Viral agents responsible for nosocomial infections including transmission  
route and control of spread in healthcare environment. 
Route Virus Control of spread Reference 
Respiratory 
Respiratory Syncytial 
Virus (RSV) 
Rapid diagnosis; wearing of 
aprons and gloves; hand 
washing; source isolation; 
surface disinfection 
Hall (1981); 
Aitken and 
Jeffries (2001) 
Influenza Viruses A 
and B 
Similar procedures to control 
RSV; wearing of masks; 
source isolation in negative 
pressure room 
Tablan et al. 
(1994) 
Parainfluenza viruses 
1 to 3 Similar procedures to control 
RSV 
Aitken and 
Jeffries (2001); 
Brady et al. 
(1990) 
Rhinovirus 
Adenovirus 
Emphasis on equipment and 
surface disinfection 
Aitkens and 
Jeffries (2001) 
Fecal-oral 
Rotavirus Patient isolation, rigorous 
hand washing with hand rubs Enteroviruses 
Blood 
Hepatitis B 
Routine immunization of 
healthcare staff 
Human 
Immunodeficiency 
Virus Type 1 
Infected health care workers 
excluded from exposure-
prone procedures 
Good hygiene practices 
Antiretroviral drug for post-
exposure prophylaxis 
 
Disinfection and good hygiene practices are essential to prevent and control 
infection spread because of the high infectivity associated to pathogenic viruses and the 
lack of effective vaccination against many viral infections. Disinfection practice is 
associated with reduction and inactivation of contaminating microorganisms. On the 
other hand, sterilisation involves the complete deactivation of viable organisms and 
pathogens from a surface or product. Disinfection can be carried out through thermal 
kill, physical removal or use of chemicals (biocides) (McDonnell and Burke, 2011). 
Biocides active against viruses are denominated virucides and their application is 
regarded in the literature as an effective measure to interrupt transmission of pathogenic 
viruses in fluid or dried on surfaces (Sakudo et al., 2010). Virucides have to be effective 
against a broad range of virus and their activity must be evaluated through standardised 
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efficacy testing. Since virucidal activity is influenced by many parameters (e.g. pH, 
temperature, surface properties, etc.), standardised efficacy test procedures are complex. 
Hence, national recommendations for virucidal activity test are usually followed 
(Steinmann, 2001). Comparison of activities against other microorganisms like bacteria 
might not be valid as some viruses can be more resistant. In order to help healthcare 
workers to decide whether equipment sterilization is necessary and which disinfection 
procedure to be carried out, the Spaulding classification system was developed and has 
been used since 1957 (Spaulding, 1957). It defines minimum levels of disinfection in 
terms of infection risks associated to medical devices as shown in Figure 1.1. 
 
Figure 3.1 The Spaulding classification system for surgical and medical devices 
(Spaulding, 1957; McDonnell and Burke, 2011). 
 
 
 
 
 
 
 
  
 
 
 According to the Spaulding system, enveloped viruses are efficiently eliminated 
by low to high disinfection and sterilisation practices, whereas non-enveloped viruses 
are only affected by high level disinfection and sterilisation practices. Figure 1.2 shows 
the revisited Spaulding classification, which includes decreasing level of resistance 
associated to different pathogens.  
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Figure 1.4: Revisited Spaulding classification system commonly used nowadays in 
healthcare settings including pathogens with distinct levels of resistance 
(adapted from McDonnell and Burke, 2011). 
 
Furthermore, biocides must be safe for the users and be in compliance with 
environmental directives (European Commission, 2013). Despite being important for 
virus infection control, activity and mechanism of actions of biocides against viruses are 
not so well studied when compared to bacteria. The susceptibility of viruses to different 
biocides as well as potential damages is summarized in Table 1.3. 
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Table 1.7: List of common active substances and effect on different viruses reported in 
the literature. 
Active substances 
(biocides) 
Damage on viruses Affected viruses References 
Aldehydes (e.g. 
Glutaraldehyde)  
Alteration of viral 
envelope; capsid 
markers and 
genome 
Enveloped and large-
enveloped viruses; 
small non-enveloped 
viruses (e.g. Human 
Rotaviruses; F116; 
poliovirus) 
Springhorpe 
et al. (1986); 
Maillard et al. 
(1995) 
Alcohols (e.g. ethanol 
and isopropanol) 
Alteration of viral 
envelope; capsid 
and markers 
Highly active against 
enveloped viruses (eg. 
Hepatitis B Virus); 
limited effect on non-
enveloped viruses (e.g. 
Norovirus; F116; MS2) 
Steinmann et 
al. (2013); 
Maillard et al. 
(1995) 
Metallic salts (e.g.: 
Copper salts; Zinc 
salts and Silver salts) 
Alteration of viral 
capsid and genome  
Enveloped and non-
enveloped viruses 
(e.g.HIV-1; R17 
bacteriophage; 
poliovirus) 
Sagripanti and 
Lightfoote 
(1996); 
Thurman et 
al. (1989) 
Quaternary 
ammonium 
compounds (e.g. 
cetylpyridinium 
chloride; cetrimide) 
Alteration of viral 
envelope and capsid 
Highly active against 
enveloped viruses (e.g. 
coronavirus); limited 
efficacy on non-
enveloped viruses (e.g. 
F116) 
Rabenau et al. 
(2005); 
Maillard et al. 
(1995) 
Phenols (e.g. essential 
oils) 
Alteration of viral 
envelope and capsid 
Highly active against 
enveloped viruses (e.g. 
Avian Influenza Virus); 
limited efficacy on non-
enveloped virus (e.g. 
F116)  
Wanaratana et 
al. (2010); 
Maillard et al. 
(1995) 
 
1.2.3 Basic Viral Structure 
 
In order to gather deeper knowledge interaction of biocides with viruses, it is 
important to define viral particles, structure and possible targets. In general terms, a 
virus is an obligate intracellular parasite that does not have any metabolic activity and 
cannot produce energy by itself (Knipe et al., 2006). By infecting a suitable host, the 
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viral genome is replicated with the help of host cellular machinery resulting in 
production of infectious progeny virions. Viral particles are relatively small (20-300 
nm) compared to other organisms and by definition they contain RNA or DNA genome 
protected by a symmetric virus-coded protein coat (capsid). The coat proteins present 
helical or icosahedral symmetry, which form an open or closed structure, respectively 
(Sakudo et al., 2010). The nucleic acid-associated and capsid proteins along with the 
genome form the nucleocapsid, which is surrounded by a lipid bilayer for enveloped 
viruses (Gelderblom, 1996). The main function of the capsid is to protect the nucleic 
acid. The 2-dimensional basic structure of an enveloped virus (infectious unit) is 
depicted in Figure 1.3. 
 
Figure 1.3: Basic mammalian enveloped virion structure (adapted from Sakudo et al. 
2010).  
 
 
 
 
 
 
 
 
Viruses are able to infect a wide range of organisms including bacteria, fungi, 
protozoa, animal and plant cells (Sakudo et al., 2010). Some viruses have hosts in more 
than one Kingdom (cross-Kingdom virus) and/or Phyla (cross-Phylum virus). For 
instance, reoviruses and bunyaviruses, possess animal and plant cells as hosts. The 
classification system based on the replication-expression strategies and the type of 
nucleic acid encapsulated was developed by Baltimore (1971) and revisited by Kooning 
(1991). It is shown in Table 1.4 as follows: 
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Table 1.8: Different classes of viruses according to their replication strategy 
(Baltimore, 1971; Kooning, 1991). 
Class Nucleic acid Examples 
I Double-stranded DNA (dsDNA) Adenoviruses, Poxviruses 
II Single-stranded DNA (ssDNA) Parvoviruses 
III Double-stranded RNA (dsRNA) Reoviruses 
IV Single-stranded positive sense RNA (+ssRNA) Picornaviruses 
V Single-stranded negative sense RNA (-ssRNA) Rhabdoviruses 
VI Reverse single-stranded positive sense RNA (+r ssRNA) Retroviruses 
VII Reverse double-stranded DNA (r dsDNA) Hepadnaviruses 
 
 The vast majority of viruses infecting prokaryotes like bacteria and archaea have 
dsDNA, +ssRNA and dsRNA, whereas eukaryotes host mostly RNA viruses and 
retroviruses. It was observed that diversity of RNA viruses as well as retroviruses 
infecting eukaryotes surpass the abundance of DNA viruses (Kooning, 2015). 
Throughout the present literature review, focus will be given to viruses responsible for 
infecting exclusively bacteria (bacteriophages) and mammalian cells (mammalian 
viruses) only.  
 
1.2.3.1 Bacteriophages 
 
Bacteriophages are bacterial viruses, which are able to invade bacterial cells. 
They can be divided into two categories according to their infection cycle: lytic and 
lysogenic phages. Lytic phages are capable of lysing bacterial cell upon release. On the 
other hand, lysogenic phages integrate viral nucleic acid within the host 
chromosome/plasmid and persist indefinitely in the host cell. For lytic phages, the 
infection cycle starts with a highly specific attachment to host with subsequent 
transcription, replication and maturation of newly synthesized virions (Kutter et al., 
2005; Pinto et al., 2012). Due to its high infectivity towards bacteria as well as ease of 
propagation, potential bacteriophages applications include alternative medical treatment 
for antibiotic resistant bacteria (Sulakvelidze et al., 2001; Hanlon, 2007; Beeton et al., 
2015); biological control for plant pathogens in agriculture (Susianto et al., 2014); 
control of bacterial population during wastewater treatment (Withey et al., 2005) among 
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others. Moreover, some bacteriophages have been used as surrogates for mammalian 
viruses to validate virucidal efficacy testing (Jones et al., 1991; Shirasaki et al. 2009; 
Do-Kyun et al., 2017). Advantages of using bacteriophages as surrogates include ease 
of cultivation to high concentrations, easy detection by rapid and inexpensive assays 
and structural similarity to some mammalian viruses (Aranha-Creado and Brandwein, 
1999; Hanlon, 2007; Magri et al., 2015).  
 
1.2.3.1.1 MS2 
 
The bacteriophage MS2 is 275 Å virus comprising a (+) single stranded RNA, 
the coat protein and the A protein. The MS2 capsid has an icosahedral shape formed by 
the arrangement of 90 coat protein homo-dimers (Caspar and Klug, 1962). The capsid 
also presents a single copy of the A protein, which is involved in RNA packing, host 
recognition, attachment and RNA transfer into the host (Stockley et al., 1994). MS2 
genome encodes four proteins: coat protein, maturation/assembly protein, a replicase 
and a lyticase (Toropova et al., 2008). MS2 bacteriophage is widely employed as a 
convenient surrogate of non-enveloped human enteroviruses, like poliovirus type 1 and 
human norovirus in virucidal activity testing of chemical disinfectants (Macinga et al., 
2008, Pinto et al., 2010). MS2 is depicted in Figure 1.4 A. 
 
Figure 1.4:  Distinct bacteriophage structures, where (A) represents bacteriophage MS2 
(Toropova et al., 2001) and (B) bacteriophage F116 (adapted from 
Maillard et al., 1995). 
 
 
 
 
 
 
 
 
 
 
 
 
(A) (B) 
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1.2.3.1.2 F116 
 
F116 is a pilus-specific Pseudomonas temperate phage comprising a linear 
genome characterized by 61.7 kb double stranded DNA. It has an icosahedral head with 
70 nm in diameter and a 70-nm-long non-contractile rod-shaped tail (Byrne and 
Kropinski, 2005). F116 has been useful for studying the effects of biocides due to its 
large size, which allows investigation of possible structural damages through electron 
microscopy (Maillard et al., 1993; Maillard et al., 1995). Bacteriophage F116 is shown 
in Figure 1.4 B. 
 
1.2.3.2 Mammalian viruses 
 
Mammalian viruses replicate by infecting eukaryotic cells, whose metabolic 
processes are organized in organelles, and membrane-trafficking is carried out through 
endocytosis as opposed to bacterial cells. Several differences can be found in terms of 
virus-host interaction and infectious cycle. For example, it has been reported that many 
RNA and some DNA viruses rely on the endosomal sorting complex required for 
transport (ESCRT) machinery for envelopment, maturation and egress from cells 
(Tandon et al., 2009). The host infection can present either cytopathic or non-cytopathic 
effects, where the first is associated to cell death and release of newly formed virions 
and the latter is associated to a persistent infection with generation of virions without 
cell death. 
Regarding their resistance to chemical disinfectants, human viruses are divided 
into three groups according to the Klein-DeForest Scheme (DeForest, 1983) as follows: 
A) lipophilic viruses (enveloped viruses), B) viruses with intermediate solubility (large 
non-enveloped viruses) whose sensitivity is moderate and C) hydrophilic viruses (small 
non-enveloped viruses) whose sensitivity to chemical agents is usually low (Sauerbrei et 
al., 2004). According to this classification system, bacteriophages F116 and MS2 would 
belong to group B and C, respectively.  Despite the classification still being valid and 
that non-enveloped viruses are generally more resistant, virus inactivation kinetics can 
still be different even for related viruses. For example, Sharp and Leong (1980) reported 
that poliovirus I (Brunhilde strain) was more resistant to free-chlorine than poliovirus I 
(Mahoney strain).  
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1.2.3.2.1 Adenovirus 
 
Adenoviruses are non-enveloped viruses members of the virus family 
Adenoviridae with icosahedral capsid ranging from 70 to 100 nm in diameter. They 
present linear double-stranded DNA molecules with 26-45 kb in size, which makes 
them regarded to be medium-sized when compared with other DNA viruses (Davison et 
al., 2003). The characteristic icosahedral-shaped capsid architecture composed of four 
major proteins such as hexon (e.g. polypeptide II), penton (e.g. penton base), fiber 
(polypeptide IV) and minor proteins (polypetides IIIa and VI), are present in all 
adenoviruses identified (Doerfler, 1996; Rux and Burnett, 2004). The icosahedral shell 
is formed by a total of 240 trimeric hexons, 12 pentamers and 12 fibre trimers (Kay, 
2011). Basic structure is depicted in Figure 1.5. 
 
Figure 1.5: Structure of adenovirus virion with relative orientation of protein 
components including a double-stranded DNA in its core (adapted from 
Brown et al. (1975)). 
 
 
 
 
 
 
 
 
 
 
 
 More than 100 different adenovirus species have been identified in different 
vertebrates including mammals (mastadenoviruses), birds (aviadenoviruses) and 
reptiles. Human adenoviruses are involved in several infections in the respiratory tract, 
conjunctivitis as well as gastroenteritis. These viruses are classified into six subgroups 
(from A to F) and then subdivided into distinct serotypes according to the induced 
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immunological response. For instance, serotype 2 and 5 of subgroup C are the most 
extensively studied human adenoviruses (Rux and Burnett, 2004). Adenoviruses have 
been widely used as model systems for study of different phases of virus infection as 
well as potential vectors for gene therapy. This is mainly due to ability of infection of 
wide range of hosts, recovery of high titres in cell culture and high level of transgene 
expression without viral genome integration into host genome (Choi and Chang, 2013). 
Adenovirus type 2 (AdV2) and type 5 (AdV5) are both recognized by ASTM 
International as representative non-enveloped viruses to be used for assessment of 
virucidal activity of biocides in suspension or against viruses adhered to non-porous 
inanimate surface through standardised tests (ASTM, 2011a and ASTM, 2011b). 
 
1.2.3.2.2 Poliovirus 
 
The poliovirus is a positive-stranded RNA non-enveloped enterovirus belonging 
to Picornaviridae family and the causative agent of poliomyelitis (Ehrenfeld et al., 
2010). The capsid diameter is around 30 nm and it presents an icosahedral geometry 
containing up to 60 copies of four structural proteins: VP1, VP2, VP3 and VP4 (Louten, 
2016). The latter is located within the capsid and function has not been fully unraveled 
yet. Figure 1.6 shows the capsid framework and disposition of VP proteins on the outer 
part of viral capsid including symmetry axes. 
 
Figure 1.6: Poliovirus capsid icosahedral framework with VP1, VP2 and VP3 proteins 
on the outer part of the capsid. Numbers represent the different symmetry 
axes of viral capsid. Adapted from Hogle (2002). 
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 Polioviruses can be divided into 3 different serotypes (type 1, 2 and 3) with 
minor structural differences between each other and all of them can cause poliomyelitis. 
The serotypes differ in terms of the ability to induce protection against second paralytic 
attacks and virulence was found to be significantly higher for serotype 1 during peak of 
poliomyelitis incidence in the United States in the pre-vaccination era (Nathanson and 
Kew, 2010). All the three different serotypes initiate host cell attachment and entry by 
interaction with human cell receptor CD155, a membrane anchored glycoprotein with 
respective extracellular domains (He et al., 2003). Poliovirus type 1 is recommended as 
a target organism for assessing virucidal efficacy of biocides by standardized method 
according to the European norm (DIN, 2013). 
 
1.3 Disinfection kinetics 
 
The selection of a biocide and design of an efficacious disinfection system 
requires knowledge about the activity and limitations associated to the chemical agent 
and material to be disinfected as well as disinfection kinetics. Moreover, it is important 
to ensure safe application of the product and avoid health risks by minimizing exposure 
to product itself and possible disinfection by-products. In order to predict disinfection 
performance and evaluate certain disinfection design criteria, kinetic models have been 
developed throughout the years. The differential rate law from which several kinetic 
models have been developed is mathematically described in Equation 1.1 as follows: 
 
   
𝑑𝑁
𝑑𝑡
=  −𝑘𝑚𝑁𝑥𝐶𝑧𝑡𝑚−1          (Equation 1.1) 
 
Where 
𝑑𝑁
𝑑𝑡
 represents the microorganism inactivation rate; k the reaction rate; N the 
number of survivors; C concentration of disinfectants; t the contact time and x, z and m 
a set of empirical constants (Gyurek and Finch, 1998). The assumptions underlying 
kinetic models are that mixing is adequate to disperse uniformly a disinfectant agent and 
a microorganism; operational parameters, such as temperature, pH and disinfectant 
concentration are constant throughout disinfection process (Somani and Ingole, 2010). 
The reaction rate is determined experimentally and according to Wigginton et al. (2012) 
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the rate constant associated to the loss of virus replication function (kreplication) is related 
to reaction rate (k) as described by Equation 1.2. 
 
  𝑘𝑟𝑒𝑝𝑙𝑖𝑐𝑎𝑡𝑖𝑜𝑛 =  𝑘 − 𝑘𝑏𝑖𝑛𝑑𝑖𝑛𝑔 − 𝑘𝑖𝑛𝑗𝑒𝑐𝑡𝑖𝑜𝑛     (Equation 1.2) 
 
Where kbinding is the rate constant associated to virus-host binding loss and kinjection is the 
rate constant for loss of virus genome injection (Wigginton et al., 2012). This way the 
authors computed the k value (inactivation rate constant) for several disinfectants by 
plotting Ln (Virus titre after exposure/Virus titre before exposure) vs. disinfectant dose 
(Wigginton et al., 2012) comparison of different disinfectants against MS2 could be 
performed. 
 Similarly to other microorganisms, virus disinfection can present a first-order 
kinetics where an exponential kill dependent on the contact time, temperature and 
disinfectant concentration is observed, thus representing an ideal scenario for 
disinfection process design. Nevertheless, disinfection process in real life tends to 
deviate from a first-order kinetics due to variation of environmental parameters (e.g. 
pH, temperature, disinfectant availability, organic load) and virus intrinsic properties. 
The latter is mainly associated to the formation of virus aggregates, conformational shift 
in the virion capsid and virus surface charges, which may affect its sensitivity to 
disinfection (Young and Sharp, 1985). 
 
1.4 Mechanisms of virucidal action 
 
Biocides present a lack of selective toxicity and target specificity in contrast to 
antibiotics for example. Rational design and improvement of novel virucides have been 
carried out because of the need for reducing virucide concentration and efficacy 
maximisation. The study of mechanisms of virucides action has been essential for the 
development of novel formulations and for gathering deeper insight about the reasons 
underlying selectivity of virucidal activity. The mechanism of action consists on a 
systematic understanding of virus inactivation through association of formulation 
components to specific modifications and loss of virus functionality, which helps the 
comprehension about virucide limitations and virus adaptation to environmental stress 
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(Wigginton et al., 2012). Figure 1.7 depicts several modes of action associated to 
different virucidal agents against non-enveloped virus. 
 
Figure 1.7: Distinct modes of action associated to virucidal agents against non-
enveloped virus (taken from Wigginton et al., 2012). 
 
 
 
 
 
 
 
 
 
 
 
 Although the study of mechanisms of action is important for development and 
improvement of disinfection systems, there is still a lack of information regarding the 
mechanism of virucidal action against non-enveloped viruses. Several proposed 
mechanisms of action of virucides are based on activity against unrelated organisms like 
bacteria and yeast. Nevertheless, this approach may not be valid as those 
microorganisms present metabolic activity and consequently higher number of target 
sites when compared to viruses (Maillard et al., 2013). 
Owing to their simpler and smaller structure, viruses present fewer target sites 
for virucidal activity when compared to bacteria. It is accepted that potential target sites 
can be the envelope (for enveloped viruses), capsid and viral genome. The viral 
envelope has a lipidic nature and can be disrupted via biocide interaction with lipids 
(e.g. alcohols and quaternary ammonium compounds). The capsid is constituted 
primarily by proteins and protects the viral nucleic acid from environmental stressors. 
Some chemical agents (e.g. glutaraldehyde, peracetic acid, copper ions) were shown to 
interact with capsid proteins resulting in conformational changes and denaturation 
(Chambon et al., 2005; Sauerbrei et al. 2007; Horie et al. 2008). The rupture of the viral 
capsid could lead to the release of potential infectious viral nucleic acid. Consequently, 
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this could give rise to a phenomenon called “multiplicity reactivation”, process whereby 
virions pool genetic information and generate an infectious unit by complementary 
reconstruction (Luria, 1947). In order for a treatment to be considered effective, 
biocides (virucidal and virustatic) must inactivate viruses to such an extent that virus 
infectivity and reproduction is hampered. Virucidal biocides refer to agents, which 
destroy completely the target virus, whereas virustatic biocides are associated to 
inhibition of virus proliferation by hampering interaction with the host.  For instance, 
this may be achieved through virus immobilization (virustatic biocide) on a given 
surface, alteration of virus receptors involved in interactions with host cell and/or 
nucleic acid inactivation (virucidal biocide) (Thurman et al., 1989). 
 
1.4.1 Alcohol as a virucidal agent 
 
 Several alcohols have been shown to be effective antimicrobials, thus they are 
widely employed in skin antisepsis products nowadays. Short-chain aliphatic alcohols 
such as ethanol, isopropanol and n-propanol are the most common used for alcohol-
based biocides. The increase use of alcohols over other antimicrobials can be attributed 
to their rapid and broad-spectrum antimicrobial activity against bacteria, viruses and 
fungi (McDonnel and Russel, 1999; Guthery et al. 2005).  
 Little is known about the mechanism of action of alcohols, but studies on 
bacteria showed that ethanol and isopropanol are membrane active agents, which 
promote membrane disorganization leading to loss of cytoplasmic membrane function 
(Fizgerald et al., 1992; Ortega Morente et al., 2013). Alcohols show substantial 
virucidal activity against enveloped viruses as compared to non-enveloped ones, which 
suggests that the viral lipid envelope is a potential target site (van Engelenburg et al., 
2002). The alcohols activity against non-enveloped viruses might be associated to 
alterations of structural proteins, which induces changes to the capsid structure and 
infectivity. Maillard et al. (1995) showed that F116 bacteriophage treated with ethanol 
and isopropanol presented fractured and folded capsids. Nath et al. (1982) studied the 
effects of different concentrations of ethanol on inactivation of DNA-polymerase 
associated with hepatitis B virus and they reported a ninety percent inactivation with 
60% w/v ethanol. Moreover, it was suggested by Ito et al. (2002) that ethanol hampered 
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HBV binding to hepatocytes through HBV surface antigen protein complex 
degeneration.  
 In order to reduce the emission of volatile organic compounds (VOCs), reduce 
risks of tissue toxicity, efforts are being made to reduce alcohol content in some 
disinfectants (Kramer et al., 2006; Suchomel et al., 2009). Therefore, alcohols in 
synergistic combination with other antimicrobials (e.g. metals) are being studied not 
only to address those issues but to confer higher efficacy and persistence to biocidal 
products as well. For instance, chlorhexidine gluconate and quaternary ammonium 
compounds have been used as preservatives to alcohol-based skin antisepsis products in 
Europe and in the United States (Gaonkar et al., 2006). 
 
1.4.2 Metal interaction with viruses 
 
 Metal ions present several roles in biological systems such as: transfer of 
electrons, mediator of interaction between proteins and ligands and nucleophilic 
catalyst. Most of those processes rely on protein-metal interactions, where metal ions 
(e.g. Cu2+ and Zn2+) are critical for protein’s stability and activity (Chatuverdi and 
Shrivastava, 2005). Since various structural and non-structural viral proteins require 
metal ions to be fully active, it can be said that metal ions are crucial for protection of 
viral genome, replication and pathogenesis. To illustrate this, it was shown that human 
immunodeficiency virus type 1 (HIV-1) nucleic acid annealing steps require the activity 
of the nucleocapsid protein, which contain several metal ion binding residues (Guo et 
al., 2000). Furthermore, it was shown that zinc ion is involved in the correct folding of 
NS3 protease related to hepatitis C virus maturation (Urbani et al., 1998). There is also 
evidence that viruses rely on the host intracellular store of zinc for their newly 
synthesized proteins. On the other hand, it was reported that host cells use metal ions to 
inhibit virus replication and alter genome of the virus (Chatuverdi et al., 2004). Despite 
the importance of metals to virus infectivity cycle, they were also found to present 
significant virucidal activity above certain concentration levels. For instance, silver 
nanoparticles were demonstrated to be highly active against influenza A virus, human 
immunodeficiency virus and adenovirus (Chen et al., 2013). Zinc and copper salts are 
also found in the literature to present virucidal activity and as such mechanisms of 
action have been proposed. 
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1.4.2.1 Zinc salts 
 
 Zinc is the most common metal to bind with virus proteins and possess an 
essential role in the folding and stability of important protein domains referred as zinc 
finger domains (Coleman, 1992). Despite its importance for virus viability, zinc has 
been shown in the literature to exert inhibitory effects against several viruses including 
gastroenteritis virus (Wei et al., 2012), rhinovirus (Korant and Butterworth, 1976), 
hepatitis C virus (Yuasa et al., 2006), respiratory syncytial virus (Suara and Crowe, 
2004), coronavirus and arterivirus (te Velthuis et al., 2010) in vitro.  
The specific mechanism of virucidal action associated to zinc ions is still 
unknown and several modes of action are suggested for different viruses. The modes of 
action proposed in the literature are: i) blockage of binding and virus-host interaction; 
ii) prevention of polypeptide breakdown during viral replication; iii) inhibition of 
transcriptase proteins and polymerases. Suara and Crowe (2004) studied the effect of 
zinc salts on respiratory syncytial virus replication and observed that zinc salts inhibited 
virus adsorption, penetration and egress. They postulated that virucidal activity of zinc 
was related to a decreased capacity of host to support virus replication rather than a 
direct effect on the virus. On the other hand, Kuemel et al. (1990) showed through 
electron microscopy studies that there is a massive deposition of zinc onto Herpes 
Simples Virus (HSV) virion components, which affects glycoprotein function involved 
in virus adsorption. Alternatively, Wei et al. (2012) affirmed that zinc activity against 
transmissible gastroenteririts virus in vitro is due to inhibition of virus penetration and 
egress instead of virus adsorption. Korant and Butterworth (1975) suggested that zinc 
complexes with rhinovirus coat proteins inhibiting the proteolytic processing of virus 
polypeptides during virus assembly. Te Velthuis (2012) reported that zinc (II) inhibited 
the activity of RNA polymerase during elongation phase of RNA synthesis, which was 
reversed by chelating the zinc ions. Yuasa et al. (2006) demonstrated that zinc inhibited 
replication of genome-length Hepatitis C RNA and it was hypothesised this could be 
caused by alteration of non-structural proteins functions involved in the viral genome 
replication. On the other hand, it was demonstrated recently that zinc salts are capable 
of blocking Hepatites E virus replication through direct inhibition of viral RNA-
dependent RNA polymerase (Kaushik et al., 2017). Furthermore, interactions of metal 
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cations like zinc with DNA in solution were shown to alter its conformation and 
properties such as conductivity although deeper knowledge about the nature of those 
interactions and consequences for DNA integrity are still required (Lee et al. 1993; 
Labiuk, 2003). Thus, it is reasonable to include possible interaction of metal ion such as 
zinc with viral nucleic acid as a possible cause for zinc virucidal activity.   
 
1.4.2.2 Copper salts 
 
 Copper salts have been used in disinfection processes for centuries due to its 
toxicity against several pathogenic microorganisms and relatively safety to humans 
below certain concentrations. Copper-based disinfectants present widespread 
application in the modern healthcare setting, where it is used in the control of 
pathogenic microorganisms in water distribution systems and for coating of medical 
devices (O’Gorman and Humphreys, 2012; Boyce, 2016). It is generally accepted that 
toxicity of copper to microorganisms might be related to its capacity to bind to thiol-
containing groups and redox properties. The binding of copper to protein thiol groups 
can denature proteins and consequently hamper binding of other important trace 
elements. On the other hand, the redox cycling between cuprous (Cu(I)) and cupric 
(Cu(II)) catalyses the generation of reactive oxygen species like superoxide anions and 
hydroxyl radicals (Borkow and Gabbay, 2005). The formation of hydroxyl radicals is 
thought to occur via a Fenton reaction in the presence of hydrogen peroxide as follows 
(Urbanski and Beresewicz, 2000): 
 
  Cu+ + H2O2 →  Cu
2+ +  OH (free radical) +  OH−∙      (Equation 1.3) 
 
Copper virucidal activity was first reported by Yamamoto et al. (1964). They 
observed that MS2 bacteriophages were fully inactivated when left on copper-based 
containers. Since then, copper either as metal complexes or salts were reported to be 
effective on inactivating viruses like HIV-1 (Sagripanti and Lightfoote, 1996), HSV 
(Sagripanti et al., 1997), avian influenza virus (Horie et al., 2008) and poliovirus 
(Yahya et al., 1992).  
 Despite wide spread use of copper for disinfection purposes, the exact 
mechanism of action by which copper promote viral inactivation has not been fully 
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understood yet. It is hypothesized that copper ions may possess a multifactorial 
mechanism of action in bacteria (Warnes and Keevil, 2011). The suggested mechanism 
of toxicity towards viruses associated to copper include alteration of protein complexes 
and function; denaturation of nucleic acid by site-specific Fenton reaction and/or 
chelation as well as free radical generation through coordination with other toxic 
molecules (Thurman et al., 1989; Carubelli et al., 1995).  
Regarding denaturation of protein complexes, Karlstroem and Levine (1991) 
reported that HIV-1 protease, which is highly involved in virus replication, was 
inhibited by stoichiometric concentrations of copper ions. They also showed that 
protease inhibition by copper was concentration-dependent and relied on the presence of 
cysteine residues, which confirms protein inactivation involved binding of copper to 
thiol groups. In terms of nucleic acid denaturation, Wong et al. (1974) obtained a 6-7 
log10 reduction of bacteriophage R17 due to cleavage of RNA by using vitamin C in 
combination with copper. These authors concluded that hydroxyl radicals generated 
from hydrogen peroxide through Fenton reaction were responsible for RNA cleavage.  
Sagripanti et al. (1997) reported HSV inactivation by copper ions and proposed that 
copper-mediated DNA damage involved binding of Cu (II) to nucleic acid, which 
produced oxidative base damage and breakage of DNA phosphodiester backbone. In 
general, nucleic acids offer several potential binding sites for metals with high proton 
affinity, which include nitrogen and oxygen groups associated to bases, hydroxyl 
groups on ribose and negatively charged O atoms in the phosphate residues. Factors like 
pH, competition with other ions (ionic strength of solution), ability to form chelation 
complexes and degree of base stacking strongly interfere with the interaction between 
nucleic acids and metal ions like copper (Martin and Mariam, 1979). The specific 
affinity of copper to G-C pairs of DNA results in crosslinking within and between 
strands, i.e. helical structure disorder. It is thought that subsequent DNA degradation 
steps are linked to generation of hydroxide radicals causing significant damages. 
Although nucleic acids are shown to be highly susceptible to copper, it is probably not 
the primary target, as nucleic acid cannot be readily accessed. The interaction of copper 
with other viral substructures and accessibility to viral nucleic acid will probably 
determine the overall virucidal activity. It was postulated that viruses with RNA 
genome and lipid envelope are highly susceptible to copper, whereas double-stranded 
DNA viruses tended to be more resilient except if they are enveloped (Li and Dennehy, 
2011). It was also found that cupric ions were able to coordinate toxic molecules like 
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adriamycin and mitomycin C. Ueda et al. (1980) observed strand scission of 
bacteriophage phi X174 DNA in the presence of previously reduced mitomycin C with 
cupric ions. The latter was responsible for generation of mitomycin C semiquinone 
radical that promoted DNA degradation.  
 In terms of structural damage, it was observed through electron microscopic 
analysis that cupric ions induced morphological abnormalities on H9N2 avian influenza 
virus. This type of damage might be related to certain protein complexes denaturation. 
Furthermore, it was reported that copper was significantly more effective than zinc in 
virus inactivation (Horie et al., 2008). 
 
1.4.3 Synergy  
 
 In contrast to additive effect, which takes place when overall biocide activity is 
the sum of activities of individual substances, synergy between biocides occur when the 
overall effect is greater than the sum of individual effects. Research into synergy 
between antimicrobials is increasing due to several factors such as, need for better 
biocide efficacy to avoid resistance and reduced costs associated to product 
development when compared to novel compounds (Lambert et al., 2003). One of the 
bases for antimicrobial synergy research is that synergy is more likely to occur when 
antimicrobials with distinct targets are mixed together, which must be confirmed 
through experimental verification (Hugbo, 1976).  
 Synergistic combinations of copper and zinc ions with other antimicrobial 
agents have been investigated. For example, zinc pyrithione formulations with alcohol 
have been used successfully in skin antisepsis products and are shown to have 
significant virucidal activity against human coronavirus and HIV-1 (Guthery and 
Anderson, 2005). Synergistic combination of copper with free chlorine against 
poliovirus was also reported with respective mechanism of action. Since chlorine is a 
halogen that can act in part as an oxidizing agent, it was proposed that chlorine causes 
severe damages to the protein capsid and consequently, it would facilitate interaction of 
copper with nucleic acid (Borkow and Gabbay, 2005). Moreover, combination of 
quaternary ammonium compounds and Cu (II) was reported to be an effective 
combination against complex and resilient microbial structures like biofilms, which 
demonstrates the potential role of metallic ions in increasing activity of a biocide 
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(Harrison et al., 2008). Novel microbicidal formulations containing reduced amount of 
alcohol with zinc or copper were shown to present synergistic virucidal activity against 
a wide range of viruses (Ijaz et al., 2012; Ijaz and Zhu, 2014a). However, underlying 
mechanism of action of those formulations remains to be studied. 
 
1.5 Aim of the project, hypothesis and relevance 
 
The main goals of this PhD project are (i) to understand the mechanism(s) by 
which the combination of alcohol and zinc ions, in particular low concentrations of 
ethanol (around 40% w/v) with zinc ions, exhibit virucidal effects against non-
enveloped viruses and (ii) to elucidate the mechanisms of potentiation of virucidal 
activity through combinations of those actives compounds. The working hypotheses 
based in the literature review for this project were: 
 
 Hypothesis 1: the combination of alcohol and zinc is more effective at 
inactivating non-enveloped viruses than zinc or alcohol as sole active 
ingredient 
 Hypothesis 2: the action of combination alcohol/zinc could weaken the viral 
capsid and have nucleic acid as an additional target for virucidal action.  
 
Furthermore, this work also aims to demonstrate the effect of zinc ions on 
formulation stability notably by understanding the chemical composition in such 
formulations over extended periods of time under specific storage conditions.  
The aims of the project are planned to be achieved through the following steps: 
(i) investigation of the virucidal activity related to formulations with different ratios of 
zinc/ethanol at different pHs on surrogates (bacteriophage MS2 and F116) and 
mammalian viruses (adenovirus and poliovirus); (ii) investigation of formulations 
impact on bacteriophage structure, morphology and mechanical properties; (iii) 
investigation of formulations influence on physicochemical properties of the phages 
(surface charge, aggregation capacity, protein and nucleic acid damages); (iv) 
identification of chemical elements responsible for the virucidal action and formulation 
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stability studies and (v) investigation of formulation activity and mode of action on 
mammalian viruses (adenovirus type 2 and poliovirus LSc-1ab). 
Given the aforementioned importance of biocides to control infection spreads in 
many different sectors, especially household and healthcare settings, it becomes evident 
the need for the development and improvement of biocides. In this context, the present 
project will also have an impact on development of novel biocidal products as gathering 
information about synergism between active compounds and their mechanisms of action 
is essential for the rational design and improvement of biocidal products with a 
virucidal activity.  
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2. General materials and methods 
 
2.1 Rationality behind research methodology 
 
The initial focus was given to formulations containing ethanol and zinc at a 
given pH. The goals of the study were therefore set as follows: (i) to confirm the 
virucidal activity of formulation containing ethanol and zinc at pH 10.5 (prepared 
according to Reckitt Benckiser (RB) instructions based on Patent WO 2014/006380) 
against bacteriophages and human viruses; (ii) to study the impact of the complex 
zinc/ethanol on virus capsid morphology and susceptibility to mechanical stress (e.g. 
spring constant and breaking force); (iii) to verify possible interactions of alcohol/zinc 
with viral nucleic acid and (iv) to evaluate the chemical entities present in the 
formulation at a given temperature and pH conditions and possibly relate them to 
virucidal activity. Those aspects were crucial for proposing a mechanism of virucidal 
action associated to the combination of alcohol and zinc as active ingredients. Figure 
2.1 shows a summary of different experiments performed throughout the research 
project divided into three main aspects: general activity, mechanism of action and 
chemistry of formulations. 
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Figure 2.1: Methodology for the present study divided by topics and respective 
scientific questions. 
 
     2.1.1 Testing formulations 
 
 The initial testing formulations in the present project included distinct alcohol 
concentrations combined with a fixed zinc salt concentration as active ingredients plus a 
fixed amount of excipients at a given pH. This initial testing was performed in order to 
screen for virucidal activity at different ethanol concentrations with zinc salt and 
analyse virucidal activity patterns. At later stage, a formulation system comprised by a 
fixed amount of alcohol with zinc salt including excipients at fixed pH was selected 
based on its virucidal activity against bacteriophage MS2 for mechanism of action 
studies. The selection made it possible to analyse a formulation through different 
experiments and infer about the mechanism of action within a reasonable time frame for 
this project. Since the project was carried out in partnership with RB, an industrial 
partner, there was a growing interest to evaluate activity of alcohol and zinc in a 
formulation as close to the final biocidal product formulation as possible. Therefore, 
testing formulations included excipients at a given pH as described in Patent WO 
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2014/006380 rather than active ingredients alone (Ijaz and Zhu, 2014). Additionally, it 
was intended from the very beginning of the project that proposed mechanism of action 
was to be included in RB’s intellectual property portfolio. 
 
     2.1.2 Virucidal activity of formulations 
 
Virucidal activity of a biocide can be affected by several parameters such as 
contact time, pH, temperature, organic load, virus type and concentration of both virus 
and active ingredients (Maillard et al., 2013). Several standardised virucidal activity 
tests were develop at national scale to standardise the experimental methods and 
parameters which resemble as accurate as possible those found in actual practice (DVV, 
2012; Rabenau et al., 2014). Therefore, standardised virucidal efficacy tests of 
formulations were performed throughout the present study not only to evaluate activity 
of testing formulations and establish comparisons amongst them but also to verify 
compliance with current national standards for virus disinfection efficiency. 
Standardised virucidal efficacy tests of biocide in suspension (ASTM E1052-1: 
2011; EN13610: 2013) or dried on an inanimate surface (ASTM E1053: 2011) were 
carried out to confirm the virucidal activity of formulations. The EN13610 was used as 
a screening test for initial virucidal activity assessment of formulations, whereas the 
ASTM E1053 was used to simulate formulation activity on surfaces and to compare 
with data produced by RB. The reasons for using bacteriophage MS2 for both tests 
were: (i) that it is a harmless organism, (ii) easy and fast to propagate and (iii) a well-
known surrogate for non-enveloped viruses (Macinga et al., 2008; Sinclair et al., 2012; 
Gallandat and Lantagne, 2017). On the other hand, the virucidal suspension test on 
F116 aimed to evaluate the use of F116 as a model for structure damage study through 
transmission electron microscopy. It allowed for the selection of an appropriate contact 
time at which the virus would not be severely killed (i.e. <99% reduction in 
concentration) to allow observation of distinct virion structural changes induced by 
formulations. It was hypothesized that ethanol may allow better penetration of zinc ions 
into the virions through denaturation of capsid proteins, followed by zinc interaction 
with nucleic acid materials.  
Standard activity tests (EN13610: 2013) in suspension were performed against 
both adenovirus and poliovirus in order to compare with data obtained by activity tests 
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against bacteriophages and evaluate surrogacy capacity as well as formulation efficacy 
against human pathogens.  
 
     2.1.3 Mechanisms of virucidal action of formulations and specific interactions with 
viral targets 
 
The mechanism of action (MoA) of a given biocide consists about revealing 
possible target sites on viruses, which are responsible for the observed virucidal 
activity. As an example, it is generally accepted that infectivity of enteric viruses (e.g. 
MS2, Adenovirus, Poliovirus) relies heavily on functional integrity of the viral capsid as 
well as its genome (Fong and Lipp, 2005; Hijikata et al., 2016). The stability of the 
capsid is especially important as it is in involved in virus attachment and entry into host 
and protection of genome against degradation from surroundings (Pecson et al., 2009). 
Therefore, the focus was given on the study of the influence of testing formulations on 
virus capsid integrity and genome integrity, i.e. formulation potential to fully inactivate 
non-enveloped viruses.  
Regarding the impact of testing formulations on viral capsid, nano-indentation 
studies and transmission electron microscopy imaging upon exposure of viruses to 
testing formulations were performed to analyse possible damage to the viral capsid 
integrity. Transmission electron microscopy (TEM) against F116 was shown to be 
effective at showing morphological changes induced by different biocides (Maillard et 
al., 1995; Pinto, 2010). F116 has been shown to be an interesting model because of its 
complex structure including capsid and tail. Nano-indentation studies on adenovirus 
capsid were shown to be effective methodology for analysis virus capsid mechanics 
after exposure to different environmental parameters (Ortega-Esteban et al. 2013; 
Marchetti et al., 2016). Therefore, the overall impact of testing formulations on virus 
capsid structure was analysed through aforementioned methodologies. 
In terms of viral genome as potential target for alcohol/zinc virucidal action, the 
screening of possible adenovirus and F116 viral DNA damage upon exposure to testing 
formulation was analysed by gel electrophoresis and restriction enzyme digestion 
pattern analysis as described in the literature (Maillard et al., 1996; Sutherland et al., 
2006 Pinto, 2010). The DNA damage analysis is also relevant as it was demonstrated by 
Marchetti et al. (2016) viral capsid structural changes are closely related to possible 
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genome conformational changes. Therefore, those studies were able to provide a full 
picture about what happens to viruses upon exposure to alcohol and zinc and possible 
relation to formulation virucidal activity. 
 
     2.1.4 Formulation composition and speciation 
 
Regarding formulation chemistry analysis, Proton Nuclear Magnetic Resonance 
Spectroscopy (1H-NMR) was envisioned as a method to analyse zinc coordination and 
bioavailability in formulation by identification of distinct chemical elements, which 
could be responsible for the virucidal activity. The methodology was based on the study 
by 1H-NMR on zinc interactions with nucleic acid carried out by Aoki and Kimura 
(2004). In this project, a preliminary experiment was performed to evaluate the 
formation of zinc complexes with triethanolamine, a chemical compound present in the 
formulation. Additionally, techniques based on mass spectroscopy were employed to 
possibly identify complexes and other chemical entities as performed by Bester and 
Lamani et al. (2010). The main goal was to identify chemical entities, which could be 
associated with efficacy against non-enveloped viruses observed through activity tests.  
 
2.2 Biocide formulation and preparation 
 
 Formulations with different ethanol concentrations and with same amount of 
zinc were prepared, in order to study the influence of different ethanol concentrations 
on virucidal activity and mechanism of action.  
Formulation composition and buffering system at pH 10.5 was based on Example 41 
found in the Patent WO 2014/006380 (Ijaz and Zhu, 2014). The formulation protocol 
for the formulation was supplied by Reckitt Benckiser (Montvale, USA) and the main 
composition of the formulation is presented in Table 2.1. 
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Table 2.1: Formulation composition associated to biocide with 0.1% Zinc at pH 10.5 
with varying ethanol concentrations based on the Example 41 of Patent WO 
2014/006380. 
Chemicals Concentration (% w/v) 
Citric acid anhydrous (Acros Organic, UK) 0.12 
Zinc sulphate heptahydrate (Sigma 
Aldrich, UK) 
0.10 
Ethanol (Fisher Chemical, UK) 25.0 to 80.0 
Triethanolamine (Acros Organic, UK) 0.10 
Ammonium hydroxide (Fisher, UK) 0.10 
Monoethanolamine (Acros Organic, UK) 1.04 
 
 Formulations were prepared with deionized water and stored in glass bottles in 
dark environment for 4 months and the pH was measured on a weekly basis. 
In addition to formulations prepared in Cardiff according to Table 2.1, Reckitt 
Benckiser sent two batches of formulations with similar chemicals in December 2014 
and September 2015. Three sets of formulations were therefore studied throughout the 
present study and labelled as presented in Table 2.2.  
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 Table 2.2: Different formulations analysed throughout experimental work. 
Set Formulation Composition 
Formulations prepared in 
Cardiff 
CA001 (base formulation)_ 
40% (w/v) Ethanol + 0.1% (w/v) Zinc 
sulphate heptahydrate + excipients 
CA001-A 
35% (w/v) Ethanol + 0.1% (w/v) Zinc 
sulphate heptahydrate + excipients 
CA001-B 
33.5% (w/v) Ethanol + 0.1% (w/v) 
Zinc sulphate heptahydrate + excipients 
CA001-C 
30% (w/v) Ethanol + 0.1% (w/v) Zinc 
sulphate heptahydrate + excipients 
CA001-D 
27.5% (w/v) Ethanol + 0.1% (w/v) 
Zinc sulphate heptahydrate + excipients 
CA001-E 
25% (w/v) Ethanol + 0.1% (w/v) Zinc 
sulphate heptahydrate + excipients 
CA001-F 
80% (w/v) Ethanol + 0.1% (w/v) Zinc 
sulphate heptahydrate + excipients 
CA001-X 40% (w/v) Ethanol + excipients 
CA001-AX 35% (w/v) Ethanol + excipients 
CA001-BX 33.5% (w/v) Ethanol + excipients 
CA001-CX 30% (w/v) Ethanol + excipients 
CA001-DX 27.5% (w/v) Ethanol + excipients 
CA001-EX 25% (w/v) Ethanol + excipients 
CA001-FX 80% (w/v) Ethanol + excipients 
CA-001-G 
0.1% (w/v) Zinc sulphate heptahydrate 
+ excipients 
CA-001-EXCP Excipients 
Formulation sent by RB 
(December 2014) 
RB-001 (base formulation) 
40% (w/v) Ethanol + 0.1% (w/v) Zinc 
sulphate heptahydrate + excipients 
RB-001-A 
35% (w/v) Ethanol + 0.1% (w/v) Zinc 
sulphate heptahydrate + excipients 
RB-001-B 
33.5% (w/v) Ethanol + 0.1% (w/v) 
Zinc sulphate heptahydrate + excipients 
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RB-001-C 
30% (w/v) Ethanol + 0.1% (w/v) Zinc 
sulphate heptahydrate + excipients 
RB-001-D 
27.5% (w/v) Ethanol + 0.1% (w/v) 
Zinc sulphate heptahydrate + excipients 
RB-001-E 
25% (w/v) Ethanol + 0.1% (w/v) Zinc 
sulphate heptahydrate + excipients 
RB-001-F 
80% (w/v) Ethanol + 0.1% (w/v) Zinc 
sulphate heptahydrate + excipients 
RB-001X 40% (w/v) Ethanol + excipients 
RB-001-AX 35% (w/v) Ethanol + excipients 
RB-001-BX 33.5% (w/v) Ethanol + excipients 
RB-001-CX 30% (w/v) Ethanol + excipients 
RB-001-DX 27.5% (w/v) Ethanol + excipients 
RB-001-EX 25% (w/v) Ethanol +  excipients 
RB-001-FX 80% (w/v) Ethanol + excipients 
RB-001-G 
0.1% (w/v) Zinc sulphate heptahydrate 
+ excipients 
RB-001-EXCP Excipients 
Formulation sent by RB 
(September 2015) 
RB-002 (base formulation) 
40% (w/v) Ethanol + 0.1% (w/v) Zinc 
sulphate heptahydrate + excipients 
RB-002G 
0.1% (w/v) Zinc sulphate heptahydrate 
+ excipients 
RB-002EXCP Excipients 
Lysol formulation sent by 
RB 
C0042-042 Lysol commercial formulation batch 1 
C042-084 Lysol commercial formulation batch 2 
 
2.3 Neutraliser preparation 
 
 The neutraliser formulated to quench the formulations under study was 
composed by a mixture of L-Cysteine (1g.L-1) (Sigma-Aldrich, UK) with sodium 
thiosulphate [0.1% w/v] (Sigma-Aldrich, UK) in distilled water. The neutraliser was 
prepared according to Allan et al. (2011), where heavy metal (Zinc) and alcohol 
activities are quenched by L-cysteine and dilution, respectively. Neutraliser quenching 
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efficacy was evaluated prior virucidal activity tests (see section 2.7). After preparation, 
neutraliser was sterilized by autoclaving at 121oC for 15 min (Sanders, 2012).  
 
2.4 Host propagation and enumeration 
 
 The hosts for bacteriophage MS2 and F116 were Escherichia coli (NCIMB 
9481) and Pseudomonas aeruginosa PAO1 (NCIMB 10548), respectively. Both hosts 
were cultivated in 10 mL tryptic soy broth (Oxoid, Cambridge, UK) for 24 h at 37oC 
and centrifuged at 3276g for 15 min (Primo R, Thermo Scientific).  After supernatant 
removal, the bacterial pellet was resuspended in 5 mL of phosphate buffered saline 
(PBS) solution (Fisher Chemical, UK).  
 The bacterial enumeration was performed by drop counting method according to 
Miles and Misra (1938), where suspension is 10-fold serially diluted by adding 100 μL 
of suspension in 900 μL of PBS. Five drops of 10 μL of selected dilutions are plated in 
Tryptic Soy Agar (TSA) plates for a total of 3 biological replicates. Colonies were 
counted for each dilution after 24 h incubation at 37oC. 
 In addition, several cryogenic vials were prepared for each cultivated host by 
mixing 900 μL of bacteria suspension with 100 μL glycerol (Fisher Scientific, UK) and 
stored at -80oC. Each vial was used only once for bacterial propagation and discarded 
afterwards. The resulting bacterial suspension was kept at 4oC and used for further 
bacterial propagations within the next 4 days.  
 
2.5 Phage propagation, purification and enumeration 
 
 Bacteriophage MS2 (NCIMB 10108) and F116 (NCIMB 10882) were 
propagated according to Pinto et al. (2010). Phages were propagated in plate cultures, 
which consisted of agar supplemented with 0.5 mM and 1 mM calcium chloride (Fisher 
Chemical, UK) for MS2 and F116 propagation, respectively. Phages were harvested 
from plates presenting more than 30 plaques by adding 2 mL of SM Buffer (composed 
by 0.05 M Tris/HCl, 0.2% w/v MgSO4 and 0.01% w/v fish-skin gelatin) to the 65% 
agar layer and removing it with a plastic L-shaped spreader. Layers were transferred to 
propylene centrifuge tubes and centrifuged at 11,000g (Rotor JA25.50, Beckman 
Coulter) for 15 min at 4oC. Following that, the supernatant was filtered in a two-step 
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filtration process by using 0.45 μm and 0.20 μm membrane filters. Stocks were prepared 
adding 10% w/v glycerol to phage suspension and stored at -80oC. 
 Phages were enumerated by Soft Overlayer Agar technique as described by 
Pinto et al. (2010). Ten-fold serial dilutions of phages were prepared by adding 100 μL 
of phage to 900 μL SM Buffer. Then, 100 μL of phages were mixed with 100 μL of host 
cells (108 colony forming unit (CFU) mL-1) in 5 mL of 65% w/v molten agar and 
suspension was poured into TSA plates. After 24h incubation at 37oC, plaques were 
counted and expressed as plaque forming units per mL (PFU mL-1). 
 
2.6 Poliovirus propagation, purification and enumeration 
 
 Mammalian viruses were propagated and purified according to Ichim and Wells 
(2011). To produce viruses, human cervical epithelioid carcinoma (HeLa) cells were 
grown in Dulbecco’s Modified Eagle Medium (DMEM) with 10% FBS and 
penicillin/streptomycin (Growth media) (Life Technologies, UK) mix until 70 to 80% 
confluence was reached. HeLa cells were infected by adenovirus at multiplicity of 
infection (MOI) of 10 and viral supernatant was harvested 5 days post-infection. Viral 
supernatant was filtered by 0.45 μm pore size membrane filter and added to centrifuge 
tube, which was spun down at 49,000g (Rotor SW28, Beckman Coulter) for 90 min at 
4oC. The medium was decanted into bleach-filled container and final drops were 
carefully removed so tubes have similar volumes. Then, 30 mL of viral supernatant 
were loaded to the tubes for another round of centrifugation under same conditions 
described previously. In total, 4 rounds of centrifugation were performed and pellets 
resuspended by careful pipetting. 
 The viral pool was titrated according to the Spearman-Kaeber method (Flint and 
Enquist, 2008). HeLa cells were grown on a 24-well microplate with 2mL of growth 
media for 2 days at 37oC under 5% carbon dioxide. Serial dilutions of virus pool until 
10-8 infective units/mL were prepared with DMEM containing 2% FBS with 
penicillin/streptomycin mix (maintenance media). One hundred microliters of each 
virus dilution were added to each well and incubated for 1 h at 37oC under 5% carbon 
dioxide. After short incubation, 2 ml of maintenance media was added to each well and 
incubation for 5 to 7 days at the same conditions previously described took place. 
Cytopathic effect was observed under microscope (objective 20X, Leica) and 50% 
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tissue culture infectious dose (TCID50) was determined by the Spearman-Kaeber 
formula. 
 
2.7 Purification of attP Adenovirus type 5 (attP AdV5) and Adenovirus type 
2 (AdV2)  
 
The attP Adenovirus type 5 and Adenovirus type 2 were propagated in HEK293 
HeLA and HeLA cells respectively and highly purified by ultracentrifugation in 
caesium chloride (CsCl) gradient as described by Condezo et al. (2015). Viruses were 
harvested 3 days post-infection. Following that, they were purified by 
ultracentrifugation at 219,000g (LE-80K Ultracentrifuge, Beckman Coulter) for 90 min 
at 18oC in 1.25 g.mL-1 and 1.40 g.mL-1 CsCl step gradient. TD1X Buffer (137 mM 
NaCl, 5.1 mM KCl, 700 mM Na2.HPO4.7H2O and 25 mM Tris base at pH 7.4) was used 
to prepare CsCl gradients. Following the first centrifugation, viral bands were extracted 
and centrifuged in 1.31 g.mL-1 CsCl step gradient for 18 hours at 219,000g. Viral bands 
obtained were desalted through column chromatography (Bio-Rad 10 DC, UK), eluted 
with HBS Buffer and stored in aliquots with 10% glycerol at -80oC. The viral titre was 
quantified as determined by Spearman-Kaeber method for 6th and 7th day post-infection 
as described by Flint and Enquist (2008). 
 
2.8 Statistical analysis 
 
 All the experiments were repeated three times independently, with exception of 
activity test against poliovirus where one single independent sample was attained. The 
Wicoxon-Mann-Whitney test was the statistical test applied throughout the study of 
formulations virucidal activity to evaluate the statistical significance associated to 
differences between two independent samples. It is a non-parametric test, which is 
commonly applied as an alternative to t-Student for samples with small dimension, 
heterogeneous variances and non-normal distributions. The statistical hypothesis 
associated to the bilateral test are described as follows: i) null hypothesis (H0): 
differences between two independent samples are not significant (p>0,05) and ii) 
alternative hypothesis (H1): differences between two independent samples are 
significant (p<0,05). On the other hand, the one-way ANOVA parametric test was used 
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for result differences found during nano-indentation studies and virucidal activity tests 
when normal distribution was observed by Kolmogorov Smirnov test (Zar, 1999; 
Wessa, 2013). 
The Chi squared test was used to analyse statistically significant differences in 
proportions among independent groups comprised by each type of damage observed 
through transmission electron microscopy. The null hypothesis (H0) corresponds to no 
effect of formulation on observed damage pattern, whereas alternative hypothesis (H1) 
states there is an effect of formulation on damage pattern.  
The software used for statistical analysis was GraphPad Prism 6.0 for Macintosh 
(GraphPad software, USA). 
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3. Virucidal activity screening of formulations containing ethanol and 
zinc with controls against bacteriophages and mammalian viruses 
 
3.1 Introduction 
 
 Biocides play a significant role on disinfection procedures and prevention and 
spread of infectious agents. Since the virucidal activity associated to active ingredients 
cannot be based exclusively on chemical composition or comparison with activity 
against microorganisms like fungi and bacteria, it becomes essential to evaluate 
virucidal activity through standardised activity tests. Authorisation of novel biocidal 
products is regulated by the EU Biocides Regulation 528/2012 (EU BPR) in the 
European Union. Guidelines for assessment of product activity for disinfection of 
viruses were elaborated by AFNOR (Association Française de Normalisation) in 
France, DEFRA (Department of Environment, Food and Rural Affairs) in the United 
Kingdom, DVV (Deutsche Verinigung zur Bekaempfung der Viruskrankheiten) in 
Germany (Maillard, 2013). This led to the development of the EN13610 and EN14476 
standard quantitative suspension tests for assessing virucidal activity against 
bacteriophages of chemical disinfectants used in food and industrial areas in Europe by 
CEN (European committee for Standardisation) (CEN, 2003; prEN14476). In the 
United States, the ASTM (American Society for Testing and Materials) guideline is 
followed and application for registration of a novel biocidal product needs to be in 
compliance with requirements imposed by EPA (Environmental Protection Agency) 
under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) (EPA, 2012). 
For instance, the ASTM guideline requires a minimum 3 log10 reduction to consider 
biocide as active against viruses (ASTM International, 2011), whereas European 
standards require a minimum of 4 log10 reduction at 5 min contact time (prEN 14476, 
2011). Some of the different standard tests for virucidal efficacy against viruses of 
biocidal products are summarised in Table 3.1. 
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Table 3.1: Details of different standard tests for quantification of disinfectants activity 
against viruses. 
Standardisation 
organisation 
Standard of 
virucidal 
activity 
Standard title Test conditions Reference 
ASTM 
ASTM 
E1052-11 
Standard Test 
Method to 
Assess the 
Activity of 
Microbicides 
against Viruses 
in Suspension 
One part of 
virus suspension 
is added to 9 
parts of test 
substance; 5 or 
60 min contact 
time depending 
on regulatory 
agency; room 
temperature 
ASTM 
(2011a) 
ASTM 
E1053-11 
Standard Test 
method to 
Assess 
Virucidal 
Activity of 
Chemicals 
Intended for 
Disinfection of 
Inanimate, 
Nonporous 
Environmental 
Surfaces 
2.0 mL of test 
substance is 
added to for 
each dried virus 
film carrier 
covering entire 
surface; contact 
time depending 
on regulatory 
agency; room 
temperature 
ASTM 
(2011b) 
ASTM 
E2011-13 
Standard Test 
Method for 
Evaluation of 
Hygienic 
Handwash and 
Handrub 
Formulations 
for Virus-
Eliminating 
Activity Using 
the Entire Hand 
Virus 
suspension is 
spread on palm 
of the hand for 
180s and 
amount of test 
substance is 
added according 
to manufacturer; 
20s contact 
time; 
Temperature at 
35±2oC 
ASTM 
(2013) 
CEN EN 14476 
Quantitative 
suspension test 
for the 
evaluation of 
virucidal 
activity of 
chemical 
One part of 
virus suspension 
is added to 8 
parts of test 
substance+1 part 
of interfering 
substance; no 
CEN (2011) 
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disinfectants 
and antiseptics 
in human 
medicine 
longer than 60 
min contact 
time; 4 log10 
virus 
inactivation 
must be 
achieved for 
validation; 20oC 
temperature for 
surface 
disinfection 
EN13610 
Quantitative 
suspension test 
for the 
evaluation of 
virucidal 
activity against 
bacteriophages 
of chemical 
disinfectants 
used in food and 
industrial areas 
– test methods 
and 
requirements 
(phase 2, step 1) 
One part of 
bacteriophages 
suspension is 
added to 9 parts 
of test 
substance; at 
least 15 min 
contact time, 4 
log10 virus 
inactivation for 
validation; 
20±1oC 
temperature 
CEN (2003) 
 
 The aim of this section was to quantify virucidal efficacy of formulations with 
different ethanol concentrations containing zinc sulphate heptahydrate at pH 10.5 
against MS2 by suspension (EN13610) and carrier tests (ASTM E1053). Virucidal 
activity test (EN13610) against F116 in suspension was also carried out to evaluate the 
capability of using the referred phage for mechanism of action studies by TEM imaging. 
In addition, two batches of formulations with similar composition were prepared by RB 
and their virucidal activity was evaluated and compared with the ones presented by 
formulations prepared in Cardiff. This was carried out in order to verify formulation 
protocol consistency between Cardiff University and Reckitt Benckiser. Moreover, the 
active role of zinc on the overall activity of formulation as well as its affinity towards 
virus was investigated through suspension tests with formulation comprising both 
ethanol and zinc as active ingredients in presence of different chelating agents. The 
activity against commonly used mammalian viruses, adenovirus type 2 (AdV2) and 
poliovirus type 1 (Pv1), through EN14476 activity standard test was carried out in order 
to evaluate efficacy of formulations for inactivation of human pathogens and surrogacy 
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capacity by bacteriophages under test. In this context, this section will elucidate the 
overall activity of aforementioned combination and it represents a first step at 
describing the mechanism of action associated to the combination of alcohol with zinc 
against non-enveloped viruses. 
 
3.2 Materials and Methods 
 
The different formulations tested in the present study and respective 
compositions as wells as the rationale behind experimental design are shown in Table 
2.2 (see Chapter 2) and Figure 3.1, respectively. 
 
Figure 3.1: Summary of all the standard activity tests performed in this section with 
corresponding formulation set under analysis and scientific questions. 
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3.2.1 Neutraliser efficacy test of virucidal activity test against bacteriophages 
 
Neutralisers were used for quenching test substance activity at specific time 
points in order to evaluate efficacy of test substance at different contact times.  
The neutraliser comprised a mixture of L-cysteine (1g.L-1) (Sigma-Aldrich, UK) 
with sodium thiosulphate [0.1% w/v] (Sigma-Aldrich, UK) in distilled water. The 
neutraliser efficacy for quenching biocidal activity was evaluated for both the host and 
the phage according to Maillard et al. (1998). Initially formulation and neutraliser were 
mixed at a ratio 1:8 and 1 mL of bacterial suspension (107 CFU mL-1) was added to the 
mixture with 10 min contact time in order to evaluate cytotoxicity of neutraliser towards 
bacteriophage host. Control was performed by adding 1 mL of bacterial suspension (107 
CFU mL-1) to the mixture of formulation with sterile water (1:8 ratio). Bacteria were 
enumerated by drop count method as described previously.  
A similar procedure was carried out for phages (108 PFU mL-1) and they were 
enumerated by soft overlayer agar technique. The viral titre reduction (R) associated to 
the neutraliser was computed through Equation 3.1 as follows: 
 
    𝑅 = log(𝑋𝑜) − log(𝑋)  (Eq. 3.1) 
 
where Xo represents initial concentration of bacteria (CFU mL
-1) or phage (PFU mL-1) 
before exposure and X the concentration after exposure (CFU mL-1 or PFU mL-1). 
 
3.2.2 Neutraliser efficacy test of virucidal activity test against mammalian viruses 
 
 The neutraliser efficacy for quenching test substance activity against mammalian 
viruses was adapted from standard EN14476 (CEN, 2011). Dilution in ice-cold medium 
was performed by adding 0.1 mL of virus suspension (108 PFU/mL for adenovirus; 105 
PFU/mL for poliovirus) to a mix comprising 9 mL ice-cold Minimum Essential 
Medium (MEM) (Sigma, UK) with 2% fetal bovine serum, 0.1 mL sterile distilled 
water and 0.8 mL test substance (formulation containing ethanol and zinc as actives). 
After 30 min contact time in ice bath, 0.1mL aliquot was added to a MicroSpin S400 
chromatography column (GE, UK) and eluate was serially diluted. Every dilution factor 
was added separately to wells with 70-80% confluence Hela cells monolayer. Virus titre 
was determined by Spearman-Kaeber method 6 to 7 days post-infection. Neutralisation 
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efficacy is attained when difference of virus titre reduction with control test substance 
(PBS) is equal or less than 0.5 log reduction. 
 
3.2.3 Virucidal suspension test against bacteriophages MS2 and F116 
 
 The virucidal suspension test against MS2 and F116 phages was performed to 
evaluate the virucidal activity of the formulations under study. The protocol was an 
adaptation of the BS EN 13610:2002 quantitative suspension test (CEN, 2003). 
Formulations were tested at room temperatures at three distinct contact times (5, 30 and 
60 min) against MS2 without any interfering substance. The contact times above 30 min 
were chosen in order to evaluate formulation efficacy throughout time and to verify at 
which contact time activity values were comparable to the ones found by Ijaz and Zhu 
(2014). The contact times chosen for suspension test against F116 were 5, 10 and 15 
min.  
One mL of phage suspension (109 PFU mL-1) was mixed with 9 mL of a 
formulation and after respective contact time, one mL of phage/formulation mixture 
was added to 9 mL of neutraliser. Subsequently, 10-fold serial dilution was carried out 
and phages from two different dilution factors were enumerated. Three biological 
replicates with 4 technical replicates were performed. A biological replicate refers to 
repeating the activity test with an independent phage samples with the same 
formulations, whereas technical replicates comprise test repetition on a given phage 
suspension sample. Controls were attained by exposing phages i) to formulations with 
similar composition without zinc to verify the direct effect of zinc and alcohol 
(CA001X and RB001X, see Table 2.2) and ii) to formulation without active compounds 
(ethanol and zinc) to test the effect of other formulation components (CA001EXCP, 
RB001EXCP, RB002EXCP, see Table 2.2) and to SM buffer (negative control). The 
viral titre reduction was calculated with equation 3.1. The biocide was regarded to be 
active against the phage when a decrease in phage concentration higher than 4 Log10 
was achieved (CEN, 2003).   
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3.2.4 Virucidal suspension test in presence of chelating agents 
 
 This experiment was designed i) to estimate the complex stability constant of 
zinc ions present in formulation with phage particles and ii) to evaluate how strongly 
zinc present in formulation comprising alcohol and zinc as active ingredients (RB001 
and RB002, see Table 2.2) tends to complex with the phage. Phages were exposed to 
formulation in presence of chelators with distinct complex stability constants with zinc. 
The concentration of each chelating agent to be added to formulation before activity test 
was estimated according to equation 3.2: 
 
    𝑘𝑠 =
⌊𝑀𝐿⌋
⌊𝑀⌋⌊𝐿⌋
     (Eq. 3.2) 
 
Where ks is the complex stability constant; [ML] is the concentration of the metal 
complex in equilibrium; [M] is the concentration of metal ion and [L] the concentration 
of ligand. The chelating agents added to the formulation RB-001 as well as respective 
concentration and complex stability constant are presented in table 3.2. 
 
Table 3.2: Different chelating agents used throughout virucidal suspension test in 
presence of chelating agents.  
Chelating agent 
Concentration 
(% w/v) 
Complex stability 
constant with Zinc (ks) 
Ethylenediaminetetraacetic acid 
(EDTA)(Fisher Chemical, UK)  
0.06 
16.50 
Nitrilotriacetic acid (NTA) (Acros Organics, 
UK) 
0.09 
10.66 
Bicine (Sigma, UK) 0.15 6.50 
 
Chelating agent was added to phage suspension (109 PFU.mL-1) and activity test was 
carried out as described in section 3.2.3. 
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3.2.5 Hard-surface carrier test against bacteriophage MS2 
 
 The quantitative virucidal carrier test carried out was adapted to bacteriophages 
from the standard test ASTM E1053-1 (ASTM, 2011). It was performed to quantify the 
virucidal activity the different formulations against MS2 in the presence of 5% fetal 
bovine serum (FBS) (Sigma, UK) at room temperature at two distinct contact times (5 
and 10 min). The main goal of this experiment was to simulate the activity of the 
biocidal product (formulation) prepared in Cardiff on a contaminated surface. That also 
enables comparison with virucidal activity reported in the patent for the same biocidal 
product described by Ijaz and Zhu (2014).  
 Four hundred μL of phage suspension (109 PFU mL-1) containing 5% FBS was 
poured into glass petri dishes and spread all over the surface. Bacteriophages were 
allowed to dry under ambient conditions for 60 min and 2 mL of biocide was added to 
glass surface covered with bacteriophage layer. After an appropriate contact time, 2 mL 
of neutraliser was added and phages scraped off the glass surface with a L-shaped 
spreader. One mL was aliquoted from resulting suspension of phages. The latter were 
enumerated as previously described in section 3.2.3. Controls corresponded to exposure 
of phages to i) formulations with similar composition without zinc (CA001X, see Table 
2.2); ii) formulations without active compounds (ethanol and zinc) (CA-EXCP, see 
Table 2.2) and iii) PBS solution (negative control). Possible loss of phage titre due to 
the drying process was investigated by comparison between enumerations of phage in 
suspension with the enumeration of phage dried on glass surface treated with PBS.  
 
3.2.6 Virucidal suspension test against adenovirus/poliovirus 
 
 The quantitative virucidal suspension test carried out against adenovirus type 2 
(AdV2) and poliovirus type 1 (Pv1) was based on the standard test EN 14476-11 (CEN, 
2011). Five hundred microliters of inoculum were prepared by adding 340 μL of 
adenovirus type 3 stock suspension (109 infectious units/mL) to 160 μL of distilled 
water. One hundred microliter of inoculum was added to 900 μL of formulation to be 
tested. Upon completion of contact time, 100 μL was added to Microspin S-200 HR 
size-exclusion chromatography column in order to quench formulation activity and 
avoid cytotoxicity by formulation towards host cells. One hundred microliters of 
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mixture were serially diluted and added to wells with 70-80% confluence HeLa cells 
monolayer. Virus titre was determined by Spearman-Kaeber method as previously 
described for 6th and 7th day post-infection (Flint and Enquist, 2008). 
 
3.2.7 Statistical analysis 
 
 All activity tests against bacteriophages were carried out with three biological 
replicates with at least 3 technical replicates each. The activity tests against AdV2 were 
performed with three biological replicates with 6 technical replicates each, whereas only 
one biological replicate was carried out for activity against Pv1. 
 The statistical significance of virucidal activity data was determined by a two-
tailed Wicoxon-Mann-Whitney non-parametric test with 95% confidence interval (see 
Appendix A). All statistical analyses were carried out by Prism 6 software (version 6.0f, 
Graphpad Software).  
 
3.3 Results 
 
3.3.1 Neutraliser toxicity and efficacy test results – activity test against bacteriophages 
 
 Prior to virucidal activity tests, neutraliser efficiency for quenching the virucidal 
activity of formulation containing both alcohol and zinc as active ingredients (CA001-F, 
see Table 2.2), and neutraliser toxicity against MS2 and F116 were investigated. The 
formulation CA001-F (80% (w/v) ethanol with 0.1% Zn as actives) was selected for 
neutralizer efficiency as it contains the highest amount of ethanol in presence of zinc 
and could theoretically present higher virucidal activity. Results are shown in Tables 3.3 
and 3.4. Negative control was performed by adding bacteriophage suspension to sterile 
water as described in section 3.2.1. 
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Table 3.3: Neutraliser efficiency test of formulation CA001 against MS2 and F116. 
Results are expressed in Log10. 
Bacteriophage 
Log10 before 
treatment (PFU 
mL-1) 
Log10 after 
treatment (PFU 
mL-1) 
Log10 Reduction 
MS2 7.10 (± 0.10) 6.90 (± 0.20) 0.26 (± 0.16) 
F116 7.87 (± 0.05) 7.86 (± 0.07) 0.04 (± 0.05) 
 
 
Table 3.4: Neutraliser toxicity test against MS2 and F116. Results are expressed in 
Log10. 
Bacteriophage 
Log10 before 
treatment (PFU 
mL-1) 
Log10 after 
treatment (PFU 
mL-1) 
Log10 Reduction  
MS2 6.44 (± 0.04) 6.30 (± 0.09) 0.14 (± 0.12) 
F116 7.90 (± 0.03) 7.86 (±0.04) 0.05 (±0.03) 
 
 It was observed that the neutraliser was suitable for quenching possible virucidal 
activity of formulation. Differences in virus concentration before and after treatment 
were not significant for both MS2 and F116 (Mann-Whitney, p>0.05). Moreover, the 
neutraliser presented no significant toxicity against bacteriophages (Mann-Whitney, 
p>0.05). 
Neutraliser efficiency for quenching activity of formulation containing 40% 
(w/v) ethanol with 0.1% zinc as active ingredients (RB002, see Table 2.2) was also 
carried out in presence of mammalian viruses as described in section 3.2.2. The 
formulation RB002 was selected for neutraliser efficiency test since it presents highest 
concentration of ethanol amongst formulation set to be tested against mammalian 
viruses. Results are shown in Table 3.5. 
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Table 3.5: Neutraliser efficiency test of formulation RB002 against adenovirus type 2 
(AdV2) and poliovirus type 1 (Pv1). Results are shown in Log10. 
Mammalian virus 
Log10 before 
treatment (PFU 
mL-1) 
Log10 after 
treatment (PFU 
mL-1) 
Log10 Reduction  
Adenovirus type 2 7.34 7.20 0.14 
Poliovirus type 1 6.18 5.90 0.28 
 
According to EN 14476 standard test for virucidal activity in suspension, neutraliser 
efficiency is verified when log10 reduction is equal or lower than 0.5. In this case, 
neutraliser was efficient at quenching formulation RB-002 activity against both viruses. 
 
3.3.2 Virucidal suspension test against MS2  
 
 A virucidal suspension test based on the EN13610 Standard was carried out in 
order to quantify the virucidal activity of formulations against bacteriophage MS2. 
Three distinct contact times (5, 30 and 60 min) were used and results are presented in 
Figure 3.2.  
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Figure 3.2: Virucidal activity of formulations CA001 (CA001A to CA001F with 
different ethanol concentrations ranging from 80% to 40% (w/v) Ethanol 
with 0.1% (w/v) zinc sulphate heptahydrate at pH 10.5; CA-001-G, CA-
001-EXCP and formulations CA001 with different ethanol concentrations 
without zinc (formulation CA001X to CA001FX) against MS2 in 
suspension at three contact times. A) 5 min; B) 30 min; C) 60 min; D) 
control formulations unformulated 80% (w/v) ethanol without zinc; 
CA001G (0.1% zinc + excipients, see Table 2.2) and CA001EXCP 
(excipients only, see Table 2.2) at distinct contact times. Three biological 
replicates with 4 technical replicates were conducted. (Note: Insert graphs 
show the results at reduced scale). 
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 The virucidal activities associated to formulations with ethanol concentration 
between 40% and 25% w/v (CA001, CA001A to CA001F, see Table 2.2) were less than 
1 log10 reduction at 5 min contact time (Fig. 3.2A). Virucidal activity at 5 min contact 
time of formulations CA001A to CA001F (containing alcohol and zinc as actives, see 
Table 2.2) was enhanced when compared to their counterparts CA001X, CA001AX to 
C001FX (formulations with different ethanol concentrations as sole active ingredient 
without zinc, see Table 2.2). There was however no significant difference (Mann-
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Whitney, p>0.05) in activity for ethanol concentration ranging from 40% (w/v) to 25% 
(w/v) with zinc (CA001, CA001A to CA001F, see Table 2.2). As contact time increases 
to 30 and 60 min, the reduction in virus concentration increased concomitantly and 
activity of formulation containing both ethanol and zinc (CA001) compared to 
counterparts without zinc (CA001X) becomes significant (p<0.05) for the ethanol 
concentration ranging from 40% (w/v) to 25% (w/v) (Fig. 3.2B and C); a 2.5 and 4 log10 
reductions in virus concentration were achieved, although these reductions in 
concentration were significantly (Mann-Whitney, p<0.05) lower that formulation 
comprising 80% ethanol with zinc. It can also be observed that increased virucidal 
activity by the addition of zinc to the formulation is more noticeable at lower ethanol 
concentrations.  
 Controls at different contact times (80% (w/v) ethanol; CA001G and 
CA001EXCP) were performed to evaluate the virucidal activity associated to zinc and 
to other components of the formulation. By comparing results obtained at 5 min contact 
time, it was observed that the activity of ethanol ranging from 40% (w/v) to 25 % (w/v) 
with zinc (Fig. 3.2D) was comparable to the control formulation containing only zinc 
(Mann-Whitney, p>0.05). This demonstrates that the observed increased virucidal 
activity might be exclusively due to zinc ions. Formulation CA001EXCP (excipients 
only, see Table 2.2) show that excipients present no significant activity over time 
ranging from 5 to 60 min against bacteriophage MS2 as expected. Differences between 
formulations comprising ethanol and zinc compared to control CA001G (containing 
only 0.1% zinc as active, see Table 2.2) are significant at 30 and 60 min contact time 
(Mann-Whitney, p<0.05) (see Appendix A).  
 Similar formulations as the ones prepared in Cardiff were made by RB in 
different batches (formulation sets RB001 and RB002, see Table 2.2). The virucidal 
activities of formulations RB001 were evaluated and the results are shown in Figure 3.3.  
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Figure 3.3: Virucidal activity of RB-001, RB-001A to RB-001F (distinct ethanol 
concentrations with 0.1% (w/v) zinc sulphate heptahydrate as active, see 
Table 2.2); formulations RB001X, RB001AX to RB001FX (distinct 
ethanol concentrations without zinc, see Table 2.2); RB-001G (zinc as 
sole active ingredient) and RB-001-EXCP (excipients only) against MS2 
in suspension at 5 min contact time. A) Activity test of formulations RB-
001 (40% ethanol with zinc), RB-001A to RB-001F (from 35% (w/v) to 
80% (w/v) ethanol respectively with 0.1% (w/v) zinc sulphate 
heptahydrate) and RB-001AX to RB001FX (formulation counterparts 
without zinc and alcohol as sole active) with different concentrations of 
ethanol; B) Control formulations RB-001G (0.1% (w/v) zinc as sole 
active) and RB-001-EXCP (excipients only). Three biological replicates 
with four technical replicates were performed. (Note: Insert graph shows 
the results at reduced scale). 
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 The virucidal activities were relatively low (less than 1 log10) for RB-001, RB-
001A to RB-001E formulations with ethanol concentration ranging from 40% to 25% 
(w/v) (Fig 3.3A). The virucidal activities of RB-001 (40% (w/v) ethanol with 0.1% 
(w/v) zinc sulphate heptahydrate, see Table 2.2) were similar (Mann-Whitney, p>0.05) 
to CA-001, which attest for method consistency. Significant increased activity 
following the addition of zinc was only observed for formulation RB001C (containing 
30% ethanol with zinc as actives) (Fig 3.3A). By comparison with control formulation 
RB001G (comprising only zinc as the active ingredient) (Fig. 3.3B), the activity of RB-
001 with ethanol concentration range between 40 to 25% (w/v) ethanol may be 
exclusively due to zinc. Significant activity difference between CA001F and RB001F 
was found (Mann-Whitney, p<0.05). After investigation of formulation ingredients 
from suppliers between Cardiff and Reckitt Benckiser, the difference in activity 
observed can be attributed to the usage of industrial denaturated ethanol by Reckitt 
Benckiser. In Cardiff ethanol grade 99.8% (Fisher Chemicals, UK) was used.  
 Additional suspension tests against bacteriophage MS2 were performed at 
different contact times using commercial Lysol formulation at distinct contact times. 
The results are shown in Figure 3.4. 
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Figure 3.4: Virucidal suspension activity test against MS2 by exposure to different 
Lysol formulations at different contact times and comparison with CA001 
formulations. A) Activity test on Lysol formulations (limit of detection 
was reached); B) Activity test on CA001 formulations. Three biological 
replicates with four technical replicates were performed. 
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 Both Lysol formulations C0042-042 and C042-084 (Fig. 3.4A) were highly 
effective against MS2 (more than 5 log10 reduction) in the first minutes of exposure 
when compared to formulations comprising zinc and ethanol (CA001, CA001A to 
CA001F) as sole active ingredients.  
Formulation RB002 represented a newer batch of RB-001 for 40% (w/v) ethanol 
and 0.1% (w/v) zinc sulphate combination and respective control formulations 
(RB001G and RB001EXCP, see Table 2.2). Activity tests of formulations RB002 and 
derivatives were performed against MS2 at 5 and 60 min contact time and results are 
shown in Figure 3.5. 
 
 
Figure 3.5: Virucidal activity of RB-002 formulation (40% (w/v) ethanol with 0.1% 
(w/v) zinc sulphate heptahydrate as actives), RB-002G (0.1% (w/v) zinc 
sulphate heptahydrate as sole active ingredient), RB-002EXCP (excipients 
only) at 5 and 60 min contact time against bacteriophage MS2. A) 5 min 
contact time; B) 60 min contact time. (Note: Insert graphs show the results 
at reduced scale). 
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 The activity test at 5 min contact time allows a direct comparison with 
formulation RB-001, a previous batch of the formulation. The virucidal activities were 
relatively low (below 1 log10) at both contact times. These activities are comparable to 
the ones obtained for RB-001 (Mann-Whitney, p>0.05) and controls (RB-001G and 
RB-001EXCP) at 5 min contact time, which highlights the similarities between 
formulations and possible comparable mode of action against bacteriophage MS2 (see 
Figure 3.3A vs. Figure 3.5A).  
 At 60 min contact time, formulation RB-002 were the only ones presenting a 
significantly higher activity than at 5 min contact time. RB-002G containing zinc as 
sole active ingredient presented a higher activity than excipients demonstrating an 
increased efficacy by the addition of zinc. Overall the activity against MS2 was 
significantly higher when both ethanol and zinc were present (Mann-Whitney, p<0.05) 
than zinc as sole active ingredient.  
3.3.3 Virucidal suspension test against bacteriophage F116 
 
The virucidal suspension test based on EN13610 standard was used to evaluate 
the virucidal activity of formulations CA001 against bacteriophage F116. The results 
were used to define the contact time appropriate for TEM imaging studies; i.e. contact 
time that produced 1-log10 reduction in virus concentration.  The results for two 
different contact times (5 and 10 min) are presented in Figure 3.6. 
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The virucidal activity associated to CA001 with 40% (w/v) ethanol (1 log10 at 5 
and 10 min contact time) was only slightly higher compared to formulations with 25% 
(w/v) ethanol (0.8 log10 and 0.9 log10 for 5 and 10 min contact time, respectively). 
However, the difference in activity was not significant (p>0.05) (Fig. 3.6A). There was 
no significant (p<0.05) activity enhancement at 5 min contact time. At 10 min contact 
time, the virucidal activity of CA-001 containing 40% (w/v) ethanol with zinc was 
significantly higher (p<0.05) than with CA-001 with 40% ethanol only and 25% (w/v) 
ethanol with zinc (Fig. 3.6B). It was also observed that the differences between 
virucidal activity of CA001 was comparable to the one obtained for the CA001G 
comprising only 0.1% (w/v) zinc at 5 min, which showed that only zinc seems to 
contribute to virucidal activity of CA001 against F116. On the other hand, the virucidal 
activities for CA001 with both ethanol and zinc were significantly (p<0.05) higher than 
activity of CA-001G containing 0.1% zinc only for 10 min exposure time. 
 Difference between the virucidal activities against MS2 and F116 were 
significant (p<0.05), indicating that F116 was more susceptible to the formulations 
under study. 
 The virucidal activity of RB-002 formulations and derivatives were performed 
against bacteriophage F116 at 60 min contact time. Results are presented in Figure 3.7. 
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Figure 3.6: Virucidal activity of CA001 (40% (w/v) ethanol with 0.1% (w/v) zinc 
sulphate heptahydrate) and CA001E (25% (w/v) ethanol with 0.1% (w/v) 
zinc sulphate heptahydrate) against F116 at two contact times. A) 5 min 
contact time; B) 10 min contact time; C) control formulations CA001-G 
(0.1% (w/v) zinc sulphate heptahydrate as sole active) and CA001-EXCP 
(excipients only). Three biological replicates with four technical replicates 
were performed. (Note: Insert graphs show the results at reduced scale). 
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Figure 3.7: Virucidal activity of RB-002 formulation and derivatives at 60 min contact 
time against bacteriophage F116. RB-002 has 40% (w/v) Ethanol with 
0.1% (w/v) ZnSO4.7H2O as active ingredient; RB-002G 0.1% (w/v) 
ZnSO4.7H2O and RB-002-EXCP is a negative control with formulation 
excipients only. (Note: Insert graph shows the results at reduced scale). 
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 Similarly to the activity test against MS2, RB-002 formulations yielded 
relatively low efficacy against F116 (lower than 1 log10). Efficacy against F116 was 
comparable to MS2 (p<0.05) and this highlights bacteriophages insusceptibility to the 
formulations. Although the formulation RB-002G with zinc as sole active ingredient 
also presented higher efficacy than excipients, the difference was not significant 
(p>0.05), similarly to the result obtained against MS2.  
 
3.3.4 Hard surface carrier virucidal activity test against MS2 
 
 The hard surface carrier test was based on the ASTM 1053 standard and adapted 
for bacteriophages. The experiment was carried out to quantify the virucidal activity of 
formulations CA001 against bacteriophage MS2 dried on an inanimate glass surface in 
presence of soil load (5% fetal bovine serum) at different contact times. Figure 3.8 
shows the results obtained for the formulations and controls at 5 and 10 min contact 
time. 
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Figure 3.8: Virucidal activity of CA001 (40% (w/v) ethanol with 0.1% (w/v) zinc), 
CA001B (33.5% (w/v) ethanol with 0.1% (w/v) zinc), CA001E (25% 
(w/v) ethanol with 0.1% (w/v) zinc) and CA001F (80% (w/v) ethanol 
with 0.1% (w/v) zinc) and counterparts without zinc (CA001X; 
CA001BX; C001EX; CA001FX formulations) against MS2 dried on an 
inanimate glass surface at two contact times. A) 5 min; B) 10 min; C) 
Control formulations unformulated 80% (w/v) ethanol CA001G (0.1% 
(w/v) zinc as sole active) and CA001EXCP (excipients only) at distinct 
contact times. Three biological replicates with four technical replicates 
were performed. (Note: Insert graphs show the results at reduced scale). 
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CA001F containing 80% (w/v) ethanol with zinc presented higher activity than 
the control formulation CA001FX comprising only 80% ethanol (w/v) (Fig. 3.8A). An 
increase in virucidal activity when zinc is present was observed for lower ethanol 
concentrations similarly to the activity tests of bacteriophage MS2 in suspension (see 
Fig. 3.2 vs. Fig. 3.8). At 5 min contact time, significant differences (p<0.05) in activity 
were found between CA001BX containing 33.5% (w/v) and CA001EX with 25% (w/v) 
ethanol only and their respective counterparts containing ethanol and zinc (Fig 3.8A). 
Nevertheless, there was no evidence (Mann-Whitney, p<0.05) of increased activities for 
the formulations containing 25% (w/v) to 40% (w/v) ethanol with zinc at 10 min contact 
time (Fig. 3.7B). The control formulation CA001G containing only 0.1% (w/v) zinc 
sulphate showed a virucidal activity similar to the test formulations within 5 min 
exposure time (0.30 log10) (Fig. 3.7C). This result shows that the activity may be 
exclusively due to zinc ions, which improves overall activity of formulations CA001 
within the first 5 minutes of contact. On the other hand, significant activity differences 
(Mann-Whitney, p<0.05) were obtained between 25 to 33.5% ethanol with zinc and 
control formulation containing 0.1% zinc only as the active ingredient at 10 min contact 
time.  It is noteworthy that results obtained for the hard surface test at 5 min contact 
time are comparable to the ones attained with the EN13610 virucidal suspension test in 
terms of activity enhancement by addition of zinc.  
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 The virucidal efficacy of RB-001 formulations was also evaluated with a hard 
surface test and results are presented in Figure 3.9. 
 
Figure 3.9: Virucidal activity of RB-001 (40% (w/v) ethanol with 0.1% (w/v) zinc), 
RB-001E (25% (w/v) ethanol with 0.1% zinc) and RB-001F (80% (w/v) 
ethanol with 0.1% zinc); RB-001X (40% (w/v) ethanol as sole active), RB-
001EX (25% (w/v) ethanol) and RB-001FX (80% (w/v) ethanol) against 
MS2 dried on an inanimate glass surface at 5 min contact time. Three 
biological replicates and two technical replicates were performed. Limit of 
detection was reached for RB-001F, hence no error bar is shown. (Note: 
Insert graphs show the results at reduced scale). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Significant (Mann-Whitney, p<0.05) increased in activity by addition of zinc 
was found for formulations containing 40 and 25% ethanol (w/v), although overall 
activities attained were low (< 1 log10). Reductions in virus concentration were 
comparable to the ones obtained with CA001 formulations (Fig 3.8), with the exception 
of the formulation RB-001FX comprising 80% ethanol.  
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3.3.5 Virucidal suspension test against MS2 in presence of chelators 
 
The virucidal suspension test based on EN13610 standardised test in presence of 
chelating agents with different degrees of complex stability with zinc was carried out 
separately with CA001 and RB-001 at 60 min contact time. Ethylenediamine tetraacetic 
acid (EDTA) was the strongest chelator, nitrilotriacetic acid (NTA) an intermediary and 
bicine the weakest chelator of zinc ions used in the present study. The formulation 
activity against bacteriophage MS2 is shown in Figure 3.10. 
 
Figure 3.10: Virucidal suspension test with CA001 and RB-001 formulations in 
presence of different chelators at 60 min contact time against 
bacteriophage MS2. A) Activity test on formulation RB-001; B): 
Activity test on formulation CA001. Three biological replicates with four 
technical replicates were performed. 
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The activity of formulation RB-001 against MS2 was more affected by addition 
of chelating agents than CA001 (Fig. 3.9). EDTA was the most efficient chelator 
(p<0.05) to decrease virucidal activity. The significant reduction in virucidal activity 
following the use of the different chelators informs that zinc ions present in RB-001 
bind weakly to bacteriophage MS2, with a complex stability lower than 6.50. On the 
other hand, CA001 was not strongly affected (p>0.05) by the addition of chelators, 
indicating that there may be a difference in terms free zinc ions between formulations 
CA001 and RB-001.  
The same test in presence of chelating agents was carried out for RB-002 
formulation and its activity was monitored over time by repeating the same activity test 
at different time points. That was performed at distinct time points in order to verify 
chemical stability of formulation system containing alcohol and zinc over time. The 
results are presented in Figure 3.11. 
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Figure 3.11: Virucidal suspension test of RB-002 formulation (40% (w/v) ethanol with 
0.1% (w/v) zinc sulphate heptahydrate as actives) against MS2 in 
presence of different chelating agents at different times. A) Activity test 
performed 1 month after formulation preparation; B) 6 months after 
formulation preparation; C) 12 months after preparation.  
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Although the activity of formulation RB-002 against MS2 remained the same 
(around 1 log10) in absence of chelating agents after 12 months, it is noteworthy that 
impact of chelators is more pronounced after 12 months of preparation. The most 
significant (Mann-Whitney, p<0.05) reduction in activity was achieved in presence of 
EDTA (see Fig. 3.11 C) as expected. Bicine and NTA presented similar impact on 
formulation activity over the first 6 months of preparation (around 0.77 and 0.79 log10, 
respectively) and led to lower activity after 12 months (around 0.56 and 0.59 log10 
respectively). This may be an indication that quantity of free zinc may change along 
time in formulation RB-002, hence there might be a distinct zinc coordination over 
time. This could possibly affect formulation stability. Similarly to formulation RB-001, 
zinc tends to bind weakly to bacteriophage and binds preferentially to the chelating 
agents as overall activity against MS2 was significantly reduced (Mann-Whitney, 
p<0.05).    
 
3.3.6 Virucidal suspension test against Adenovirus type 2 (AdV2) and Poliovirus type 1 
(Pv1) 
 
The virucidal suspension test of formulation RB-002 and derivatives was 
performed against AdV2 and Pv1 according to the EN14476 standard in clean 
conditions, i.e. with sterile hard water as the only interfering substance without organic 
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load. The main purpose was i) to evaluate formulation system activity against human 
pathogens like adenovirus and poliovirus and ii) to compare the virucidal activities 
against bacteriophage MS2 and F116 with mammalian viruses. Due to relatively low 
activity of the RB-002 formulations against bacteriophages, activity tests against 
mammalian viruses were performed only at 60 min contact time. The formulations 
activity against aforementioned mammalian viruses is presented in Figure 3.12. 
 
Figure 3.12: Virucidal suspension test of RB-002 (40% (w/v) ethanol with 0.1% (w/v) 
zinc sulphate heptahydrate as actives); RB-002X (40% (w/v) with QAC 
as actives); RB-002G (0.1% zinc sulphate heptahydrate as sole active) 
and RB-002EXCP (excipients only) formulations against mammalian 
viruses at 60 min contact time in clean conditions. A) Activity test against 
Adenovirus type 2 (AdV2); B) Activity test against Poliovirus type 1 
LSc-2ab (Pv1). Three independent biological replicates with 6 technical 
replicates were performed for activity against AdV2, whereas only one 
biological replicate with 6 technical replicates was attained for activity 
against Pv1. 
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 The virucidal activities of RB-002 formulation containing 40% ethanol and 
0.1% zinc sulphate as active ingredients against AdV2 and Pv1 were 5.2 and 3.7 log10 at 
60 min contact time respectively (see Figure 3.12 A and B). The activities were 
significantly higher when compared to formulation RB-002G (p<0.05) counterpart 
containing zinc sulphate as sole active ingredient. For instance, RB-002G activities 
against AdV2 and Pv1 were 0.8 and 2.1 log10, respectively. However, it can be noted 
that activity of RB-002G against Pv1 was much higher when compared to AdV2 
pointing out that zinc may have a more active role against Pv1 when compared with 
AdV2. The excipients as sole components represented by formulation RB-002EXCP 
presented residual activity against both AdV2 and Pv1. The activity of RB-002EXCP 
(excipients only) against Pv1 was higher indicating higher susceptibility of the virus to 
the formulation excipients. On the other hand, AdV2 was shown to be more susceptible 
than Pv1 to formulation RB-002). It is important to stress out that activity against Pv1 
was carried out with only one biological replicate, hence more replicates are necessary 
to verify the impact of formulations RB-002 against Pv1 and consequently evaluate if 
there are significant differences in susceptibilities between AdV2 and Pv1. Although 
standard activity test are not identical, the overall activities of RB-002 and RB-002G 
against mammalian viruses were significantly higher (p<0.05) than their activities 
against bacteriophages MS2 and F116 under same conditions, i.e. clean conditions with 
exposure to formulation for 60 min in suspension. Therefore, bacteriophages F116 and 
MS2 may not be suitable surrogates for mammalian viruses AdV2 and Pv1 for testing 
0
1
2
3
4
5
6
L
o
g
 r
ed
u
ct
io
n
 (
P
F
U
/m
L
)
B
RB-002
RB-002G
RB-002EXCP
RB-002 in
presence of
EDTA
 71 
these types of formulations. However, it is noteworthy that trends observed amongst 
formulations are similar between bacteriophages and mammalian viruses. For instance, 
the activity differences between RB-002 and RB-002G against F116 are similar to the 
ones presented against AdV2. Finally, RB-002 activity against Pv1 was reduced 
approximately 4 times when EDTA chelating agent was present. 
 
3.4 Discussion 
 
 The virucidal activity of formulations containing different concentrations of 
ethanol with 0.1% zinc sulphate heptahydrate at pH 10.5 against MS2 were assessed 
with different virucidal standard protocols. A summary with the main results obtained 
through different activity standard tests of several formulations against non-enveloped 
viruses is presented in Table 3.6. 
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Table 3.6: Summary of the main results of different formulations virucidal activities 
against non-enveloped viruses in the present study. 
 
Formulation 
set 
Formulation Test 
Contact 
time 
Virus 
Viral titre 
reduction 
(log10) 
Formulation 
prepared in 
Cardiff 
CA001 (base 
formulation) 
EN13610 
60 min MS2 4.18±0.12 
5 min F116 0.98±0.06 
ASTM1053 5 min MS2 0.29±0.09 
CA001A EN13610 60 min MS2 4.15±0.16 
CA001B 
EN13610 60 min 
MS2 
4.57±0.32 
ASTM1053 5 min 0.40±0.08 
CA001C 
EN13610 60 min MS2 
3.93±0.04 
CA001D 3.90±0.05 
CA001E 
EN13610 
60 min MS2 3.80±0.05 
5 min F116 0.85±0.07 
ASTM1053 5 min MS2 0.44±0.15 
CA001F 
EN13610 60 min MS2 >6 
ASTM1053 5 min MS2 3.5±0.20 
CA001X 
EN13610 
60 min MS2 2.65±0.09 
5 min F116 1.03±0.03 
ASTM1053 5 min MS2 0.17±0.05 
CA001AX EN13610 60 min MS2 1.26±0.06 
CA001BX 
EN13610 60 min 
MS2 
0.84±0.05 
ASTM1053 5 min 0.06±0.00 
CA001CX 
EN13610 60 min MS2 
0.64±0.07 
CA001DX 0.49±0.05 
CA001EX 
EN13610 
60 min MS2 0.26±0.04 
5 min F116 0.94±0.08 
ASTM1053 5 min MS2 0.05±0.07 
CA001FX 
EN13610 60 min 
MS2 
5.40±0.24 
ASTM1053 5 min 3.34±0.20 
CA001G EN13610 60 min MS2 1.07±0.03 
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5 min F116 0.95±0.07 
ASTM1053 5 min MS2 0.30±0.08 
CA001EXCP 
EN13610 
60 min MS2 0.22±0.07 
5 min F116 0.31±0.05 
ASTM1053 5 min MS2 0 
Formulations 
sent by RB 
(December 
2014) 
RB-001 
EN13610 
60 min 
MS2 
1.26±0.07 
5 min 0.32±0.17 
ASTM1053 
5 min 
0.78±0.08 
RB-001C EN13610 0.18±0.05 
RB-001E 
EN13610 0.15±0.03 
ASTM1053 0.22±0.05 
RB-001F 
EN13610 1.88±0.19 
ASTM1053 4.35±0.09 
RB-001X 
EN13610 0.29±0.10 
ASTM1053 0.21±0.05 
RB-001CX EN13610 0.02±0.02 
RB-001EX 
EN13610 0.13±0.09 
ASTM1053 0.09±0.04 
RB-001FX 
EN13610 2.64±0.32 
ASTM1053 >5 
Formulations 
sent by RB 
(September 
2015) 
RB-002 
EN13610 
60 min 
MS2 0.88±0.04 
F116 0.68±0.02 
EN14476 
AdV2 5.26±0.10 
Pv1 3.71 
RB-002G 
EN13610 
MS2 0.37±0.06 
F116 0.14±0.02 
EN14476 
AdV2 0.80±0.12 
Pv1 2.06 
RB-
002EXCP 
EN13610 
MS2 0.05±0.03 
F116 0.09±0.04 
EN14476 
AdV2 0.61±0.10 
Pv1 1.39 
Lysol #C0042-42 EN13610 5 min MS2 >5 
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 Increased activity linked to the presence of zinc was only observed after 30 min 
and 60 min contact time. Ijaz and Zu (2014) evaluated the virucidal activity of a similar 
formulation to CA001 and RB-001 against poliovirus-type 1 with the ASTM 1052 
suspension test and obtained an activity greater than 6 log10 virus titre reduction after 5 
min contact time. MS2 possesses similar properties (size, capsid geometry, nucleic acid) 
to poliovirus-type 1 (Macinga et al., 2008) and that the test methods (suspension test) 
were similar, the difference between results obtained here and the literature can be 
attributed to: i) mass transfer resistance caused by an improper mixing of active 
compounds (mass transfer resistance); ii) by the need of multiple targets on MS2 or iii) 
by differences in formulation chemistry. The mass transfer resistance hypothesis should 
be taken into account since virucidal activity of CA001 increased over time ranging 
from 5 to 30 and 60 min contact time. This might be associated to specific mixing times 
of the active ingredients and interaction with the target. For instance, MS2 
bacteriophage is known to be a non-enveloped hydrophobic phage (Farkas et al., 2014).  
Formulations containing 80% (w/v) ethanol were used as positive control to compare 
with results from the literature, i.e. those formulations were used to verify that the 
standard test was suitable for analysis of virucidal activity. Jones et al. (1991) obtained 
a 0.70 MS2 log10 titre reduction after 2 min contact time with 70% ethanol, which is 
comparable to the results obtained in the present study. Maillard et al. (1994) 
demonstrated a 3.675 log10 reduction in MS2 titre with 70% ethanol for 20 min. The 
Lysol formulations (#C0042-42 and #C042-084) were also important for evaluating 
methodology in terms of virucidal efficacy where activity against MS2 were higher than 
5 log10. Higher activity of Lysol formulations can be attributed to presence of additional 
active ingredients such as quaternary ammonium compounds (QACs), biguanides and 
synergy between ingredients. For instance, Pinto et al. (2010) obtained more than 5 
log10 reduction by exposing MS2 to formulation with polyhexamethylene biguanide as 
active ingredient. The addition of QAC (Onyxide 3300) may have an impact on 
observed virucidal activity by #C0042-42 and #C042-084 against MS2 despite QAC 
being known to present relatively lower activities against non-enveloped virus 
(Feliciano et al., 2012; Whitehead and McCue, 2010; McDonnell and Russel, 1999; 
Maris, 1995; Rutala et al., 2006). For instance, Solomon et al. (2009) observed a QAC 
(Sentramax) yielded around 0.63 log10 reduction activity against MS2 in 10 min with a 
formulations #C042-084 5 min >5 
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modified carrier test. These results are in agreement with the literature where Su and 
D’Souza (2012) found out high initial titre of MS2 was reduced by an average 2 log10 
regardless of QAC concentration at 2 hours contact time. Therefore, it is possible that 
observed activity increase for Lysol formulations against MS2 may be a purely additive 
effect of ethanol, QAC activity, metal ion and biguanides against the bacteriophage.  
By comparing the results at 5 min contact time, the activity of ethanol with zinc 
system in formulations CA001 and RB-001 is comparable to the control formulations 
(CA001-G and RB-001G) containing only 0.1% (w/v) zinc. This demonstrated that 
activity might be exclusively due to zinc ions as excipients as sole ingredients 
(CA001EXCP; RB-001EXCP and RB-002EXCP) present activities lower than 
formulations containing zinc over time.  
Virucidal efficacies lower than 1 log10 were obtained when formulations were 
tested against MS2 dried on hard surface. The control formulation CA001G containing 
0.1 % (w/v) zinc sulphate presented comparable activity at the same contact times to 
formulations CA-001 containing both active ingredients indicating that the formulation 
activity might be exclusively due to zinc ions in the first minutes of exposure. It is also 
possible that MS2 might not be a suitable human virus surrogate for evaluating the 
virucidal activity associated to these specific formulations when tested with surface test.  
Virucidal activity of formulations was also tested against bacteriophage F116. 
No evident increase in virucidal activity was observed in the presence of ethanol and 
zinc within 10 min contact times. Activity for control formulation CA001-FX composed 
by 80% (w/v) ethanol was similar to the one reported in a previous study (Maillard et 
al., 1993). Although low activities (approximately 1 log10 reduction) were observed at 5 
min contact time against MS2 and F116, it was observed that F116 was significantly 
more susceptible to the formulations comprising ethanol and zinc. Despite not being 
regarded as an accurate model for assessing biocides virucidal activity, F116 is a 
suitable model for studying the impact of formulations on virus structure (Maillard et 
al., 1995)  
 Similar virucidal activity tests were performed against MS2 with RB-001 and 
RB-002 formulations to evaluate methodology consistency between laboratories and 
formulation chemistry differences. RB-001 results were comparable to CA001, except 
for formulations containing 80% ethanol. This difference was associated to the presence 
of industrial denaturated ethanol in RB-001F for instance. Denaturated ethanol is known 
to present other alcohol molecular entities such as methanol, which may influence 
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overall formulations RB-001F and RB-001FX activities (Noda et al., 1981). 
Consequently, activity enhancement by addition of zinc at the ethanol concentration 
ranging from 33.5% (w/v) to 25% (w/v) could also be due to presence of denaturated 
ethanol. The formulation RB-002 presented similar activities to RB-001 against MS2 
since they are the same formulations from different batches.  
From the virucidal suspension test in presence of chelators, it was verified that 
zinc definitely plays a role in the activity of the formulation RB-001 and RB-002 
through interactions with the bacteriophage MS2. Moreover, it also points that zinc 
availability in the formulation CA001 may be reduced when compared to formulations 
RB-001 an RB-002 as the former was not significantly affected by addition of chelating 
agents. This may be an indication that zinc is already complexed with other formulation 
excipients and not available for chelation or binding to virions. EDTA was the most 
efficient (p<0.05) to decrease the virucidal activity due to its strong chelating capacity 
with zinc (complex stability with zinc of 16.50) (Flora and Pachauri, 2010). 
Additionally, it is reported in the literature that EDTA binds tightly with zinc ions and it 
competes with proteins containing zinc-binding motifs (Michael et al., 1992; Nyborg 
and Peersen, 2004).  Regarding formulation stability in terms of virucidal activity 
exclusively, it was shown that the impact of chelating agents such as EDTA was more 
pronounced 12 months after formulation RB-002 preparation. This may indicate a 
change of zinc coordination along time, which could possibly yield a different activity 
in the future.  
Suspension tests against mammalian viruses were also carried out in order to 
evaluate the activity of formulations RB-002. Mammalian viruses are more suitable 
target organisms than bacteriophages due to their pathogenicity towards humans. 
Besides, it is important to analyse the use of bacteriophages MS2 and F116 as 
surrogates for these formulations activities against non-enveloped viruses. AdV2 was 
shown to be more susceptible to RB-002 (ethanol and zinc as active ingredients) than 
Pv1.  
 The observed activity difference between adenovirus and poliovirus may be 
related to activity of ethanol. Several studies in the literature have reported higher 
susceptibility of adenoviruses to alcohol, where results were shown to be variable across 
different alcohol aliphatic chains (Tyler et al., 1990; Kampf et al., 2013; Steinmann et 
al., 2013; Kampf, 2016).   
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Moreover, the distinct susceptibilities between AdV2 and Pv1 could be related 
to differences in terms of capsid surface charges and hydrophobicity nature where Pv1 
was reported to be more hydrophilic than AdV2 (Bales and Li, 1993; Ionidis et al., 
2016). On the other hand, Pv1 was demonstrated to be more susceptible than AdV2 to 
zinc as sole active ingredients and excipients (RB-002G and RB-002EXCP), where RB-
002G was more effective against both viruses compared to RB-002EXCP.  
Geist et al. (1987) also showed relatively low activity of zinc gluconate against 
non-enveloped rhinovirus and concluded activity depends on zinc salt concentration. 
Relatively low activities of formulation with zinc as sole active ingredient may be also 
related to low zinc concentration (around 6 mM). Korant and Butterworth (1976) 
described a stage of virion maturation where zinc was found to complex with rhinovirus 
capsid protein altering its structure and hampering subsequent cleavage reactions for 
virion formation. That illustrates the capacity of zinc to bind virus capsid proteins and 
possibly alter structure and the role of it in virus maturation and infectivity. Wei et al. 
(2012) hypothesized that the mechanism of action of zinc salts against transmissible 
gastroenteritis was similar to the one observed for non-enveloped rhinovirus. This was 
due to zinc binding to capsid allowing virus to bind host cell but hampering penetration 
and consequently virus infectivity. Kuemel et al. (1990) noticed that inactivation of 
HSV was caused by alteration of virus glycoproteins leading to inhibition of virus 
penetration in host cell. Thus, it is possible that activity of zinc against AdV2 and Pv1 
was due to alteration on capsid protein resulting in structural changes which hampered 
virus penetration to some extent. AdV2 and Pv1 are known to require protein 
conformation (VP proteins for poliovirus, EA proteins for adenovirus) and an adequate 
capsid mechanical strength for infecting cells (Hogle, 2002). The mechanism of action 
associated to RB-002 against AdV2 may be strictly exclusively related to damage at the 
capsid level instead of nucleic acid damage. 
Surprisingly activities by RB-002 against AdV2 and Pv1 were significantly 
higher than activities against F116 and MS2 (see Table 3.4). Although those 
bacteriophages are known to be suitable surrogates for mammalian virus treated with 
various formulation systems, differences in terms of isoelectric point and surface 
charges, capsid proteins and zinc finger domains and infection pathways could be 
responsible for observed disparities in terms of activity. Some of the differences 
between bacteriophage MS2 and mammalian viruses are highlighted in Table 3.7. 
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Table 3.7: Differences between MS2 and mammalian viruses (Pv1 and AdV2) in terms 
of physicochemical properties and susceptibility to formulation RB-002. 
 
Virus 
Isoelectric point 
(pI) 
Capsid proteins 
Viral titre 
reduction 
upon 
exposure to 
RB-002 
Bacteriophage 
MS2 
3.9 (You et al., 
2011) 
Protein homo-dimers; single 
copy of protein A 
(Kuzmanovic et al., 2003) 
0.88±0.04 
Adenovirus type 5 
and 2 
4.5 (Trilisky and 
Lenhoff, 2007) 
Hexon; Penton Base 
(polypeptide III); fiber 
(polypeptide IV); polypeptide 
VI; polypeptides VIII and IX 
(San Martin, 2012) 
5.26±0.10 
Poliovirus type 1 
6.6 (You et al., 
2011) 
VP1, VP2, VP3 and VP4 
(Minor, 1996) 
3.71 
 
 This highlights possible distinct targets of alcohol/zinc against tested 
bacteriophages and mammalian viruses. For instance, Bales and Li (1993) discovered 
that MS2 was not a proper surrogate for poliovirus in filtration with silica beads as 
distinct isoelectric points between viruses contributed to different attachment rates at pH 
7. The differences of isoelectric point (pI) between MS2 (pI 3.9) and Pv1 (pI 6.6) could 
alter the electrostatic barrier between virions and zinc ions resulting in distinct 
interactions and consequently overall activities at pH 10.5 (You et al., 2011).  
The activity test of formulations containing only excipients (CA001EXCP; RB-
001EXCP and RB-002EXCP) was important to verify the influence of excipients and 
pH on formulation overall activity. Those formulations yielded residual activities when 
compared to formulations containing both alcohol and zinc as active ingredients against 
bacteriophages and mammalian viruses. The pH was kept constant at 10.5 across all the 
formulations tested in this study. The pH may influence the overall activity of alcoholic 
solutions and could explain why relatively low activities were attained for both 
bacteriophages and higher activities were attained against mammalian viruses. For 
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instance, it was shown in the literature that activity of 70% ethanol against non-
enveloped feline calicivirus went from 2.6 to 4.4 log10 reduction when pH was lowered 
from 7.4 to 3.0 (Park et al., 2010). The pH amongst ionic strength, temperature and 
hydrostatic pressure are environmental factors that have an impact on virus behaviour in 
suspension and capsid protein conformation, stability and virus aggregation (Furiga et 
al., 2011). It has been reported in the literature that pH solutions lower than virus pI 
lead to virus aggregation and consequently lower penetration and virucidal efficacy of 
the active ingredient (Pinto, 2010). However, that should not be an issue impairing 
activity of the formulations containing both alcohol and zinc as active ingredients as 
formulation pH of 10.5 is much higher than pI of viruses under study. On the other 
hand, alkaline pH of 11.8 at was reported to degrade MS2 RNA through phosphate 
hydrolysis and affinity reduction for the capsid by deprotonation of lysine side chains 
over a 4 h contact time (Hooker et al., 2003). It has also been shown that capsid stability 
of Adv5 (Rexroad et al., 2006) and Pv1 (Wet and Kucinski, 1991) decreases as pH 
increases under different ionic strengths at 2 h or more contact time. Therefore, it is 
possible that the action of pH against MS2 at some extent may be due to formation of 
empty capsids, whereas against AdV2 and Pv1 capsid stability may be more 
predominant factor. The differences of RB-002EXCP activities against AdV2 and Pv1 
may be mostly related to differences of physicochemical properties and proteins at the 
capsid level.  
The reduction of RB-002 activity against Pv1 of approximately 4 times in 
presence of EDTA (see Figure 3.12B) was more pronounced than the one obtained 
under same conditions against MS2 (see Figure 3.11C). Date (1979) discovered divalent 
cations such as Mg2+and Zn2+ are essential for binding of MS2 to the host (E. coli F-
pilus) forming a highly stable complex important for infectious pathway. Hence, it is 
possible that differences in term of viral titre reduction by RB-002 between MS2 and 
Pv1 might be caused by possible higher attachment of MS2 to host and hampering of 
Pv1 host cell penetration. In other words, overall activities observed for RB-002 against 
bacteriophage and mammalian viruses may be due to virion structural damage but also 
the impact of monovalent and divalent cation present alters the dynamics between virus 
and hosts in a different manner.  
In this context, the tested combinations of 40% ethanol with 0.1% zinc sulphate 
heptahydrate at pH 10.5 yielded viral inactivation to some extent where bacteriophages 
MS2 and F116 had around 1 log10 reduction (around 90% viral population) with RB-
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001 and RB-002 at 60 min contact time for instance. The degree of virus inactivation by 
RB-002 against both AdV2 and Pv1 was even higher than the ones attained against 
bacteriophages. The data acquired throughout the present study is valuable as it shows 
the limitations of a novel formulation system. It also allowed inferring about the 
formulations stability over time and the role of free zinc ions in solution. The data is 
helpful to develop and design a potential new biocidal product with relatively low 
ethanol concentration. It was demonstrated the activity against non-enveloped viruses 
could be further enhanced by the addition of active ingredients like biguanides and/or 
QACs. Finally, the activity screening provided important data to discuss about the 
mechanism of action of alcohol and zinc against non-enveloped. It is possible that the 
activity of alcohol with zinc may be associated to capsid alteration and interaction with 
nucleic acid. Moreover, viral penetration to host caused by zinc may also play an 
important role in overall formulation efficiency against non-enveloped viruses. Further 
analysis of formulation activity containing alcohol and zinc against bacteriophage and 
adenovirus will be carried out in order to verify whether the hypothesis of having 
different mechanisms of action of alcohol and zinc combination against F116 and 
adenovirus is valid.  
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4. Mechanism of action of ethanol-zinc formulations against 
bacteriophage F116 and Human Adenovirus (AdV2 and attP AdV5)  
 
4.1 Introduction 
 
 Understanding the mode of action of a biocidal product against viruses has been 
shown to be relevant for establishing scientific principles and for improvement of active 
ingredients (Myers, 2008). However, there is still relatively little information about the 
mechanism by which biocides interact with specific target sites leading to virus 
inactivation. Viruses are known to present less target sites for biocidal action than 
bacteria and fungi as they do not possess metabolic activity (e.g. transmembrane proton-
motive force, efflux pumps and respiratory chain). Since biocides are multi-target 
antimicrobial agents with broader spectrum of action than more specific antimicrobials 
such as antibiotics, understanding interactions between biocides with pathogens 
(targets) will increase knowledge of mechanisms of viral inactivation, viral resistance 
mechanisms, and consequently it will improve efficacy of usage of biocides in practice 
(Russel, 2003). 
In general, enveloped viruses are reported to be more susceptible to biocides 
than non-enveloped ones as the latter do not possess an envelope, which is a lipidic 
structure susceptible to membrane active agents action. Non-enveloped viruses still 
offer targets for virucidal action including the capsid, viral markers and genome (Maris, 
1995; Maillard, 2001). However, mechanism of virucidal action against non-enveloped 
virions still remains largely unknown. Yoon et al. (2011) showed that inactivation of 
Adenovirus type 5 by sulfonic acid is mainly due to capsid protein conformational 
changes promoted by selective oxidation of sulphur-containing aminoacids, which leads 
to loss of viral infectivity. Lara et al. (2010) demonstrated that silver nanoparticles 
inhibit HIV-1 infectivity by interactions with glycoprotein 120, a viral marker, 
hampering virus binding to host cells. Yeap et al. (2015) showed that chlorine dioxide is 
a multi-target biocide against Murine Norovirus 1 as viral inactivation was caused by 
degradation of both viral capsid protein and viral RNA.  
The resilience of pathogens towards a given biocide and associated inactivation 
kinetics are not only dependent on targets for virucidal action but also on many 
environmental parameters like temperature, pH, concentration of the active agent, 
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surface roughness and application techniques (Gerba, 2015). For instance, it was 
observed that quaternary ammonium compounds (QACs), known to be highly effective 
against enveloped viruses mainly due to disruption of lipid envelope, could also 
inactivate human enteric viruses (non-enveloped viruses) and more effectively than 
chlorine at higher concentrations in a given biocidal product formulation applied to a 
contaminated surface with hydraulic spraying (Bolton et al., 2013). QACs also were 
shown to have the potential to bind and alter conformation of DNA (Zinchenko et al., 
2004). Thus, knowledge of potential targets of action of a biocide against 
microorganisms, effect of environmental parameters as well as effective application 
techniques  are crucial information for the selection of the most suitable biocide for an 
all-round effective disinfection practice. Figure 4.1 summarises the main targets on a 
virus with envelope and examples of active ingredients, which were shown to inactivate 
viruses in the literature.  
 
Figure 4.1: Factors influencing overall virucidal activity of biocides including potential 
interaction sites with viruses (targets) leading to virus inactivation. Each 
target depicted is followed by a brief description and examples of active 
agents known to cause virus inactivation through interaction with that 
particular viral component (Adapted from Russel (2003); Maillard et al. 
(2013) and Maris (1995)). 
 
 
 
 
 
 
 
 
 
 
 
 In this context, the main goal of this chapter is to analyse the capacity of 
ethanol/zinc system to promote structural changes on non-enveloped viruses and 
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identification of possible targets of action leading to a better understanding of the modes 
of action. Initially the impact of testing formulations on bacteriophage F116 
morphology was assessed through Transmission Electron Microscopy studies. Energy 
dispersive analysis of X-rays (EDAX) study of the distribution of zinc atoms on 
bacteriophage F116 was performed to evaluate possible zinc deposition and localisation 
on damaged bacteriophages. Moreover, the influence of formulations on mammalian 
virus (adenovirus) capsid susceptibility to mechanical stress and virus integrity was 
verified through nano-indentation studies by Atomic Force Microscopy (AFM). 
Furthermore, viral purification and subsequent DNA extraction after exposure of viruses 
to formulations was performed in order to verify whether viral nucleic acid is a potential 
target for the virucidal formulation system under study.  
 
4.2 Materials and methods 
 
4.2.1 Transmission electron microscopy (TEM) Imaging on bacteriophage F116 and attP 
Adenovirus type 5 (attP AdV5) 
 
4.2.1.1 Bacteriophage F116 
 
 TEM Imaging was performed to evaluate the impact of CA-001 and RB-002 
formulations on structure and morphology of bacteriophage F116 and adenovirus type 2 
according to Maillard et al. (1995).  
 The experimental procedure consisted in mixing 100 μL of F116 phage stock 
(1011 PFU.mL-1) with 900 μL of the biocide for the appropriate contact time. The 
selected contact times are the ones that produce a 1 Log10 reduction in F116 (see section 
3.3.3). Negative control with SM buffer solution was carried out for both formulation 
sets at 60 min contact time. After exposure, 20 μL of sample was aliquoted and mixed 
with 20 μL of 1% methylamine tungstate (Agar Scientific, UK) for 5 min. Copper-
coated carbon grid (Agar Scientific, UK) was put in contact with negatively stained 
phage for 2 min and excess liquid was dried for 5 min on filter paper. Grids were left 
drying for 20 min. The imaging of samples was made through a JEOL 2100 electron 
microscope operating at 80 kV accelerating voltage with magnifications ranging from 
x10000 to 60000x. 
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4.2.1.2 attP Adenovirus type 5 
 
 TEM was performed to verify structural integrity of attP adenovirus upon 
exposure to formulations RB-001 or RB-002 diluted 1:1 in HBS buffer (20 mM Hepes, 
0.15 M NaCl, pH 7.8) and compared with results obtained from the AFM study. HBS 
Buffer was used as negative control. 
 Carbon coated grid (Agar Scientific, UK) was glow discharged for 1 min and 5 
μL virus droplet (1011PFU.mL-1) was added to the grid and incubated for 5 min. 
Following blotting with Whatmann paper, grid with adenovirus on the surface was put 
in contact with 45 μL of RB-001 or RB-002 diluted 1:1 for 1 min. Then, 500 μL HBS 
buffer was added and sample was stained with 1% Uranyl acetate. The imaging of 
samples was obtained through JOEL JEM 1230 transmission electron microscope at 
100 kV. 
 The formulations, controls and contact times for each TEM analysis are shown 
in Table 4.1. 
 
  
 85 
Table 4.1: Formulation sets under TEM analysis with respective controls and contact 
times. 
Formulation 
set 
Formulations Composition 
Contact 
time (min) 
Virus 
Formulations 
prepared in 
Cardiff 
CA001 
40% (w/v) 
Ethanol + 0.1% 
(w/v) Zinc 
sulphate 
heptahydrate + 
excipients 
5 
Bacteriophage 
F116 
CA001E 
25% (w/v) 
Ethanol + 0.1% 
(w/v) Zinc 
sulphate 
heptahydrate + 
excipients 
5 
CA001X 
40% (w/v) 
Ethanol + 
excipients 
5 
CA001EX 
25% (w/v) 
Ethanol + 
excipients 
5 
CA001FX 
80% (w/v) 
Ethanol + 
excipients 
5 
CA001G 
0.1% (w/v) Zinc 
sulphate 
heptahydrate + 
excipients 
15 
CA001EXCP Excipients 60 
Formulations 
prepared by RB 
(September 
RB-002 
40% (w/v) 
Ethanol + 0.1% 
(w/v) Zinc 
1 
attP 
Adenovirus 
type 5 
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2015) sulphate 
heptahydrate + 
excipients 
RB-002X 
40% (w/v) 
Ethanol + 0.3%  
Zinc sulphate 
heptahydrate + 
QAC + 
excipients 
1 
RB-002G 
0.1%  Zinc 
sulphate 
heptahydrate + 
excipients 
1 
RB-002EXCP  Excipients 1  
 
4.2.2 Energy dispersive X-ray Spectrometry (EDAX) on bacteriophage F116 after 
exposure to CA001 formulations 
 
 Sample preparation was based on EDAX studies carried out by Maillard et al. 
(1995b). Phages were exposed to CA-001 for the 5 min contact time, concentrated by 
centrifugation at 12000×g for 20 min and washed in 500 μL ultrapure water (Sigma, 
UK). This procedure was repeated twice. Samples were stained as described earlier in 
4.2.1 and placed in contact with a nickel-based carbon grid (Agar scientific, UK). The 
EDAX analysis was performed by an energy dispersive analyser (X-MaxN 80T, Oxford 
Instruments) coupled to a JEOL 2100 electron microscope. The beam with accelerating 
voltage of 200kV was focused on an individual phage with a given structural damage 
for 5 min and data was analysed by the latest version of AZtecTEM software (Oxford 
Instruments).  
 
4.2.3 Purification of attP Adenovirus type 5 (attP AdV5) and Adenovirus type 2 (AdV2) 
 
 The attP Adenovirus type 5 (attP AdV5) and Adenovirus type 2 (AdV2) were 
propagated in HEK293 HeLA and HeLA cells respectively and highly purified by 
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ultracentrifugation in caesium chloride (CsCl) gradient as described by Condezo et al. 
(2015). Viruses were harvested 3 days post-infection. Following that, they were purified 
by ultracentrifugation at 219,000g (LE-80K Ultracentrifuge, Beckman Coulter) for 90 
min at 18oC in 1.25 g.mL-1 and 1.40 g.mL-1 CsCl step gradient. TD1X Buffer (137 mM 
NaCl, 5.1 mM KCl, 700 mM Na2.HPO4.7H2O and 25 mM Tris base at pH 7.4) was used 
to prepare CsCl gradients. Following the first centrifugation, viral bands were extracted 
and centrifuged in 1.31 g.mL-1 CsCl step gradient for 18 hours at 219,000g. Viral bands 
obtained were desalted through column chromatography (Bio-Rad 10 DC, UK), eluted 
with HBS Buffer and stored in aliquots with 10% glycerol at -80oC. The viral titre was 
quantified as determined by Spearman-Kaeber method for 6th and 7th day post-infection 
as described by Flint and Enquist (2008). 
 
4.2.4 Nanoindentation on attP Adenovirus type 5 through Atomic Force Microscopy 
 
This experiment aimed to investigate the influence of RB-002 formulations on 
capsid mechanical properties of a mutant adenovirus type 5 (attP AdV5). The 
adenovirus mutant contains two insertions downstream the packaging domain and two 
deletions (E1 and E3), where the insertions correspond to one recombinase target 
sequence (attP) from bacteriophage phi and the other one to green fluorescent protein 
(Alba et al., 2011). The virus was obtained from Carmen San Martin’s research group at 
Centro Nacional de Biotecnologia (Madrid, Spain). This type of mutant adenovirus was 
used due to lack of pathogenicity towards humans and the fact it has been extensively 
studied through nano-indentation in the literature (Alba et al., 2011; Alba et al., 2007). 
The mechanical stability was assessed in terms of viral capsid spring constant by 
applying a force to virus without structural damages according to the Hooke’s Law 
spring constant equation (Equation 4.1) as follows: 
 
   𝐹 = −𝑘 × 𝑑 (Equation 4.1) 
 
Where F stands for applied force (nN); k the spring constant (nN/nm) and d is the total 
deformation (nm). 
 The experimental procedure was based on mechanical stability studies carried 
out by Herando-Perez et al. (2014). Virus fixation was achieved by leaving 20 μL of 
attP Ad5 viral particles stored in HBS Buffer (20 mM HEPES and 0.15 M NaCl, pH 
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7.8) on a muscovite mica surface (Agar Scientific, Spain) disk for 20 min at 4oC. 
Viruses attached to the surface were washed five times with HBS buffer to remove viral 
particles not associated with the surface. Prior to virus exposure to formulation, virus 
adhered to mica surface are visualised by AFM as a control for virus structural integrity 
and stability on the aforementioned surface.  Then, 180 μL of formulation RB-002 
under analysis and diluted 1:1 with distilled water was put in contact with viruses on 
mica. After incubation time ranging from 30 seconds to 10 min, 500 μL of HBS buffer 
was added at the same time formulation is removed. The tip (Olympus, Japan) was pre-
wetted with 20 μL of HBS Buffer and AFM equipment (Nanotec Electronica S.L., 
Spain) run in jumping mode with a rectangular cantilever (RC800PSA, Olympus, 
Japan) with nominal spring constant of 0.05 N.m-1. The force vs distance curve was 
obtained by stopping lateral piezo scan when the tip was on non-structurally damaged 
virus centre point of symmetry and elongating z-piezo until the tip established 
mechanical contact with a virus and indented viral particle once at high enough force 
(200 nN) to cause virus capsid deformation. The linear deformation observed provided 
the spring constant k according to the Equation 4.1.  
Additionally, breaking force was calculated as the force necessary to displace 
viral capsomers and cause capsid rupture. Capsid morphology was analysed by 
measuring capsid height (h) during AFM imaging. The viral capsid brittleness was 
assessed by determining the yield strength ratio (Y) according to Equation 4.2. 
 
    𝐾 (%) =
𝛿𝑐𝑟𝑖𝑡𝑖𝑐𝑎𝑙
ℎ
× 100 (Equation 4.2) 
 
Where 𝛿𝑐𝑟𝑖𝑡𝑖𝑐𝑎𝑙 stands for capsid deformation (nm) at which it breaks and h is capsid 
height (nm). 
 For imaging, 128 x 128 point images of viral particles were recorded by using 
the lowest force to reach high resolution of virus structure (100 pN) in jumping mode. 
All data processing was performed by using WSxM software (WSxM solutions, Spain). 
Statistical analysis was performed using ANOVA test for three independent samples 
when number of viruses analysed was higher than 24. 
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4.2.5 Effect of formulations on viral nucleic acid - Viral DNA extraction, quantification, 
analysis of DNA damage by biocides and presence of zinc in viral DNA 
 
 The following procedures were carried out in order to evaluate whether viral 
DNA damage is induced by formulations. This data will be very important to have a 
clear picture about the mechanism of action including viral DNA as a potential target 
for the combination of alcohol with zinc as active ingredients. The methodology was 
based on the one presented by Maillard (1994). 
 
4.2.5.1 Bacteriophage F116 
 
 Bacteriophage F116 was propagated in P. aeruginosa PAO1 (ATCC BAA-47) 
and harvested as described in Chapter 2 with final concentration of 1011 PFU/mL. 
 
4.2.5.1.1 Bacteriophage F116 exposure to biocide, nucleic acid extraction, 
purification and quantification 
 
 After bacteriophage harvesting, 200 μL of F116 suspension (1011PFU/mL) was 
mixed with 800 μL of each formulation (see Table 4.1) for 2h contact time at 25oC. 
Controls consisted of performing the same nucleic acid extraction from 1 mL F116 
suspension and F116 suspension mixed with ultrapure water (Sigma, UK). F116 nucleic 
acid was extracted by a Phage DNA Isolation Kit (Norgen Biotek, Canada) with DNase 
treatment to digest possible DNA from the host bacteria prior viral DNA extraction. 
Five μL of RNase-Free DNase I (Norgen Biotek, Canada) was added to 1mL of 
phage/formulation mix and incubated for 15 min followed by DNase inactivation at 
75oC for 5 min. Then 500 μL of Lysis Buffer B (Norgen Biotek, Canada) was added to 
phage suspension, incubated at 65oC for 20 min and added to binding column. The latter 
was centrifuged for 3 min at 6,000g, washed with 400 μL Wash Solution A (Norgen 
Biotek, Canada) twice with flow-through being discarded afterwards. The elution of 
viral DNA occurred by adding 50 μL of Elution Buffer B (Norgen Biotek, Canada) and 
centrifugation at 6,000g for 1 min. Purified dsDNA was quantified through fluorometric 
quantitation (Quibit 3.0 Fluorometer, ThermoFischer) and stored at -20oC. 
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4.2.5.1.2 F116 DNA gel electrophoresis and DNA digestion by selected restriction 
enzymes 
 
 Analysis of bacteriophage dsDNA integrity after exposure to formulations and 
purification steps was performed. Three hundred and fifty ng of purified viral dsDNA 
was mixed with 5 μL gel loading buffer (ThermoFischer, United Kindgom) and loaded 
on 1.2% (w/v) agarose gel in TAE buffer (Sigma-Aldrich, United Kingdom) with 
SYBR Safe DNA gel stain (ThermoFischer, United Kingdom). The lambda 
DNA/HindIII Marker size profile and running buffer composition used for this study are 
presented in Table 4.2. 
 
Table 4.2: Marker size profile bands and running buffer composition. 
Marker size profile (bp) Running buffer 
23130 
0.1% bromophenol blue 
50% (v/v) glycerol 
100 mM EDTA 
0.5% sodium dodecyl sulphate 
9146 
6557 
2322 
2027 
564 
125 
 
Electrophoresis was performed at 80V for 45 min and nucleic acid bands were 
visualised and photographed in a transilluminator (BioRad Gel Doc XR System, 
Germany).  
 In order to assess possible specific nucleic acid damage caused by alcohol/zinc 
combination, viral dsDNA purified after exposure to each formulation was digested by 
restriction enzyme Sau3AI (Thermo Scientific, Germany) as described in Table 4.3 
prior to gel loading. The samples were loaded into 2% (w/v) agarose gel in TAE Buffer 
and electrophoresis was performed at 90 V for 1 h and 30min. Analysis was performed 
in triplicate with independent biological samples. 
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Table 4.3: Restriction enzymes used to digest F116 and AdV2 dsDNA extracted after 
exposure to formulations. 
Viral 
dsDNA 
Restriction 
enzyme 
Recognition 
sequence 
Digestion 
prediction 
Reaction mix 
F116 Sau3AI GATC 
1733 bp; 915 
bp; 850 bp; 799 
bp; 789 bp; 719 
bp; 662 bp; 648 
bp; 646 bp; 645 
bp; 624 bp; 622 
bp; 579 bp; 527 
25-30 μL 
DNA; 1 μL 
enzyme; 2 μL 
10X Buffer; 
12-17 μL 
nuclease free 
water. 
Incubation at 
37oC for 1h  
AdV2 
 
SmaI CCCGGG 
6923 bp; 6480 
bp; 5522 bp; 
4457 bp; 2925 
bp; 2463 bp; 
2269; 1503 bp; 
1403 bp; 1008 
bp; 575 bp; 230 
bp; 179 bp 
15-20 μL 
DNA; 1 μL 
enzyme; 2 μL 
Fast Digest 
buffer; 3-8 μL 
nuclease free 
water. 
Incubation at 
37 oC for 5 min AatII GACGTC 
13273 bp; 
10744 bp; 9975 
bp; 1945 bp 
 
4.2.5.2 Adenovirus type 2 (AdV2) 
 
 AdV2 was propagated in HeLa cells and highly purified as described in section 
4.2.4. Aliquots with viral concentration of 109 PFU/mL determined by viral titration 
were used for subsequent DNA damage analysis. 
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4.2.5.2.1 Adenovirus type 2 exposure to biocide, nucleic acid extraction, 
purification and quantification 
 
 Twenty μL of AdV2 suspension was put in contact with 80 μL of each 
formulation (see Table 4.1) for 2 h at 25oC. Control consisted of mixing virus 
suspension with PBS at the same ratio. AdV2 DNA was extracted and purified by a 
High Pure Viral Nucleic Acid Kit (Roche, Switzerland). Two hundred μL of Binding 
Buffer supplemented with 50 μL Proteinase K and Poly (A)(Roche, Switzerland) was 
added to 100 μL of virus mixed with formulation and mixture was incubated at 72oC for 
15 min. Following that, mixture was added to a high pure filter column and centrifuged 
three times at 8,000g for 1 min with flow-through being discarded after each 
centrifugation cycle. Then, column was washed twice with 450 μL Wash Buffer. 
Elution of AdV2 dsDNA occurred by adding 40 μL of elution buffer and centrifugation 
at 13,000g for 1 min. Viral DNA was stored -20oC for further analysis. 
 
4.2.5.2.2 Adenovirus type 2 DNA gel electrophoresis and DNA digestion by 
selected restriction enzymes 
 
 AdV2 nucleic acid integrity resulting from aforementioned purification step was 
analysed by electrophoresis. One hundred and fifty ng of purified viral dsDNA was 
mixed with 5 μL of gel loading buffer and loaded on 1.2% (w/v) Agarose gel in TBE 
buffer with SYBR Safe DNA gel stain (ThermoFischer, United Kingdom). The lambda 
DNA/HindIII Marker size profile and running buffer composition were used as 
described earlier. Electrophoresis was performed at 100 V for 45 min and bands were 
visualised as described earlier.  
 Similarly to the analysis on F116 DNA damage, purified AdV2 dsDNA was 
digested separately by SmaI and AatII restriction enzymes (Thermo Scientific, 
Germany) in order to evaluate more specifically potential damage to viral nucleic acid 
caused by formulations (see Table 4.3 for more details). After digestion, electrophoresis 
was performed on a 2% (w/v) agarose gel in TBE buffer at 100 V for 1 h and 30 min. 
Viral nucleic acid bands were visualised as mentioned earlier. Analysis was performed 
with three biological independent samples. 
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4.2.5.3 Quantification of zinc in DNA samples after purification by inductively 
coupled plasma-mass spectrometry (ICP-MS) 
 
 The analysis of zinc presence in purified viral DNA samples upon exposure to 
formulations RB-002 and RB-002G was performed by inductively coupled plasma-
mass spectrometry (ICP-MS) according to Li et al. (2012). Viral nucleic acid samples 
were diluted 1:20 and analysed by standard addition method. The latter consists of 100 
μL of viral nucleic acid sample mixed separately with 4, 5, 6 and 7 μL of standard 
solution.  The method of internal standard addition was performed in order to reduce 
matrix effects where zinc absorbance could be interfered by other components and to 
enhance overall plasma stability. Samples were analysed by ICP-MS (Agilent 7900 
ICP-MS, United States) with operational conditions described in Table 4.4.  
 
Table 4.4: Operation parameters associated to the ICP-MS performed for zinc 
quantification. 
Operational Parameters Agilent ICP-MS 
Laser ablation system  
Wavelength of Nd:YAG laser (nm) 266 
Laser energy per pulse (mJ) 5 
Laser power density (W cm-2) 5x108 
Nebuliser type  
Spray chamber Desolvator 
RF Power (W) 1250 
Cooling gas flow rate (L.min-1) 18 
Auxiliary gas flow rate (L.min-1) 1.1 
Nebuliser (carrier) gas flow rate (L.min-1) 1.32 
Solution uptake rate (mL.min-1) 2 
Ion extraction lens voltage (V) 2000 
Mass resolution (m/Δm) 4400 
Analysis time (min) 5 
Number of runs 6 
Number of blocks of runs 5 
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4.2.6 Statistical analysis 
 
 All the experiments in this chapter were performed as four independent 
biological replicates. For TEM studies on attP AdV5 and F116, statistical significance 
in terms of different types of damage observed was analysed by two-tailed Chi squared 
test with 95% confidence interval. One-way ANOVA was performed throughout nano-
indentation studies to validate statistical significant after empirical normal distribution 
was confirmed by Kolmogorov-Smirnov test. For non-normal distribution, non-
parametric analysis by Wilcoxon-Mann-Whitney statistical test was carried out. 
 All statistical analyses were carried out by GraphPad Prism 6 software (version 
6.0f, Graphpad Software).  
  
4.3 Results 
 
4.3.1 Structural and morphological changes induced in F116 by formulations prepared in 
Cardiff  
 
TEM imaging of bacteriophage F116 was carried out following exposure of 
bacteriophage F116 to CA001 with different ethanol concentrations. A total of 1360 
single phages were observed. Initially different types of damages were observed and 
divided into different groups: (i) intact phage, (ii) head or tail damage, (iii) head with no 
tail and (iv) tail with no head. Damages were then subdivided into different groups 
associated to structural changes such as: i) intact phage; ii) concentrated material inside 
head; iii) expanded material inside head; iv) folded head; v) folded head; vi) fractured 
head; vii) empty head; viii) damaged tail and ix) tail only. Figure 4.2 presents images 
collected throughout the present analysis for each type of structural changes. 
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Figure 4.2: Representative F116 structural damages identified throughout TEM 
analysis. Structures are highlighted by a blue circle. A) Intact F116 (x 
60000); B) F116 head with concentrated material inside (x 50000); C) 
F116 empty head (x 25000); D) F116 fractured head (x 60000); E) F116 
folded head (x 60000); F) F116 with damaged tail (x 25000) and G) F116 
head with expanded material inside. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Morphological changes induced by different formulations were observed for a 
given number of phages and results are shown in Table 4.5. Significant morphological 
damage differences were found between formulation CA001 containing 40% (w/v) 
ethanol with zinc and formulation CA001-FX containing 80% (w/v) ethanol (Chi-
Square p<0.05). Formulations CA001 and CA001-E comprising both ethanol and zinc 
yielded significant different morphological changes compared to formulation CA001-
EXP without the mentioned active ingredients (Chi-Square p<0.05). Furthermore, 
formulations with and without both active ingredients yielded higher number of phages 
without tail when compared with phages treated with SM Buffer (negative control). It 
was also observed that formulations CA001 containing both ethanol and zinc produced 
a higher level of morphological damages, where formulation CA001 comprising 40% 
(w/v) ethanol with 0.1% (w/v) zinc was the most effective as lowest percentage of intact 
phages was observed. By comparing formulations CA001-EX with 25 % ethanol and its 
counterparts containing zinc sulphate heptahydrate, damages to the phage head and tail 
were higher (Chi-Square p<0.05) for the latter, however head or tail damage percentage 
are comparable between 40% with and without zinc sulphate. 
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 Regarding structural changes, results are summarised in Table 4.6. Significant 
structural differences (p<0.05; see Appendix A) were found by comparison of 
formulation CA001-EX containing 25% (w/v) ethanol with zinc with formulation 
CA001-FX 80% ethanol and formulation CA001-G comprising zinc as the only active 
ingredient. Formulation CA001 comprising 40% (w/v) ethanol with zinc presented a 
significant (p<0.05) higher percentage of phages with concentrated material inside head 
compared to its counterpart without zinc and formulation CA001-G comprising 0.1% 
(w/v) zinc sulphate only. Moreover, formulations comprising ethanol and zinc led to 
significantly higher percentage (p<0.05) of phages with expanded and concentrated 
material inside head and capsid denaturation (head with folded structure), which may 
suggest that the formulation interact with phage nucleic acid. By taking into account 
only head with concentrated, head with expanded material inside and folded head, 
significant (p<0.05) differences are found by comparison of formulations CA001 and 
CA001-E containing both ethanol and zinc with formulation CA001-FX comprising 
80% ethanol, indicating a distinct mode of action between the mentioned formulations. 
Formulation CA001-E containing 25% ethanol with zinc yielded higher damages to the 
virus capsid than 40% ethanol with zinc as higher percentage of phages with folded and 
fractured heads was observed. However, no significant difference (Chi-Square p>0.05) 
was found at this point between formulations CA001 and CA001-E in terms of overall 
structural damage pattern. Formulation excipients seemed to have an impact of virus 
structure as shown by structural changes induced by formulation CA001-EXCP without 
ethanol and zinc, more specifically in terms of capsid damage. Nevertheless, damage 
pattern observed for formulation CA001-EXCP was significantly (p<0.05) different 
compared to formulations CA001 and CA001-E with both active ingredients.  
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Table 4.5: Percentage of morphological changes induced by different formulations CA001 prepared in Cardiff and respective controls. Numbers 
in bold show statistical significant differences when compared to other formulations. 
 
 
 
 
 
 
 
 
Formulation Composition 
Percentage of phage (%) 
 
Intact 
phage 
Head or 
tail 
damage 
Head with 
no tail 
Tail with 
no head 
Total number 
of phage 
observed 
CA001 (Base) 40% Ethanol + 0.1 % Zn 13.5 36.7 49.8 5.3 207 
CA001-E 25% Ethanol + 0.1% Zn 25.7 37.4 36.9 4.9 206 
CA001-G 0.1 % Zn 14.2 31.3 54.5 3.7 134 
CA001X 40% Ethanol 32.1 38.9 33.3 3.1 162 
CA001-EX 25% Ethanol 33.6 13.3 51.7 4.9 143 
CA001-EXCP Formulated w/o Ethanol and Zinc 22.9 24.7 50.6 7.8 166 
CA001-FX 80% Ethanol 27.9 17.7 54.4 5.4 147 
Negative control SM Buffer 50.3 7.9 38.7 12 191 
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Table 4.6: Percentage of structural changes induced by different formulations CA001 prepared in Cardiff and respective controls (1360 phages 
were observed in total). Numbers in bold show statistical significant differences when compared to other formulations. 
 
Formulation Composition 
Percentage of phage (%) 
Intact 
phage 
Head with 
concentrated 
material 
inside 
Head with 
expanded 
material 
inside 
Folded 
head 
Fractured 
head 
Empty 
head 
Damaged 
tail 
Intact tail 
CA001 (Base) 
40% Ethanol + 0.1% 
Zn 
13.5 31.4 23.2 11.1 9.7 13.5 9.2 3.4 
CA001-E 
25% Ethanol + 0.1% 
Zn 
25.7 24.8 14.1 14.1 11.2 7.8 9.2 2.9 
CA001-G 0.1 % Zn  14.2 14.9 29.9 15.7 11.9 11.2 11.2 3.7 
CA001X 40% Ethanol 31.5 12.3 9.9 16.0 16.0 19.1 6.8 1.9 
CA001-EX 25% Ethanol 33.6 11.2 12.6 11.2 14.0 17.5 4.2 4.9 
CA001-EXCP 
Formulated w/o 
Ethanol and Zinc 
22.9 5.4 6.6 17.5 25.9 23.5 3.6 3.0 
CA001-FX 80% Ethanol 27.9 12.9 17.7 8.2 12.2 15 6.1 5.4 
Negative control SM Buffer   50.3 3.1 8.4 5.8 7.9 11.0 2.1 11.5 
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4.3.2 Energy-dispersive X-ray (EDAX) for detection of zinc associated to F116 virions 
exposed to formulations prepared in Cardiff 
 
 With a preliminary EDAX analysis, a line scanning of zinc was carried out for 
several phages exposed to distinct formulations. The results are shown in Figure 4.3. 
 
Figure 4.3: Counts per second of zinc atoms across phages with distinct damages after 
exposure to formulation CA001 containing 40% Ethanol with 0.1% Zinc 
and SM Buffer (negative control) with respective scanning transmission 
electron microscope (STEM) images. A) Intact F116 (x60000); B) F116 
head with concentrated material inside (x60000); C) F116 with empty head 
(x60000) and D) Intact F116 after exposure to SM Buffer (x60000). 
(A) (B) 
(C) (D) 
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 Damaged phages presented higher number of zinc counts around the phage 
particle when compared to intact one (Fig. 4.3 B and C), indicating that zinc may be 
involved with phage head damage. Zinc atoms strongly bound the phages and their 
immediate surrounding as samples were washed with ultrapure water after exposure to 
formulation. In addition, zinc frequency obtained for phage with concentrated material 
inside head was higher than the one attained for phage with empty head, suggesting a 
higher dispersion of zinc associated to the head of damaged phages. The control 
consisting of phage exposed to SM Buffer showed that trace amounts of zinc in the 
background can be detected, but it was not comparable to the amount associated with 
phages damaged by the complete formulation CA001. 
In order to have a better insight on the dispersion of zinc across phage structures, 
the mapping of zinc atoms across phages with distinct structural damages exposed to 
formulation comprising 40% ethanol with 0.1% zinc was also performed by EDAX 
analysis. The preliminary result is presented in figure 4.4. 
 
Figure 4.4: Zinc atoms (red points) detected by Energy Dispersive X-ray on 
bacteriophage F116 after exposure to formulation prepared in Cardiff 
comprising 40%(w/v) Ethanol with 0.1%(w/v) Zn. A) Head with 
expanded material inside head (x1000000); B) Intact phage (x1000000). 
 
 
 
 
 
 
 
 
 
 
More zinc hits were observed all over the phage presenting material expanded 
within the capsid comparing to intact phages (Fig. 4.4 A). The higher number of zinc 
hits is an indication that zinc may be involved in structural damage. However, more 
(A) (B) 
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replicates and controls should be performed in order to analyse possible background 
noise and statistical significance of this experiment. 
 
4.3.3 Nanoindentation study of attP Ad5 upon exposure to old and new formulations 
prepared by RB 
 
In order to investigate the mechanical strength of adenovirus capsid following 
exposure to RB-002 formulations, atomic force microscopy (AFM) in jumping mode 
was carried out. Firstly, images of virions were obtained in order to determine virion 
symmetry and target for nano-indentation experiments. Images recorded before and 
after nano-indentation procedure are presented in Figure 4.5. 
 
Figure 4.5: Selected individual frames of attP AdV5 before and after nano indentation 
upon exposure to RB-001 and RB-002. A) Virions at 3-fold symmetry 
before nano-indentation exposed to formulation RB-001; B) Virions at 3-
fold symmetry after nano-indentation exposed to formulation RB-001; C) 
Virion at 3- fold symmetry nano-indentation exposed to formulation RB-
002 and (D) Virion after nano-indentation exposed to formulation RB-002. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(A) 
 
(B) 
 
(C) 
 
(D) 
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Figure 4.5 showed that misplacement of attP AdV5 capsomers (Fig. 4.5 B) and 
eventual viral disassembly (Fig 4.5 D) occurred throughout nano-indentation studies. 
The results for mechanical properties of virus capsid after exposure to RB-002 
formulations are shown in table 4.7. 
 
Table 4.7: Spring constants (k) of attP AdV5 adenovirus at symmetry 3 before 
exposure and after exposure to different formulations within 1 min contact 
time. 
 
 Exposure to all the formulations reduced the spring constant of the virus in 
comparison with the negative control, suggesting capsid weakening induced at some 
degree by the formulations. Significant spring constant variation (ANOVA, p<0.05) 
was found between formulations containing both alcohol and zinc (RB-002) with 
formulation comprising excipients only (RB-002EXCP) and negative control (HEPES). 
However, no significant change was found between formulations RB-002 and RB-002G 
at 95% confidence interval. The results suggest excipients have the capacity to influence 
virus spring constant at some level. 
Regarding the amount of deformation a virus capsid withstand before rupture 
evaluated through calculation of the critical strain, no significant difference was found 
between virus capsid exposed to different formulations (ANOVA, p<0.05). 
Nevertheless, exposure to formulations promoted minor increase in the critical strain of 
the virus, i.e. less virus brittleness.  
Formulation 
Number of 
viruses 
Symmetry 
Spring 
constant (k) 
(nN/nm) 
Breaking 
force (nN) 
Critical 
strain (%) 
RB-002 38 3 0.40 (±0.02) 4.2 (±0.1) 18.8 (±7.8) 
RB-002G 37 3 0.38 (±0.02) 3.9 (±0.2) 19.8 (±7.7) 
RB-002EXCP 31 3 0.36 (±0.02) 4.3 (±0.1) 18.7 (±5.0) 
HEPES (negative 
control) 
130 3 0.55 (±0.01) 4.7 (±0.1) 17.4 (±7.5) 
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 Topography of viruses attached to mica surface and exposed to different RB-002 
formulations prepared by RB were characterized in terms of height and results are 
shown in figure 4.6.  
 
Figure 4.6: Topography and capsid height analysis of attP adenovirus type 5 exposed to 
different formulations at different contact times. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
There was no significant virus topography variation in terms of viral height 
within the first minutes of contact between the different formulations. As contact time 
increases, the capsid height variation induced by formulation RB-002 is significantly 
higher (ANOVA, p<0.05), which shows the combination of both alcohol and zinc have 
an impact on overall virus topography. This suggests a distinct mode of action by RB-
002 when compared to other formulations and may be caused by possible interactions of 
alcohol and zinc with virus capsid.  
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4.3.4 Transmission electron microscopy (TEM) imaging of attP Ad5 exposed to new 
formulations prepared by RB 
 
TEM analysis was carried out in order to evaluate structural integrity of attP 
adenovirus after exposure RB-002 formulations. Micrographs are presented in Figure 
4.7. 
 
Figure 4.7: TEM images of aTTP adenovirus after exposure to distinct formulations. 
A) Virus exposed to RB-002 (x 75000); B) Virus exposed to formulation 
RB-002-G; C) Virus exposed to formulation RB-002-EXCP; D) Virus 
exposed to HBS Buffer as negative control (x 75000). 
 
A 
B D 
C 
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The structural appearance of viruses exposed to formulation RB-002G and RB-
002EXCP (Fig. 4.7 B and 4.7 C, respectively) is comparable to the ones in the negative 
control (exposed only to HBS buffer) (Fig. 4.7 D). Viral particles exposed to 
formulations RB-002 (see Fig. 4.7 A) presented a different staining than remaining 
formulations. Staining of the samples was performed by addition of uranyl acetate, a 
well-known negative staining agent, which interacts with phosphates groups of DNA 
(Pandithage, 2013). It is possible that differences of staining may be due to structural 
damage to virus capsomers allowing higher penetration of uranyl acetate, which 
indicates possible structural damage at the capsid level. The quantification of damage 
and number of virus with distinct staining compared to other in the same sample was 
carried out and results are shown in table 4.8.  
 
Table 4.8: Total number of viruses as well as percentage of virus with affected 
staining upon exposure to new formulations prepared by RB diluted twice 
with 30s contact time. 
Formulation Composition 
Percentage of 
virus with 
affected 
staining (%) 
Percentage 
of broken 
capsids (%) 
Total number of 
virus 
RB-002 
40% (w/v) Ethanol + 0.1% 
(w/v) Zn + excipients 
9.6 2.2 230 
RB-002-G 0.1% (w/v) Zn + excipients 1.7 0.85 118 
RB-002-
EXCP 
Excipients only 4.4 0.74 135 
Negative 
control 
HBS Buffer 2.6 2.6 116 
 
 Taking into account mechanical properties results through AFM nano-
indentation, relatively low percentage of damaged virus after exposure to formulations 
RB-002 diluted 1:1. It suggests that despite formulations having an impact on virus 
spring constant, their structure and architecture seems to be preserved for the vast 
majority of viral population at 30s contact time. However, the percentage of virus with 
affected staining after exposure to RB-002 is significantly higher than ones obtained 
 106 
after exposure to control formulations. Once more, it could indicate possible damages at 
capsid level (capsomeres displacement for instance) caused by the combination of 
alcohol and zinc as active ingredients. 
 
4.3.5 DNA damage analysis – Is it an actual target for the formulation under study? 
 
 Previously TEM studies on the mode of action of alcohol/zinc combination 
against F116 showed this combination yields higher percentage of phages with 
expanded and concentrated material inside phage head. From there, it was hypothesized 
that the viral nucleic acid is a potential target for the virucidal combination under study. 
Therefore, AdV2 and F116 DNA were extracted after exposure to formulations and 
analysed by electrophoresis and restriction enzyme digestion in order to assess presence 
of DNA damage. 
 
4.3.5.1 Viral DNA extraction – F116 and AdV2 DNA extraction after exposure to 
formulations 
 
 Initially viruses were separately exposed to different formulations and dsDNA 
was extracted after a given contact time with an appropriate extraction kit as described 
earlier. The concentration of viral dsDNA obtained is presented in table 4.9. 
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Table 4.9: Bacteriophage F116 and Adenovirus type 2 dsDNA extracted after exposure 
of virions to different formulations with 2 h contact time at room 
temperature. 
Virus Extraction kit Formulation 
dsDNA concentration 
(ng/μl) 
Bacteriophage F116 
Phage DNA 
isolation kit 
(Norgen Biotek, 
Canada) 
RB-002 156 (±17) 
RB-002G 86 (±13) 
PBS (negative control) 46 (±13) 
Adenovirus type 2 
(AdV2) 
High Pure Viral 
Nucleic Acid Kit 
(Roche, Germany) 
RB-002 9.9 (±1.3)  
RB-002G 7.9 (±0.3) 
RB-002EXCP 6.4 (±0.9) 
HEPES (negative control) 7.3 (±1.6) 
 
 
 The concentration of DNA obtained after exposure of both viruses to 
formulation containing an alcohol/zinc combination (RB-002) was significantly higher 
(ANOVA, p<0.05) when compared to other formulations under study. It is possible that 
combination of alcohol and zinc enhances DNA extraction procedure due to damages 
caused to virus capsid. On the other hand, negative controls (PBS and HEPES buffer 
solutions) and RB-002EXCP yielded lower dsDNA concentration, which could be 
related to lower damage extent to virus capsids and subsequent less effective DNA 
extraction. In terms of AdV2 dsDNA extraction, dsDNA concentration obtained was 
significantly higher upon exposure to formulation containing zinc as sole active 
ingredient (RB-002G) when compared to counterparts containing formulation 
excipients only (RB-002EXCP). Hence, it seems zinc as sole active ingredients may 
have some impact on virus integrity which leads to more effective dsDNA extraction 
when compared to excipients only based formulation. 
 
4.3.5.2 DNA damage analysis – is F116 DNA damaged to some extent? 
 
 Subsequently to extraction, F116 dsDNA integrity was analysed qualitatively by 
agarose gel electrophoresis before and after digestion by restriction enzymes for more 
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detailed DNA damage analysis. The DNA bands obtained after exposure to 
formulations as well as the ones obtained after restriction enzyme digestion are shown 
in Figure 4.8. 
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Figure 4.8: Bacteriophage F116 DNA damage analysis after exposure to formulations 
by agarose gel electrophoresis running with TBE buffer. A) F116 DNA 
bands extracted after exposure to different formulations in 1% agarose; B) 
F116 DNA bands obtained after exposure to formulations and digested by 
Sau3AI in 2% agarose gel. 
 
 
(A) 
R
B
-0
0
2
 
R
B
-0
0
2
G
 
P
B
S
 (
S
to
ra
g
e 
b
u
ff
er
) 
M
a
rk
er
  
  
  
 
2322 bp 
9416 bp 
23130 bp 
9557 bp 
4371 bp 
2027 bp 
125 bp 
R
B
-0
0
2
 
P
B
S
 (
S
to
ra
g
e 
b
u
ff
er
) 
M
a
rk
er
  
  
  
 
(B) 
 110 
 
 A smear can be observed in the lanes corresponding to DNA extracted upon 
exposure to formulations containing zinc (RB-002 and RB-002G) when compared to 
DNA extracted from virus exposed to storage buffer (negative control) (see Figure 4.8 
A). A more detailed analysis of possible DNA damage induced by RB-002 was carried 
out by digestion of F116 DNA with Sau3AI restriction enzyme. Figure 4.8 B shows that 
DNA extracted after exposure to RB002 presents a slightly different profile containing 
bands with different migration distances when compared to negative control. This result 
suggests there may be minor damages to F116 DNA induced by formulation RB002 at 
the contact time under study. 
 
4.3.5.3 DNA damage analysis – is Adenovirus DNA damaged to some extent? 
 
 Similarly to the F116 DNA damage analysis, the possibility of formulation 
induced AdV2 DNA damage was investigated by similar methodology. The AdV2 
DNA bands obtained after exposure to formulations and extraction procedure are shown 
in Figure 4.9 
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Figure 4.9: Adenovirus type 2 (AdV2) DNA damage analysis after exposure to 
formulations by agarose gel electrophoresis running with TAE buffer. A) 
AdV2 DNA bands extracted after exposure to different formulations in 
1% agarose; B) AdV2 DNA bands obtained after exposure to 
formulations and digested separately by SmaI and AatII restriction 
enzymes in 1% agarose gel. 
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 Results show no significant migration distance differences between formulation 
RB-002 and RB-002G and no smear (see Figure 4.9 A). This indicates DNA samples 
are pure and that no apparent DNA damage is observed after exposure to different 
formulations. The difference in terms of migration between RB-002 and RB-002G may 
be related to the presence of ethanol in the sample, hence an artefact rather than actual 
nucleic acid damage. A more detailed analysis through digestion with two different 
restriction enzymes show no migration or band pattern difference between DNA 
extracted from AdV2 exposed to formulations and virus exposed to storage buffer. 
Those results show there is no apparent DNA damage when AdV2 is exposed to 
formulations for 2 h at room temperature. 
 
4.3.5.4 DNA damage – zinc presence in extracted F116 DNA samples 
 
 In order to verify a possible link between zinc and F116 DNA damage, a 
preliminary quantitative analysis through ICP-MS was carried out in terms of zinc 
concentration present in aliquots of extracted F116 DNA. The zinc content found in 
DNA solutions extracted after exposure of F116 to different formulations is presented in 
table 4.10. 
 
Table 4.10: Zinc content in samples of F116 DNA extracted after exposure of virus to 
different formulations through ICP-MS. 
 
Formulation Zinc content detected (in ppm) 
RB-002 0.798 (±0.025) 
RB-002G 1.192 (±0.027) 
RB-002 in presence with EDTA 0.355 (±0.0347) 
70% (w/v) Ethanol 0.299 (±0.053) 
Negative control (PBS) 0.337 (±0.051) 
 
 As expected, higher amount of zinc was detected in F116 DNA samples 
extracted from bacteriophage F116 exposed to formulations containing zinc as an active 
ingredient. Nevertheless, the amount of zinc detected reduced drastically when the same 
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formulation was in presence of EDTA chelating agent, which may indicate higher 
affinity of zinc to the chelating agent instead of virus or its genome. The zinc content 
found for the F116 DNA exposed formulation RB-002 in presence of chelating agent 
was comparable to negative controls such as 70% (w/v) ethanol and storage buffer. The 
negative control point to minimal zinc content possibly already present in those 
formulations and/or add during the DNA extraction process. Difference between RB-
002 and RB-002G were significant (ANOVA, p<0.05) which may indicate zinc is 
possibly coordinated to other ingredients of formulation when alcohol is present. The 
preliminary data shows higher zinc concentration in F116 DNA samples extracted after 
virus exposure to formulations with zinc as active ingredient which could be associated 
with viral DNA. However, zinc coordination and metal binding to viral nucleic acid 
could not be observed yet. 
 
4.4 Discussion 
 
TEM imaging was crucial to have a deeper insight on the effect of the 
formulations on virus structure. The present study revealed a damage pattern associated 
to the formulations comprising zinc and ethanol as they induced higher percentage of 
morphological changes to the head and the tail of F116 bacteriophages. This confirmed 
that the formulation can structurally damage viruses. In terms of structural damage, 
formulations CA001 and CA001-E containing both ethanol and zinc ingredients led to 
higher number of phages with expanded and concentrated material inside head, and 
folded head, which suggest an interaction of the referred formulations with virus genetic 
material. Zinc ions may be responsible for such effects. Kuemel et al. (1990) observed 
that interaction of zinc with herpes simplex virus not only lead to virus aggregation, but 
also to zinc deposition in virion components, resulting in a loss of infectivity. In order 
to confirm the zinc presence onto F116 capsid, an energy-dispersive X-ray (EDAX) 
spectroscopy was carried out and results show that phage with condensed material 
inside head present higher extent of zinc across its structure when compared to intact 
phage or phage with an empty head although a higher number of phages would be 
necessary to attest for statistical significance for each type of damage observed.  
One of the aspects of zinc toxicity is related to oxidative stress by generation of 
reactive oxygen species (ROS) (Morina et al., 2010). Those species were shown to 
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induce several damages to proteins, nucleic acids and cell membranes through extensive 
oxidation (Wu et al., 2015). ROS were shown to cause structural alterations in DNA 
through base pair mutation, rearrangements, deletions and species such as singlet 
oxygen and hydroxyl radical have been reported in the literature to be virucidal against 
HIV and Hepatitis B viruses (Wiseman and Halliwell, 1996; Baugh, 2000).  
Ethanol was reported in the literature to confer internal structure changes on 
non-enveloped virus (Maillard, 2001). By comparing 80% (w/v) ethanol solution with 
the formulations containing ethanol and zinc, it was shown that damage pattern was 
more diverse for the latter, which may result from the combination of action of both 
ethanol and zinc against different targets such as capsid proteins and nucleic acid, 
respectively. Formulation CA001 containing 40% (w/v) ethanol with 0.1% (w/v) zinc 
sulphate heptahydrate led to highest damage extension among other samples. 
The AFM nano-indentation studies on attP AdV5 allowed the evaluation of the 
effects of formulations RB-002 on virus mechanical properties and morphology. The 
summary of the results about the influence of different formulations on the virus 
mechanical properties analysed through nano-indentation studies is shown in Figure 
4.10 as follows 
 
Figure 4.10:  attP Adenovirus type 5 (attP AdV5) mechanical properties variation upon 
exposure to formulation RB-002 and respective controls. Red squares 
represent data series related to breaking force; black squares are related to 
virus spring constant. 
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A lower spring constant of the virus exposed to the formulation was observed 
when compared to HBS storage buffer (negative control). This would make the virus 
more susceptible to environment chemical and mechanical stress (Hernando-Perez et 
al., 2014b). Significant spring constant variation was found between formulations RB-
002, RB-002G and RB-002EXCP, where the latter surprisingly yielded the lowest virus 
spring constant. This suggests a distinct mode of action when zinc as an active 
ingredient is present in the formulation as this is the only ingredient that differentiates 
RB-002 and RB-002G from RB-002EXCP. On the other hand, virions exposed to RB-
002EXCP could withstand higher breaking force highlighting formulations containing 
zinc as active ingredient tends to weaken the virus capsid.  
It is known that mechanical properties of viruses such as stiffness and capacity 
to withstand certain pressures such as DNA packing, cell entry process and extracellular 
conditions like osmotic pressure water activity and pH plays a significant role for their 
viability (Carrasco et al., 2011; Greber, 2016). In this case, virions exposed to 
formulations RB-002 and RB-002G presented a higher susceptibility to mechanical 
stress, which could hamper virus infectivity. The fragility rather than virus stiffness was 
verified to be more important in terms of capacity virus capsid withstand certain 
mechanical stress (Hernando-Perez et al., 2014a). Additionally, Llauro et al. (2015) 
demonstrated calcium ions could alter the mechanics of tomato bushy stunt virus capsid 
through calcium ion sequestration from intra-capsid binding sites reducing virus rigidity 
and resilience to mechanical stress and making it more susceptible also to internal 
pressure. Hence, it is possible that zinc may interact with the viral capsid in a similar 
way altering capsid mechanical stability.  
Although RB-002 and RB-002G seemed to yield comparable changes to virion 
mechanical properties, it was verified that RB-002 led to significant viral capsid height 
reduction as contact time increases, i.e. viral capsid has shrunk with time. This indicates 
a distinct mode of action between RB-002 and RB-002G where the presence of both 
alcohol and zinc as active ingredients induced higher extent of structural damage to the 
adenovirus capsid. Ivanovska et al. (2007) reported that there was a direct relation 
between viral genome size including conformational changes with overall capsid 
mechanical stability as lambda phages capsid with wild-type genome could withstand 
twice force applied to lambda phages with DNA 78% shorter. It is possible that 
formulation containing both ethanol and zinc may induce certain capsid protein and 
DNA conformational changes. This can be involved in reduction of adenovirus capsid 
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stability not only by capsid structural changes but also through alteration of viral nucleic 
acid packing within capsid and consequently internal pressure variation. Kennedy and 
Parks (2009) hypothesized that tight packaging of unmodified DNA within adenovirus 
capsid may be important to exert a force on adenosome, i.e. virus capsid pentons present 
in the vertex region to be reoriented in a position, which favours capsid mechanical 
stability.  
Moreover, TEM analysis of attP AdV5 upon exposure to formulations RB-002 
prepared by RB diluted 1:1 show that virions did not present any significant structural 
damage even tough formulations RB-002 showed a different staining compared to 
formulations without ethanol or zinc. This may be associated to the presence of ethanol 
in the formulations RB-002, which can cause substructure damages on the capsid of 
non-enveloped viruses as reported in the literature (Macinga et al., 2008; Liu et al., 
2010). The presence of alcohol as an active ingredient in RB-002 may be the reason that 
formulation had higher impact on virus topography as compared to RB-002G 
containing zinc as sole active ingredient. 
 Finally, the hypothesis of viral DNA damage induced by the combination of 
alcohol and zinc formulation was studied through a qualitative methodology based on 
the gel electrophoresis of DNA extracted after exposure of viruses to different 
formulations. The DNA bands extracted from F116 and AdV2 exposed to storage buffer 
negative control (see figure 4.8A and 4.9 A, respectively) were comparable to the ones 
found in the literature showing there is no apparent DNA damage caused by PBS and 
HBS storage buffers (Maillard, 1994; Elnifro et al., 2000). It was shown that presence 
of zinc in the formulation could lead to minor damage to F116 DNA as evidenced by 
presence of a smear and distinct restriction pattern obtained by DNA digestion by 
Sau3AI restriction enzyme. This result agrees with the ones obtained through TEM 
where higher percentage of phages heads with concentrated and expanded material 
inside was found for formulations containing zinc. On the other hand, no apparent DNA 
damage was observed under same conditions for AdV2. The difference of results 
between F116 and AdV2 may be related to distinct mechanism of action by alcohol/zinc 
combination and/or limitations of the technique to assess overall DNA damage. 
Damages observed against F116 DNA is most likely due to the presence of zinc in 
formulations as it was shown in the literature viral DNA is not a target for the action of 
alcohol (McDonnell and Russell, 1999; Pfaender et al., 2014). 
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 It is known that free zinc ions (Zn2+) have the potential to bind to DNA and 
consequently change its secondary structure mainly through interactions with DNA 
phosphate sugar backbone as well as guanine and cytosines by imino protons 
replacement (Aich et al., 1999). Furthermore, it was discovered that a high ratio of Zn2+ 
to DNA has the capacity of destabilizing the DNA double helix decreasing melting 
temperatures of DNA molecules (Souza et al., 2000; Labiuk, 2003). Thus, it is possible 
that zinc in formulations may bind to F116 DNA inducing conformational changes and 
double helix destabilization. This can make nucleic acid more prone to damages caused 
by chemical environment such as oxidative stress, cleavage by zinc complexes at 
alkaline pH (Yuan et al., 2006) and DNA crosslinking in presence of zinc (Labiuk et al., 
2001). The preliminary quantitative analysis of zinc pool in solutions of F116 DNA by 
ICP-MS after extraction showed there were higher zinc concentrations in DNA samples 
from F116 exposed to formulations RB-002 and RB-002G as expected. Formulation 
RB-002 in presence of EDTA chelating agent yielded similar result as negative control 
(PBS), which indicate higher zinc concentration observed in DNA samples are due to 
exposure of viruses to formulations containing zinc. However, it was not possible to 
verify whether zinc pool was directly bound to extracted DNA.   
 The combination of alcohol and zinc showed to induced structural damages to 
both bacteriophage F116 and Adenovirus (AdV2 and attPAdV5) which could explain 
the virucidal activity of the formulation system under study. It is proposed that the viral 
nucleic acid is a potential target for the formulation against bacteriophage F116 where 
DNA conformation and potential damage was confirmed through TEM and gel 
electrophoresis analysis. On the other hand, AdV2 did not present significant DNA 
damage, which may be explained by a distinct mode of action and/or limitations of 
DNA damage analysis by electrophoresis. In order to verify the presence of DNA 
damage in adenovirus, it is recommended the quantification of lesions per kb by real-
time polymerase chain reaction. Nevertheless, the presence of zinc in formulation had a 
significant impact on overall attPAdV5 mechanical properties where virions became 
less stiff and more prone to capsomere displacement by normal force (mechanical 
stress). The presence of alcohol in combination with zinc in formulation RB-002 led to 
profound viral topography changes like capsid height reduction, which could severely 
affect virus infectivity.  
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5. Formulation chemistry 
5.1 Introduction 
 
 Biocidal products usually comprise not only the active molecules, but also other 
ingredients important for formulation stability such as co-solvents, pH buffers and anti-
corrosive agents. For instance, the potential for triethanolamine present in the 
formulations under study to form complexes with metal ions such cadmium and zinc is 
well known (Shaban et al., 2003). Proton NMR spectroscopy was performed aiming to 
analyse potential complex formation of zinc and triethanolamine in the formulation. 
 According to basic zinc speciation diagrams, zincate ([Zn(OH)4]
2-) is the most 
common species found under alkaline solutions (pH 10-11) in aqueous system (Winand, 
2010). Zincate salts have been reported in the literature to present antifungal activity, 
but no virucidal activity has been demonstrated yet (Amim et al., 2011). The 
Henderson-Hasselbach equation is presented below: 
 
    pH = pKa + log10(
[A−]
[HA]
)     (Equation 5.1) 
 
Where [A−]  is the molar concentration of acid’s conjugate base; [HA]  is the molar 
concentration of the undissociated acid and pKa is the –log10 of the acid dissociation 
constant. Assuming that the pKa of the zinc complex with water molecules is around 9.5 
(Gilson and Durrant, 2009) and by taking this equation into account, it is possible to 
affirm that at pH of 10.5 concentration of the zinc complex in its hydroxide form is ten 
times higher than undissociated zinc complex in formulation. The Lewis acidic zinc 
complex with water in its base form is capable of promoting solvolysis cleavage of 
phosphate diesters of RNA through general-base-catalysed mechanism as depicted in 
Figure 5.1 (Zhang et al., 2014). 
 In this chapter, the main goal is to observe formulation chemistry in terms of 
zinc availability and possible identification of zinc species as well as possible 
complexation with formulation excipients.  
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Figure 5.1: General-base catalysed mechanism of solvolysis cleavage of 
phosphodiester by mononuclear zinc complex. LG stands for leaving 
group. 
 
 
 
 
 
 
 
 
5.2 Materials and Methods 
5.2.1 Proton Nuclear Nuclear Magnetic Resonance (1H-NMR) Spectroscopy 
 
 The NMR spectroscopy has been used to analyse the chemical content and 
structure of chemical and biological samples. The technique is based on the fact nuclei 
in different chemical environments will resonate at different frequencies due to electron 
shell differences culminating into a chemical shift (Chatham and Blackband, 2001). In 
the present study, NMR spectroscopy was carried out in order to analyse the chemical 
environment (chemical species and structures) present in the formulation under study, 
more specifically the possible complexation of triethanolamine with zinc, which could 
be responsible for lower virucidal activity observed by previous experiments. 
 Six mg of triethanolamine were mixed with 2 mg zinc sulphate heptahydrate 
using 40% (v/v) deuterated ethanol (D6-Ethanol) with 60 % (v/v) deuterated water 
(D2O) as solvent. Solution was prepared in a 5mm NMR tube (Norell, US) and Proton 
NMR spectroscopy was performed by using a 400 MHz instrument. Controls consisted 
of triethanolamine and zinc sulphate heptahydrate mixed separately with the 
aforementioned solvent.  Data was analysed through MestReNova software (v9.1.0, 
Mestrelab Research). 
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5.2.2 Liquid chromatograph mass spectrometry (LC/MS) analysis of RB002 formulations 
 
In order to analyse the different RB002 formulations and possibly identify 
chemical species, which could be related to observed virucidal activity samples were 
analysed by LC/MS. The method was carried out according to Oestman et al. (2017).  
Initially samples were diluted ten times with ultrapure water (MilliQ, UK) and 
10 μL injected to liquid chromatography (Dionex UltiMate 3000 Thermofisher, UK) 
using acetonitrile (Fisher, UK) and ultrapure water as solvent A and B, respectively. 
The gradient program started at 3% (v/v) with solvent A ramping to 97% (v/v) at a flow 
rate of 0.3 mL/min through a C18 column at 40oC. Following that, sample with eluent 
was submitted to a mass spectroscopy (amaZon SL Bruker, USA) module including an 
ion trap. The MS detector performed scans from 100 to 1000 amu/sec in positive mode. 
Syringe used for injection of samples as well as LC-MS system was cleaned with 
ultrapure water two times in between analyses of different formulations. The product 
ion mass spectra for each formulation was obtained and mass-to-charge ratio (m/z) was 
used to identify possible chemical species through MassBank software (MassBank 
Project, version 1.8). 
 
5.2.3 Small angle X-ray scattering spectroscopy (SAXS) on bacteriophage MS2 
 
 The SAXS was carried out in order to characterize bacteriophage MS2 capsid 
conformational changes and RNA core during exposure to RB-001 and to highlight 
possible chemical interactions between formulation active ingredients and virus capsid 
proteins along prolonged contact times. The experimental procedure was based on the 
one described by Nguyen et al. (2011), except for bacteriophage purification where they 
were prepared by soft overlayer agar technique and dialysed with SM buffer. Samples 
of bacteriophage MS2 (1011PFU.mL-1) in contact with RB-001 were sealed in 1.5 mm 
diameter quartz glass capillaries and SAXS was performed at 10keV on beamline 21 in 
a synchrotron based in Diamond Light Source facility (Oxford, UK). The radiation 
scattered by sample under analysis was collected by a MarCCD 165 camera (Rayonix, 
USA) with pixel size 73.2 × 73.2 μm2. The data was analysed was performed through 
ScAtter in BiosIsis software package (BioIsis, UK).  
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5.3 Results 
5.3.1 Proton NMR Spectroscopy  
 
Proton NMR spectroscopy was carried out in order to analyse the formulation 
chemistry and verify possible coordination of zinc ions to other formulation 
components at around pH 8.0. 
 The potential for triethanolamine to form complexes with metal ions such 
cadmium and zinc is well known (Shaban et al., 2003). Proton NMR spectroscopy was 
performed aiming to analyse potential complex formation of zinc and triethanolamine in 
the formulation. Spectra obtained for the solvent (60% D2O with 40% D6-Ethanol), 
triethanolamine and mixture of triethanolamine and zinc sulphate heptahydrate is shown 
in Figure 5.2.  
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Figure 5.2: Proton NMR at 400 MHz spectra of different solutions: (A) solvent only (60% D20 + 40% D6 Ethanol); (B) Triethanolamine in solvent and (C) 
Triethanolamine + Zinc sulphate heptahydrate in solvent. Peaks correspond to methyl (6.79 ppm in D2O) and methylene groups of ethanol (4.32 ppm in 
D2O).  
-CH2 
-CH2 
-CH2 
 3
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The solvent spectrum shows three main peaks. From left to right, first peak 
corresponds to non-deuterated water molecules, the second peak is related to methyl 
groups (6.79 ppm in D2O) and the third one to methylene groups of ethanol (4.32 ppm 
in D2O). In Figure 5.2 B, peaks corresponding to methylene groups of triethanolamine 
(6.84 ppm and 5.90 ppm) are more intense than the ones related to ethanol from the 
solvent. By comparing comparison with Figure 5.2 C, it was found that presence of zinc 
complexes with triethanolamine is not significant as chemical shifts obtained for 
solutions containing both zinc and triethanolamine were similar to the ones obtained 
with triethanolamine only. Further analysis with other sample components at a distinct 
operation frequency is necessary to validate the method. 
 
5.3.2 Analysis of RB-002 formulation chemistry by LC-MS – was it possible to identify 
active compounds? 
 
As previously described, RB-002 formulation chemistry was further analysed by 
LC-MS as an attempt to verify and identify possible chemical entities responsible for 
activity against viruses. The results for the RB-002 formulation set are presented in 
figure 5.3. 
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Figure 5.3: Product ion mass spectra obtained by LC-MS analysis of different RB-002 formulations. (A) RB-002 – 40% (w/v) ethanol + 0.1 
(w/v) zinc + excipients; (B) RB-002G 0.1% (w/v) zinc + excipients and (C) RB-002EXCP excipients only at pH 10.5.  
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As expected, different m/z diagram profiles for different formulations presented 
distinct distributions of ions and abundance thereof. Formulation RB-002EXCP 
containing excipients only presented higher noise and extent of ionisation when 
compared to formulations RB-002 and RB-002. It was not possible to find hits for the 
obtained m/z peaks in positive mode by MassBank chemical database, thus 
identification of chemical species in the formulations was not possible.  
 
5.3.3 Small-angle X-ray scattering spectroscopy on MS2 upon exposure to formulation 
RB001 (40% (w/v Ethanol+0.1(w/v) zinc sulphate heptahydrate + excipients) 
 
 SAXS analysis aims to evaluate the influence of formulations on bacteriophage 
MS2 overall size and structure of the protein shell and conformational changes as well 
as the amount of encapsulated RNA. In the present study, purified bacteriophage MS2 
in presence of formulation CA001 was analysed. After obtaining the first set of data, 
Guinier analysis was performed in order to estimate particle radius of gyration and 
aggregation and obtained Guinier fit is shown in figure 5.4 as follows: 
 
 Figure 5.4: Guinier fit of sample composed of bacteriophage MS2 exposed to 
formulation CA001, where I(q) represents the scattering intensity 
resulting from the subtraction of the buffer from the sample and q 
represents the momentum transfer. 
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There was a non-linear dependence between Ln [I(q)] and q2, especially for 
lower values of the latter (Fig. 5.4). The observed non-linear relation indicated the 
presence of aggregates in suspension, which strongly influenced data analysis and 
compromised its reliability (Putnam et al., 2007). Therefore, sample analysed was not 
suitable for verifying MS2 structure and conformational changes through SAXS.  
 
5.4 Discussion 
 
Since virucidal activities obtained in the present study was not comparable to the 
ones found in the literature (Ijaz and Zu, 2014), it was hypothesised that zinc was 
possibly coordinated to other formulation ingredients capable of forming complexes 
with metal ions, more specifically triethanolamine. Proton NMR spectroscopy at 400 
MHz was performed to analyse formation of complexes between zinc ions and 
triethanolamine. The presence of zinc complexes with triethanolamine was not 
significant as chemical shifts obtained for solutions containing both zinc and 
triethanolamine were similar to the ones obtained with triethanolamine only (Fig. 5.2B). 
Nevertheless, it is suggested that further analysis with other sample components at a 
distinct operation frequency is necessary to validate the method and gather deeper 
understanding about the zinc coordination in the formulations and chemical 
environment (Skinner and Laurence, 2008). High presence of base form of zinc 
complexes with water are expected to be present in solution at that pH according to 
equation 5.1. However, it is essential to determine speciation diagram of zinc sulphate 
heptahydrate in formulation at different pHs. In this study, LC/MS of formulation RB-
002 was carried out in order to verify whether it was possible to identify possible zinc 
species, which could be responsible for virucidal activity. Unfortunately, analysis of 
possible species from the given formulation did not reveal discrete Zn-ethanolamine 
adducts or any other zinc-related adduct. A more comprehensive chemical analysis of 
formulation set RB-002 through direct injection LC-MS/MS (tandem MS) analysis of 
solutions comprising one of RB-002 pure ingredient mixed with ultra pure water should 
be carried out in the future in order to reduce possible interferences from formulation 
excipients as well as matrix effects (Andersson et al., 2008). After obtaining LC-MS 
diagrams of each formulation ingredient in solution at pH 10.5, active ingredients like 
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ethanol and zinc sulphate heptahydrate could be added in order to possibly identify 
formation of active chemical species (Yamaguchi et al., 2007).  
 Regarding the analysis of viral capsid protein conformational changes and MS2 
RNA structural alterations by SAXS, it is recommended that additional purification 
steps such as 2-step centrifugation in caesium chloride gradient and diafiltration will be 
performed to increase sample purity. In addition, PIPES (piperazine-N, N’-bis (2-
ethanesulfonic acid)) buffer at pH 6.5 could be used in order to avoid virus aggregation 
and lead to initial viral titres up to 1015PFU/mL as described by Nguyen et al. (2011). 
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Chapter 6 – General Discussion 
 
6.1 Introduction  
    6.1.1 Biocides, viruses and public health 
 
 Biocides are synthetic or semi-synthetic chemicals, which can control growth 
and/or eliminate microorganisms associated to inanimate objects, solutions, surfaces or 
intact skin. Biocides can either be classified as sterilants, disinfectants or preservatives 
depending on whether they destroy all microbial life, eliminate infectious pathogenic 
microorganisms or hamper further growth of microbial population, respectively 
(SCENIHR, 2009). Biocidal products containing biocides are employed in a wide range 
of industrial, healthcare and household settings in which they play a crucial role in 
effective cleaning and disinfection procedures (Bloomfield, 2002; SCENIHR, 2009; 
WTO, 2014). 
 Mammalian viruses are obligate parasites grouped in different families and 
classified according to shape, size, envelope or lack thereof and genome differences 
(Regenmortel et al., 2000). Those viruses may represent serious threat to public health 
and are often associated to nosocomial infections in healthcare settings (Maillard, 
2005). It is estimated that viruses alone account roughly 5% of approximately 7 million 
hospital acquired infections worldwide although it is thought to be an underestimated 
percentage (Aitken and Jeffries, 2001; Wright and Bieluch, 1993; Borkow and Monk, 
2012). Carducci et al. (2011) discovered that 16.7% of all surface samples in healthcare 
settings were contaminated with viral nucleic acid. This impact is mainly due to the ease 
of viral transmission to hosts via contaminated surfaces like hospital floors, bedrails, 
doorknobs, medical devices and contaminated textiles which may even be source of 
aerosol contamination or directly contaminate patients and hospital personnel (Borkow 
and Monk, 2012). Besides, some viral characteristics contribute to ease of viral spread 
such as: i) high infectivity efficiency and ii) resilience for a long time when dried on 
inanimate surfaces in presence of organic load depending on environmental pH, 
temperature, level of viral aggregation and moisture (Kocwa-Haluch, 2001; Firquet et 
al., 2015). Hence, medical and scientific communities have been showing increased 
concern about control and prevention of pathogen outbreaks mainly in hospital settings. 
Disinfection and sterilisation practices have been incorporated as general measures to 
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prevent spread of pathogens (Rutala et al., 2017). The choice of a suitable disinfectant 
(biocidal product) with broad range of action and disinfection protocols is crucial to 
hamper virus spread and possible outbreaks.  
 Viruses present variable physicochemical properties, genome and structure, and 
as such distinct targets for virucidal action. This accounts for variability in susceptibility 
profiles to different biocides (Sauerbrei et al., 2004; Eterpi et al., 2009). In this context, 
the type of virus, biocide and its mechanism of action as well as environmental 
conditions should be taken into account in order to elaborate an effective disinfection 
protocol. For instance, non-enveloped viruses are known to be more resistant to certain 
biocides due to the lack of a lipid membrane (viral envelope) (Maillard, 2001). Table 
6.1 shows clinically relevant non-enveloped viruses nowadays as well as effective 
biocides found in the literature. 
 Non-enveloped viruses present higher resilience to certain biocides (e.g. 
membrane active ingredients) and persistence for longer periods of time than enveloped 
counterparts on inanimate surfaces. Therefore, it is advisable to develop a disinfectant 
highly active against non-enveloped viruses and with a rapid and broad antiviral 
spectrum. Novel active ingredients and biocidal products are being developed not only 
to improve disinfection practices in different settings by higher bactericidal, fungicidal 
and virucidal efficacy but also to comply with toxicity and environmental guidelines. In 
addition, the possible link between co-selection and resistance of bacteria to certain 
biocides including excessive commonly use of the same active ingredient at sub-lethal 
concentrations highlight the need for the development of novel biocidal products with 
different combination of active ingredients (Wales and Davies, 2015). Biocidal products 
are an integral part of multi-barrier strategy to prevent spread of viruses and good 
hygiene practices as a whole. 
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Table 6.1. Most relevant human pathogenic non-enveloped viruses nowadays and 
respective pathogenesis. 
Family Viruses Genome Pathology References 
Adenoviridae 
Adenovirus type 
2, 5, 8, 40 and 
41 
dsDNA 
Upper tract 
respiratory 
infection; 
keratoconjuctivitis; 
pneumonia  
Kojaoghlanian 
et al. (2003); 
Rutala et al. 
(2006); 
Sauerbrei et 
al. (2004) 
Caliciviridae  
Astrovirus, 
Caliciviruses, 
Norovirus 
+ssRNA 
Epidemic 
gastroenteritis 
Magulski et 
al. (2009) 
Picornaviridae 
Cocksackievirus, 
Rhinovirus 
Echovirus, 
Hepatitis A, 
Poliovirus type 1 
+ssRNA 
Common cold 
syndrome; 
Hepatitis; 
Poliomyelites 
Ionidis et al. 
(2016); 
Wilton et al. 
(2014) 
Reoviridae 
Rotavirus and 
Reovirus 
dsRNA 
Severe diahrreia in 
infants 
Sattar et al. 
(1994) 
Mimiviridae 
Acanthamoeba 
polyphaga 
mimivirus 
dsDNA Pneumonia 
Campos et al. 
(2012) 
 
6.1.2 Alcohol and zinc as active ingredients 
 
 Alcohols represent a group of active ingredients including mainly ethanol, n-
propanol and isopropanol, which are present in low to mid-level disinfectants (WHO, 
2014). This group of active ingredients tends to present a fast and wide spectrum of 
action, i.e. fungicidal, bactericidal and virucidal activity to some extent. The mode of 
action is mainly due to protein denaturation in presence of water. Higher activity against 
enveloped viruses when compared to non-enveloped ones suggests that viral envelope is 
also potential target for virucidal action (Soulet et al., 1998; Ionidis et al., 2016). 
However, the exact mechanism of virucidal action by alcohols against non-enveloped 
 131 
viruses little is not entirely known yet. Furthermore, alcohols are supplemented with 
other active ingredients in order to increase the efficacy against wide range of 
pathogens. For instance, alcohol-based hand-rub sanitisers supplemented with hydrogen 
peroxide are formulations recommended by the World Health Organization (WHO) for 
hand disinfection in healthcare settings when commercial hand rubs are too expensive 
or out of reach (WHO, 2010).  
 Metallic ions such as copper, silver and zinc and respective salts were also 
shown as group of active ingredients effective against pathogenic microorganisms and 
are often used in conjunction with alcohols. For example, zinc pyrithione has been used 
as a preservative system in combination with alcohol in various skin antisepsis and 
cosmetic products (Crutchfield et al., 1997; Gutery et al., 2005). Although zinc salts are 
known in the literature to play a vital role in viral infective pathways and virus-host 
interactions, inhibitory effects against both enveloped and non-enveloped viruses have 
been also reported (Chatuverdi and Shrivastava, 2005; Husliz, 2003). Nevertheless, the 
mechanism of virucidal action associated to zinc salts is still largely unknown. 
 
     6.1.3 Objectives of the project 
 
 The main goal of the present project was to gather deeper insight into the 
mechanisms of virucidal action associated to formulations comprising the combination 
of ethanol and zinc sulphate as active ingredients against non-enveloped viruses. 
Initially, the virucidal efficacy tests of zinc/alcohol combinations against model virus 
(bacteriophages MS2 and F116) were performed for activity screening and structural 
studies. Subsequently, the efficacy of those formulations against human non-enveloped 
viruses (Adenovirus type 5 and Poliovirus type 1) was performed and structural studies 
allowed assessing potential viral targets for zinc/alcohol combination. 
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6.2 General considerations about the virucidal activity and mechanism of 
action associated to combination of ethanol and zinc as active ingredients 
against non-enveloped viruses 
 
     6.2.1 Impact of zinc and alcohol combination against non-enveloped viruses. What is 
the real impact? 
 
 At a first stage, the virucidal activity of formulations prepared in our laboratory 
containing a fixed amount of zinc sulphate heptahydrate with different ethanol 
concentrations against model viruses (bacteriophage MS2 and F116) was evaluated. The 
bacteriophage MS2 was firstly used for the following reasons: i) it is generally 
recognized to be a suitable surrogate for certain mammalian viruses like poliovirus type 
1, norovirus and adenovirus) (Dawson et al., 2005); ii) it is safer to handle and iii) its 
propagation and quantification of plaque forming units is faster than with mammalian 
viruses allowing rapid screening of virucidal efficacy against non-enveloped viruses 
(Bae and Schwab, 2008). The formulation system containing 40% (w/v) ethanol with 
0.1% (w/v) zinc sulphate hydrate was chosen for further investigation as it yielded 
higher viral log10 reductions for relatively low ethanol concentrations. Hence, that 
formulation system seemed to encompass the most beneficial trade off in terms of 
alcohol concentration reduction and virucidal activity at 60 min contact time. Table 6.2 
shows a summary of the main virucidal efficacy tests of the aforementioned formulation 
system at pH 10.5 and respective controls against both bacteriophages and mammalian 
viruses at 1h contact time. Table 6.3 shows the virucidal efficacy tests of CA001 and 
RB-002 performed after different storage periods at room temperature and dark 
environment. 
 The virucidal activity of formulations containing both alcohol and zinc as active 
ingredients was predominantly higher than activity of formulation containing zinc as 
sole active ingredient against different non-enveloped viruses across different 
formulation batches. Furthermore, significant differences between virucidal activity of 
formulation containing zinc as sole active ingredient and formulations with excipients 
only, demonstrates the impact of zinc on the viability of non-enveloped viruses. It was 
noteworthy that formulation prepared in Cardiff (CA001) presented much higher 
activity than formulations prepared by RB (RB-001 and RB-002 series) (Table 6.2). 
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This could be due to differences in terms of ingredient purity and usage of denatured 
ethanol by RB as one of the active ingredients.  
 
Table 6.2: Summary of the virucidal efficacy test results of different batches of the 
formulation system comprising 40% (w/v) ethanol with 0.1% (w/v) zinc 
sulphate at pH 10.5 against non-enveloped viruses in suspension. Only 
results at 60 min contact time are presented.  
Formulation set Formulation (composition) Virus 
Virus titre 
reduction 
(log10) 
Batch 1: 
formulation 
prepared in 
Cardiff 
CA001 (40% (w/v) ethanol+0.1% (w/v) zinc 
sulphate+excipients) 
MS2 
4.18±0.12 
CA001G (0.1% (w/v) zinc sulphate+excipients) 1.07±0.03 
CA001EXCP (excipients) 0.22±0.07 
CA001 in presence of 0.06% (w/v) EDTA 0.39±0.02 
Batch 2: 
formulation 
prepared by RB 
(December 
2014) 
RB-001 (40% (w/v) ethanol+0.1% (w/v) zinc 
sulphate+excipients) 
MS2 
1.26±0.07 
RB-001 in presence of 0.06% (w/v) EDTA 0.33±0.03 
Batch 3: 
formulation 
prepared by RB 
(September 
2015) 
RB-002 (40% (w/v) ethanol+0.1% (w/v) zinc 
sulphate+excipients) 
MS2 0.88±0.04 
F116 0.68±0.02 
AdV2 5.26±0.10 
Pv1 3.71* 
RB-002G (0.1% (w/v) zinc sulphate+excipients) 
MS2 0.37±0.06 
F116 0.14±0.02 
AdV2 0.80±0.12 
Pv1 2.06* 
RB-002EXCP (excipients) 
MS2 0.05±0.03 
F116 0.09±0.04 
AdV2 0.61±0.10 
Pv1 1.39* 
* only performed once; AdV2: adenovirus type 2; Pv1: poliovirus type 1 
 134 
 
Table 6.3: Summary of virucidal activities obtained for formulations containing both 
alcohol and zinc as active agents after different storage times. Formulations 
were stored at room temperature in dark environment. 
 
Formulation set 
Formulation 
(composition) 
Storage time 
Virus titre 
reduction (log10) 
Batch 1: formulation 
prepared in Cardiff 
CA001 (40% (w/v) 
ethanol+0.1% (w/v) 
zinc 
sulphate+excipients) 
0.5 month 4.18±0.12 
13 months 0.59±0.08 
Batch 2: formulation 
prepared by RB 
(September 2015) 
RB-002 (40% (w/v) 
ethanol+0.1% (w/v) 
zinc 
sulphate+excipients) 
1 month 1.07±0.05 
6 months 1.00±0.04 
12 months 0.89±0.06 
RB-002 in presence of 
0.06% (w/v) EDTA 
1 month 0.61±0.12 
6 months 0.55±0.04 
12 months 0.33±0.04 
 
Besides, the activity of CA001 formulations decayed significantly with time (see Table 
6.3 CA001 after 13 months storage in Batch 1) when formulation was stored at room 
temperature in dark environment. The pH of the formulation was measured every two 
weeks and it was constant over the storage period under analysis. RB-002 formulations 
also yielded lower virucidal efficacy against MS2 over 12 months of storage although 
observed activity reduction from 1 to 12 months was lower than the one observed for 
CA001. In addition, storage time of RB-002 seemed to have an impact on how 
formulation activity is affected by presence of chelating agent (EDTA, see Table 6.3). 
This may be an indication that presence of free zinc ions in formulation and its 
coordination may change over storage time (Maret, 2015). These data show storage 
time is also a factor to take into account for overall formulation activity against non-
enveloped viruses (see Table 6.3).  
 Overall, the formulations containing both alcohol and zinc yielded significantly 
lower activities in the presence of a strong chelating agent towards zinc such as EDTA. 
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This points out the importance of zinc to produce the observed virucidal activity. The 
importance of zinc was also shown to be more relevant at longer contact times (30 min 
and 60 min) against bacteriophage MS2 (see Chapter 3). This could be associated to 
mass transfer resistance for zinc and alcohol to reach their respective target on 
bacteriophage. Mass transfer is associated to the diffusion capacity of those active 
ingredients in liquid phase to reach targets on virus surfaces and also to the diffusion of 
virions in a liquid suspension by convection for example (Yakimovich et al., 2012; Liu 
et al., 2015). In this case, it is possible that there is a series of mass transfer resistances 
between virus target sites and active ingredients, which could be caused by improper 
mixing for example. Furthermore, the divalent cations like zinc may play a role at 
increasing phage attachment rate to the bacterial host, which questions the mechanism 
of virus inactivation of the formulation system under study. Indeed, the differences 
observed in virucidal activity between bacteriophages and mammalian viruses could be 
related to a different dynamic of virus/host cell receptor interaction. The dual effect of 
zinc as a divalent cation essential for virus infectivity but also virucidal at certain 
concentrations has been reported in the literature (Date, 1979; Lazarczyk and Favre, 
2008; Geist et al., 1987; Wei et al., 2012). For instance, it is possible that zinc ions have 
a much more pronounced dual role in the bacteriophage infectious cycle compared to 
the mammalian virus one. The addition of chelating agents to RB-002 against poliovirus 
suggests mammalian viruses could be blocked from entering the host (see section 3.3.6 
in Chapter 3). That observation raises interesting questions about the differences of 
dynamic of viral attachment and binding of zinc ions to specific viral capsid receptors 
and effective usage of bacteriophages as valid surrogates when formulations containing 
cations are used.  
 Bacteriophage F116 and adenovirus were used to investigate the impact of zinc 
and alcohol on virus structure and to identify possible targets for virucidal action. It was 
found that the presence of both alcohol and zinc could be associated to a specific 
damage pattern on bacteriophage F116 where material inside phage head presented a 
distinct conformation (concentrated + expanded) with severe damage to tail. F116 DNA 
was observed to be a potential target for alcohol/zinc virucidal action as nucleic damage 
was observed through gel electrophoresis (see Chapter 4). On the other hand, 
transmission electron microscopy showed that adenovirus exposed to formulation 
containing both alcohol and zinc showed possible damages to the capsid, which may 
have led to a distinct uptake of the negative stain. The nano-indentation investigation 
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with adenovirus showed that all RB-002 formulations led to less stiff virus capsid 
(lower spring constant) although formulations containing zinc as active ingredient (RB-
002 and RB-002G) yielded fragile viruses where their capsid was more susceptible to 
mechanical stress (lower breaking force). The capacity of viral capsid to withstand 
certain force and alter capsid conformation is crucial for different steps of the infectious 
cycle such as cell attachment, cell entry and release of viral genome (Greber, 2016). The 
higher mechanical susceptibility of the viral capsid may be a net result of capsomer 
displacement, protein conformation changes and pressure variation exerted by potential 
nucleic acid conformational changes (Bauer et al., 2015). Nevertheless, adenovirus 
DNA damage was not observed upon exposure to formulation through the protocol 
carried out in the present project.  
 The virucidal activity differences observed for RB-002 formulation against 
different viruses could be due to the following factors: i) different targets for zinc 
action; ii) effect of zinc on phage attachment to bacterial host; iii) possible impairment 
of mammalian virus cell entry by an excess of zinc. Although bacteriophages 
susceptibility to RB-002 formulations was significantly lower than mammalian viruses, 
virucidal activity trends were similar between the tested mammalian viruses and 
bacteriophages. For example, the highest activities were consistently observed against 
mammalian viruses and bacteriophages when both alcohol and zinc were present as 
active ingredients, whereas the control formulation comprising zinc as sole active 
ingredient yielded lower inactivation of both bacteriophages and mammalian viruses. 
Therefore, bacteriophages MS2 and F116 could be used as preliminary indicators of 
virucidal activity associated to alcohol/zinc formulation system against mammalian 
viruses under pre-defined environmental conditions (pH, temperature, presence of 
absence of organic load and/or chelating agents). However, surrogacy capacity in terms 
of inactivation has not been proven for this particular formulation system and virucidal 
activity quantification despite biological attributes of MS2 and F116 being similar to 
Pv1 and AdV2, respectively. Sinclair et al. (2012) stresses out that underestimating or 
overestimating inactivation of an organism may impact negatively on the elaboration of 
a risk assessment and consequently jeopardize safety levels of a given disinfection 
protocol. In this project, inactivation of non-enveloped viruses by alcohol/zinc 
combination is underestimated by activity test in suspension against bacteriophage MS2 
and F116, which potentially invalidate usage of those microorganisms as ultimate 
surrogates for mammalian viruses for the present formulation system.  
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     6.2.2 Proposed mechanism of action by zinc/alcohol combination against non-enveloped 
viruses 
 
 Knowledge about a given biocide mechanism of action (MoA) is essential to 
optimise its use, understand its limitations as well as improve biocidal product design 
and detect potential resistance mechanisms by target organisms (Chapman, 2002). The 
discovery of potential targets for biocidal action against pathogen microorganisms is an 
essential part of the MoA elucidation. The proposed MoA for the combination of 
alcohol with zinc along contact time is presented in Figure 6.1. 
 Initially non-enveloped virus is in contact with formulation containing both 
alcohol and zinc, which will tend to promote internal capsid protein conformation 
changes and bind to potential zinc finger motifs on viral capsid protein as time 
progresses (Phase I and II Figure 6.1). The interaction zinc and alcohol with the viruses 
is likely to be time-dependent since virucidal efficacy increases significantly with 
contact time (see Chapter 3). At a later stage (Phase III Figure 6.1) the viral capsid is 
weakened and zinc ions could penetrate the virus more efficiently (EDAX data, Chapter 
3) interacting with viral nucleic acid nucleic (Phase IV) yielding damage to F116 
virions (DNA damage by electrophoresis, Chapter 4). On the other hand, the presence 
of ethanol and zinc led to weaker and reduced adenovirus capsid compromising its 
infectivity (Nano-indentation studies, Chapter 4). Unfortunately, it was not possible to 
identify successfully possible chemical species, such as zincate, involved at different 
stages of formulation virucidal action (Chapter 5). The proposed MoA for formulations 
comprising 40% (w/v) ethanol and 0.1% (w/v) zinc salt with excipients has its 
limitations as possible interaction and damage to mammalian virus nucleic acid still 
remains to be confirmed. Future experiments aiming to gather deeper look on the 
proposed MoA will be suggested by the end of the present chapter. 
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Figure 6.1: Proposed mechanism of action (MoA) of alcohol/zinc combination against non-enveloped viruses along contact time 
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6.3 Relevance of the project and impact on public health  
 
 The usage of zinc salts and oxides as antimicrobial agents is still relatively 
limited nowadays. The main usage of zinc is as a preservative in combination with other 
active ingredients in biocidal products used as pesticide in agriculture (Rajasekaran et 
al. 2016), as hand and skin antisepsis in household and healthcare products (Guthery et 
al., 2005) and as antifouling agent in paints for metal surfaces treatment (Ytreberg et al., 
2010). The only example of biocidal product based on the combination of alcohol with 
zinc salt found to date is the usage of zinc pyrithione as an effective agent to increase 
antimicrobial activity persistence in skin antisepsis biocidal products. This combination 
allows higher activity for longer period of times in topical antiseptics containing alcohol 
as main active ingredient. Biocidal products based on that antimicrobial system is in 
compliance with FDA guidelines and used frequently as shampoos for control of 
dandruff in in shampoos for control of dandruff and surgical handrubs for example 
(FDA, 2007; Goncalves et al., 2011). Usage of other zinc salts such as zinc sulphate (as 
used in the present study) in combination with alcohol has not been commercially 
reported yet. 
 Despite alcohol in concentrations between 59-90% (w/v) showing a fast acting 
and broad-spectrum of antimicrobial action (McDonell and Russel, 1999; Macinga et 
al., 2008; Alhmidi et al., 2017), persistence of action is relatively low as alcohol 
evaporate quickly and residual activity after short periods of time is compromised 
(Rutala and Weber, 2014; Alhmidi et al., 2017). Hence, there is a need to combine it 
with other active ingredients. Moreover, usage of 60-90% (w/v) alcohol in surface and 
hand disinfectants can be problematic mostly due to increased flammability and toxicity 
affecting user safety (Kramer et al., 2006). It is also known that volatile organic 
compounds (VOCs) generated by alcohol-based household products may have short and 
long-term adverse health effects on animal and human in indoor environments such as 
sensory irritation, allergies, asthma and leukemia (Dai et al. 2017). The European Union 
and several states within U.S. have put in place environmental directives imposing 
limitations on VOCs emission in industrial settings (EU Council, 2004; EPA, 2017). 
Therefore, it is recommended that alcohol concentrations are reduced in many of those 
products while maintaining or preferably enhancing overall antimicrobial activity. In 
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this context, the present study indicated that combination of zinc with relatively low 
alcohol concentration can be effective against resilient microorganisms like non-
enveloped viruses while complying with environmental and safety guidelines.  
 Data from our study helped understand how the zinc with low alcohol amount (< 
45% w/v) combination inactivates viruses and provided information on the limitations 
of the formulation like relatively long contact time for larger extent of virucidal action 
and stability over period of storage. In this context, this research is an important step 
towards the development of novel biocidal products, which are effective, less toxic, 
safer to handle and store as well as in compliance with environmental guidelines and 
market trends of VOCs reduction.  
 
6.4 Conclusion 
 
 It is undeniable that biocides (active ingredients) in biocidal products play a key 
role in surface disinfection procedures. Those procedures are carried out in different 
areas ranging from household to healthcare and industry settings in order to prevent 
infections and product spoilage. Synergistic combinations of active ingredients aim to 
increase microbicidal efficiency while decreasing product development and production 
costs, reducing toxicity, enhance surface compatibility and increase compliance with 
environmental guidelines. The need for gathering information about the mechanism of 
microbicidal action associated to a biocide is essential for rational improvement, design, 
development and assessing the toxicological and environmental impact of a given 
product. In this context, the present project aimed to gather a deeper understanding of 
the mechanism of action associated to the combination of alcohol and zinc against non-
enveloped viruses. Research on the mechanism of action of alcohol and metallic ions in 
combination provided insightful information about those active ingredients interaction 
with viruses and limitations.  
 The initial screening of virucidal activity allowed verifying the combination of 
both alcohol and zinc against bacteriophage MS2 was more effective than counterparts 
containing one of the active ingredients only and that zinc had a more pronounced 
impact at lower ethanol concentrations (ranging from 25% w/v to 40% w/v) and at 
longer contact times (see Chapter 2). Surprisingly, activity of formulation RB-002 (40% 
(w/v) ethanol + 0.1% (w/v) zinc salt; pH 10.5) against AdV2 and Pv1 in suspension 
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induced 5.26 and 3.71 log10 reduction in virus concentration at room temperature, 
respectively. Those virucidal activities were significantly higher than the ones obtained 
against bacteriophage MS2 and F116. Thus, some caution is required about the usage of 
MS2 and F116 as virus surrogates for that formulation system and experimental 
conditions. Formulation storage time was also shown to have an effect on virucidal 
efficacy as formulations prepared in Cardiff led to lower viral inactivation 13 months 
after initial preparation. That was also reflected on the impact chelating agents had on 
overall activity along time on formulations CA001 and RB-002 (see section 3.3.5, 
Chapter 3). Structural studies showed that presence of zinc and alcohol has an impact on 
adenovirus capsid mechanical properties, which could potentially affect the ability to 
attach and infect a host cell. It is hypothesized that the combination weakens the viral 
capsid enabling zing to penetrate the nucleocapsid and interacts with the viral nucleic 
acid. Electron microscopical investigations showed the F116 capsid was affected to 
some extent and F116 nucleic acid was shown to be a target for virucidal action against 
bacteriophage F116 where the presence of zinc could be detected by EDAX and nucleic 
acid damage was observed by agarose gel electrophoresis. With adenovirus, the 
formulation was shown to weaken the capsid but unfortunately, the protocol used to 
exemplify DNA damage in adenovirus did not show any nucleic acid damage following 
formulation exposure. 
 There was an attempt of formulation speciation by identification of possible 
chemical entities responsible for activity as well as zinc coordination. It was shown by 
NMR analysis that interaction of zinc salts with triethanolamine, one of the excipients 
of the formulation known to be a chelating agent, was not significant indicating 
excipients may not be affecting zinc activity. Other analytical chemistry techniques 
were performed; however, no chemical species could be identified. It was hypothesized 
that zincate would be the most predominant zinc salt form at pH 10.5 complexed with 
other formulation ingredients such as triethanolamine for instance (Long and Angino, 
1977). Unfortunately, no complexation was observed and zincate could not be identified 
through LC-MS studies.  
In summary, the combination of alcohol with zinc salt revealed to be promising 
on their own against non-enveloped viruses at room temperature and pH 10.5. It was 
showed that viral capsid and nucleic acid are potential targets for the observed virucidal 
action as hypothesized beforehand. Based on those observations, a mechanism of action 
for both active ingredients was proposed although some aspects of it are still unclear 
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such as the impact of the formulation on i) mammalian/virus receptors and ii) 
mammalian virus nucleic acid as well exact chemical entities responsible for virucidal 
action. 
 
6.5 Current project limitations and prospects 
 
 The data obtained throughout this project is an asset towards the unravelling of 
mechanism of action of alcohol and zinc combination against non-enveloped viruses. 
Nevertheless, this project had some limitations, which should be acknowledged. The 
proposed mechanism of action is only valid at the experimental parameters chosen for 
virucidal efficacy screening and testing, i.e. pH 10.5, room temperature in absence of 
organic load) at a specific alcohol/zinc ratio. Moreover, the virucidal activity of the 
formulations was evaluated against viruses in suspension, which is intrinsically less 
challenging for the viruses when compared to tests on viruses adhered to inanimate 
surfaces (Klein, 2007). Hence, the observed viral inactivation may be an 
underestimation and testing of the biocide in different situations reflecting the end user 
experience should be carried out under compatible parameters (Brinch et al., 2016; 
Lambert et al., 2003). In this context, the present study can be seen as proof of principle 
justifying further work to understand how the combination of alcohol and zinc performs 
with non-enveloped viruses using more appropriate standard efficacy tests for different 
usage scenarios.  
From this research, several questions arose and ideas for future experiments can 
be suggested. All these questions would also help understanding the possible 
differences between bacteriophages and mammalian viruses and their possible usage as 
surrogates or not 
 
 What is the influence of different environmental parameters (pH, 
temperature, organic load on overall activity) on the virucidal activity of 
a given ratio of alcohol/zinc?  
 How specific is the interaction of the formulation with the viral capsid? 
Is it mediated by zinc finger motifs? How does capsid conformation 
change along time? How does it affect virus attachment and cell entry? 
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 How specific is the interaction of zinc ions with viral nucleic acid? How 
severe is nucleic acid damage? 
 What are the chemical species involved in virucidal activity and zinc 
coordination throughout contact time? 
 
The influence of different key environmental parameters and different 
alcohol/zinc ratios would allow the kinetic modelling of inactivation kinetics under 
different experimental conditions and a better understanding of the mechanism of action 
against viruses (Wigginton et al., 2012). That could be a useful tool for the prediction of 
the virucidal activities and rapid development of a given biocidal product and rapid 
screening for the most suitable alcohol/metal ion ratio for further analysis. Additionally, 
the very same virucidal efficacy analysis should be performed against a wide range of 
non-enveloped viruses. It has been reported that related viruses may present different 
susceptibilities towards a given biocide (Baxter et al., 2007). This study could also 
highlight potential emergence of resistance mechanisms by viruses through selective 
pressure for example (Zhong et al., 2016).  
The viral capsid mechanical properties (stiffness and fragility) were shown to be 
severely damaged by the combination of alcohol with zinc. Viruses may present zinc 
finger binding motifs on their capsid and/or proteins associated to viral nucleic acid 
conformation (Kirthi and Savithri, 2003; Chatuverdi and Shrivastava, 2005). Thus, it 
would be useful to investigate specific point of interaction of zinc with viral capsid 
proteins and the impact of their conformation and virus stability. It would also be an 
additional information about the dual effect of zinc as a divalent cation essential for 
virus infectivity but also virucidal at certain concentrations. The virus capsid 
conformational changes including pressure variation by nucleic acid along contact time 
could be analysed by small angle X-ray spectroscopy of highly purified viruses exposed 
to formulation (Bauer et al., 2015). Sodium dodecyl sulfate polyacrylamide gel 
electrophoresis of capsid proteins extracted after exposure to formulation could reveal 
potential protein alterations. Additionally, points of interaction of zinc ions with 
proteins could be revealed by in-gel screening of zinc ions through laser ablation 
inductively coupled plasma mass spectrometry (LA-ICP-MS) (Becker et al., 2004). 
The nucleic acid was demonstrated to be a target for virucidal action against 
bacteriophage F116 in this project although damage could not be observed for 
adenovirus. Extra-long range quantitative real-time PCR (LR-qPCR) could be 
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performed in order to quantify DNA damage as well as to estimate inactivation of virus 
exposed to formulation (Rodriguez et al., 2013). That experiment could provide rapid 
insightful information about extension of nucleic acid lesions on DNA and RNA 
viruses, whereas the gel analysis could exclusively provide a qualitative analysis for 
DNA viruses. The quantification of DNA damage would be an additional parameter to 
be taken into account into modelling the virus inactivation kinetics by alcohol and zinc. 
In this project, it was shown that the role of zinc is essential for observed 
virucidal activity and that presence of different chelating agents (see Chapter 3) can 
affect significantly virus inactivation. Besides, it was observed that formulation 
chemistry may change with time and that virucidal activity will tend to decrease with 
long storage periods in dark environment. The chemical speciation of formulation and 
analysis of zinc coordination including the influence of external factors like pH and 
temperature would be important to predict virucidal activity decay and get insightful 
information about biocide limitations. It is recommended that analytical techniques like 
nuclear magnetic resonance (NMR) and direct injection tandem mass spectrometry are 
performed at different stages of formulation preparation.  
Finally, it would be useful to evaluate activity of alcohol/zinc combination 
against a wide range of potential resilient pathogenic microorganisms like bacteria, 
spores and mycobacteria in order to attest for its usage as a suitable standalone 
disinfectant product in healthcare, household or industrial settings. 
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